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The dual nature of reactive oxygen species (ROS) is a widely recognised paradox.  
For many years, mitochondrial ROS were characterised as the main cause of ageing 
and chronic ROS production was documented in many age-related diseases. In 
contrast, recent studies have described ROS as signalling molecules essential for 
maintaining cellular homeostasis.  
 
Further experimentation has revealed that the extent of ROS production, as well as 
the location, can be important in determining the behaviour of ROS. The best 
example is the process known as Reverse Electron Transport (RET). RET is 
associated with a large increase in site-specific ROS production at CI and is 
responsible for stimulating key signalling pathways that control stress adaptation and 
cellular fate. Additionally, the expression of the alternative NADH dehydrogenase, 
Ndi1, which promotes ROS-RET, leads to extension of lifespan in Drosophila 
melanogaster. Exploring ROS-RET signalling may be instrumental in understanding 
the role of ROS in health and disease.  
 
In the following chapters, I investigate the mechanisms behind ROS-RET.  I use ex 
vivo ROS measurements in the brain of Drosophila melanogaster to demonstrate that 
ROS-RET occurs under physiological conditions when flies are exposed to heat 
stress. I describe in detail how manipulation of the electron transport chain affects the 
occurrence of ROS-RET. My results reveal that the entry of electrons through CI and 
CII is essential for ROS-RET to occur. However, blocking the exit of electrons (CIII-
CIV) increases ROS production but not via ROS-RET. Finally I have performed a 
genome-wide RNAi screen, taking advantage of the alternative oxidase (AOX) that 
supresses ROS-RET, where I have found new candidate genes responsible for 
regulating mitochondrial ROS levels. 
 
In summary, I provide evidence of how ROS-RET can be regulated in vivo including 
its physiological stimulation, factors essential for its generation and new genes 
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Chapter 1 Introduction 
 
1.1 Overview of Mitochondria  
Mitochondria are essential cytosolic organelles found in most eukaryotic cells. The 
primary role of mitochondria is the production of energy, in the form of adenosine 
triphosphate (ATP). ATP is popularly known as the cellular ‘energy currency’, as it is 
instrumental in allowing cells to perform all fundamental biological processes. Hence, 
mitochondria are most commonly referred to as the ‘powerhouses of the cell’ and are 
present in all human cell types, except for mature erythrocytes (Cedikova et al., 
2016). Additionally, mitochondria are responsible for other vital cellular functions and 
in the last two decades, have also been shown to participate in cellular signalling 
(Chandel, 2014), as I shall discuss below. The mitochondrial density of a cell varies 
between specific cell types, depending on the total energy demand. For example, 
mitochondria are more abundant in cells that require a continuous supply of energy, 
such as brain and muscle cells, which are metabolically highly active (van der Bliek et 
al., 2017). Most cells heavily rely on the energy that mitochondria generate to 
maintain cellular homeostasis. This includes the brain, the central organ of our 
nervous system, responsible for controlling our basic physiological functions, as well 
as being the centre of our consciousness that makes us human (Stefanatos and 
Sanz, 2018).  
 
Given that mitochondria possess such an integral role in energy production within our 
cells, it is no surprise that the occurrence of mitochondrial dysfunction is associated 
with a wide range of diseases. There are two types of disease related to 
mitochondrial dysfunction, (i) mitochondrial diseases that are a consequence of 
mutations in mitochondrial proteins (Wallace, 1999) and (ii) diseases where 
mitochondrial dysfunction occurs independently of mutations in genes encoding 
mitochondrial proteins (Wallace, 2005). A few examples of the latter group includes; 
diabetes, metabolic syndrome and many neurodegenerative diseases, such as 
Parkinson’s disease (Lane et al., 2015).  In addition, the link between mitochondria 
and ageing is well established and the accumulation of defective mitochondria is one 
of the hallmarks of the ageing process (Lopez-Otin et al., 2013). For these reasons, 
mitochondrial research is at the forefront of current scientific agenda (Picard et al., 
2016). Scientists are focusing on attempting to elucidate the mechanisms behind 
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mitochondrial dysfunction, which could lead to the discovery of future therapeutics 
and solutions to facilitate healthy ageing (Sun et al., 2016) (Cedikova et al., 2016).  
 
  Origins and evolution of mitochondria 
The origin of mitochondria began approximately 1.5 billion years ago, as single 
prokaryotic cells that were engulfed by primordial eukaryotic cells and later became 
dependent on each other, forming a symbiotic relationship (Margulis, 1975). 
Subsequently, the endosymbiont evolved into pleomorphic structures possessing a 
double membrane and their own circular double-stranded DNA, known today as 
mitochondria (Roger et al., 2017). Over the millions of years of evolution, 
mitochondria have retained a small fraction of their genetic system. In humans, 
mitochondria are responsible for encoding 1% of mitochondrial proteins, amounting 
to 37 genes. The mitochondrial DNA encodes 13 core hydrophobic subunits of the 
respiratory chain, along with 22 transfer RNAs (tRNAs) and 2 ribosomal RNAs 
(rRNAs), required for mitochondrial protein synthesis (Anderson et al., 1981). The 
nuclear DNA currently encodes the majority of mitochondrial proteins, as the original 
mitochondrial genes have been transferred over to the nucleus. Mitochondrial 
proteins encoded by the nuclear genome are synthesised in the cytoplasm and then 
imported into mitochondria via specific translocation machinery, involving 
mitochondrial-targeting sequences (Kang et al., 2018). Since the endosymbiotic 
event, mitochondria have evolved into dynamic organelles and developed a range of 
vital cell signalling processes. The close relationship developed over time, between 
mitochondria and the rest of the cell, is crucial for maintaining cellular homeostasis 
(Malina et al., 2018).  
 
 Structure and function of the mitochondria  
The fundamental structure of mitochondria encompasses a double membrane, which 
defines two aqueous compartments (Figure 1.1). Individually, these 4 components 
each have their distinct roles in the production of energy (McCarron et al., 2013). The 
outer mitochondrial membrane (OMM), which resembles eukaryotic membranes in 
function and biochemical composition, separates the contents of the mitochondria 
from the cytosol. It functions in regulating the passage of proteins and small 
molecules in and out of the mitochondria (Crompton, 1999). This is predominantly 
mediated by the Translocase of the outer membrane (TOM) complex, which resides 
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in the OMM and governs the transport of larger polypeptides, through the recognition 
of mitochondrial targeting sequences (Hill et al., 1998) (Endo and Yamano, 2010). 
Also present are a family of porins, which allow smaller (<10 kDa) proteins and ions 
to freely diffuse across the membrane (Weeber et al., 2002). Unlike the OMM, the 
inner mitochondrial membrane (IMM) is only permeable to small-uncharged 
molecules such as oxygen, carbon dioxide and water. In order to complete the 
transport of nascent mitochondrial proteins, the translocase of the inner membrane 
23 (TIM23) family, is present to facilitate the final steps of the TOM complex 
(Wiedemann and Pfanner, 2017). The IMM assists with the generation of energy as it 
accommodates the electron transport chain (ETC), necessary for oxidative 
phosphorylation (OXPHOS). It forms characteristic folds known as cristae, to 
establish a high surface area, thereby increasing the abundance of the respiratory 
chain and the yield of energy production (Cogliati et al., 2016). 
 
Another key component involved in the production of energy is the intermembrane 
space (IMS), formed in-between the OMM and the IMM. Transportation of protons 
across the IMM to the IMS, by respiratory complexes within the ETC, allows the 
creation of an electrochemical proton gradient, which drives ATP synthesis (Berry et 
al., 2018). Due to the permeability of the OMM, the IMS is chemically equivalent to 
the cytoplasm, unlike the mitochondrial matrix, (the second aqueous compartment), 
which is enclosed by the IMM (Mannella et al., 2001). The matrix is a dense 
environment and residence to many enzymes involved in the citric acid cycle (CAC) 
and β-oxidation, as well as the mitochondrial DNA (mtDNA). The CAC results in the 
oxidation of pyruvate and amino acids, whilst β-oxidation predominantly oxidises fatty 
acids. The circular mtDNA found in the mitochondrial matrix is stored into structures 
known as nucleoids. Nucleoids are spherical structures lacking a membrane and 
filled with a protein network, which function to regulate mitochondrial DNA 
transcription and replication and protect the mtDNA from damage (Lee and Han, 
2017). Additionally, the mitochondrial matrix possesses nuclear-encoded ribosomes, 
necessary for the transcription and translation of the mitochondrial proteome (Mai et 
al., 2017). The matrix is also required for the maintenance of the electrochemical 
proton gradient across the IMM. Here, the matrix is kept at a high pH of ~7.8, in 
comparison to the IMS, which is kept at ~7.0-7.4, to make proton translocation into 












Figure 1.1 Diagram of mitochondria 
The complex structural architecture of mitochondria is responsible for the diverse 
array of biological processes that occur within these organelles. One of the major 
processes occurring in mitochondria is OXPHOS, which in many cell types supplies 
most of the cellular ATP (Mookerjee et al., 2017). OXPHOS receives electrons from 
CAC and β-oxidation, two other metabolic processes that occur within the 
mitochondria (Bratic and Trifunovic, 2010). During β-oxidation, fatty acids transported 
into the mitochondrial matrix are oxidised by a 4-step reaction, to ultimately produce 
acetyl-CoA. Acetyl-CoA can then be further oxidised by CAC, leading to the 
production of reducing equivalents, used to feed electrons into the respiratory chain 
(Sajnani et al., 2017). The central role of mitochondria in OXPHOS, CAC and β -
oxidation highlight their importance. However, they also contribute to a wide range of 
other biochemical reactions, for example the ornithine cycle. This process is 
responsible for converting ammonia into urea, in which the first two steps occur within 
the mitochondria. Additionally, mitochondria are also essential for the production of 
iron-sulphur clusters that are involved in electron transfer processes, in the 
mitochondria and other cellular compartments (Lill, 2009). Without mitochondria and 
consequently iron-sulphur clusters, essential cellular processes, such as nuclear 
DNA replication or transcription, cannot occur (Stehling and Lill, 2013).  
 
Mitochondria are also pivotal for maintaining and regulating calcium (Ca2+) 
homeostasis. Ca2+ is sequestered in the mitochondrial matrix and used for signalling 
This diagram highlights the double membrane structure which mitochondria possess (OMM 
(outer mitochondrial membrane) and IMM (inner mitochondrial membrane), giving rise to the 




purposes. The release of Ca2+ from mitochondria can influence different cell survival 
pathways, such as apoptosis and autophagy (Rizzuto et al., 2012). Furthermore, 
mitochondria have also been reported to play a role in numerous signalling pathways 
including growth factor signalling, hypoxic and immune responses and processes of 
cellular differentiation and migration through the production of reactive oxygen 
species (ROS), discussed in detail below (Tait and Green, 2012).  
 
 The electron transport chain (ETC) 
The primary function of mitochondria is the production of energy through the process 
of OXPHOS. In many cell types, this is the primary source of ATP generation, 
covering an approximate 80% of cellular energy demand (Papa et al., 2012). The 
synthesis of ATP requires the intricate arrangement of four individual complexes 
(complex I, II, III, and IV) collectively known as the ETC and the mitochondrial ATP 
synthase (complex V). These five complexes are embedded into the IMM, and each 
possesses its own distinct functions, which co-operatively orchestrate the generation 
of energy (Rutter et al., 2010). The first four complexes (complexes I – IV) participate 
in the step-wise transfer of electrons to the final electron acceptor, which in aerobic 
organisms is oxygen. 
 
Electrons enter the ETC via reducing equivalents from CAC or β-oxidation, such as 
NADH (nicotinamide adenine dinucleotide) and FADH2 (flavin adenine dinucleotide), 
which function to shuttle electrons to complexes I and II (CI and CII), respectively.  
Other sites of electron entry include the glycerol-3-phosphate dehydrogenase 
(G3PDH), which also donates electrons directly to the Coenzyme Q (CoQ) pool 
(Mracek et al., 2013). Additionally, the electron-transferring-flavoprotein 
dehydrogenase (ETF-QO) and dihydroorotate dehydrogenase (DHODH) are also 
involved in the reduction of CoQ. Once electrons are donated to CI and CII, they are 
transferred down the chain to CoQ. Complex III (CIII) then passes the electrons, from 
the CoQ pool, further down the chain to the next electron carrier, cytochrome C (Cyt 
C). From here complex IV (CIV) receives the electrons from Cyt C and passes them 
to oxygen, which acts as a final electron acceptor. These continuous redox reactions 
are also coupled with the transport of protons from the matrix, into the IMS, by three 
of the respiratory complexes (CI, CIII and CIV). The movement of protons across the 
IMM contributes to the production of a proton motive force (pmf), which promotes the 
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fifth complex (CV) to carry out the final reaction of ATP synthesis (Figure 1.2) (Berry 
et al., 2018). 
 
Figure 1.2 Schematic diagram of the ETC. 
 Mitochondrial mobile electron carriers  
Two mobile electron carriers accomplish the transfer of electrons between the ETC 
complexes: CoQ and Cyt C. CoQ is a lipid-soluble cofactor, which resides in the IMM 
and can freely diffuse across the membrane. It accepts electrons from CI and CII, as 
well as the several other mitochondrial dehydrogenases, mentioned previously and 
transfers them onto respiratory CIII (Quinzii and Hirano, 2010). In its oxidised state 
(CoQ, ubiquinone) receives electrons, whereas in its reduced state (CoQH2, 
ubiquinol) it donates electrons. The latter allows CoQ to function as an antioxidant 
within the mitochondria and other cellular compartments (Hernandez-Camacho et al., 
2018). However, under its radical intermediate form (CoQ_., semiubiquinone) it also 
exists as a pro-oxidant. CoQ is involved in a wide range of other cellular pathways 
(Lenaz, 2001), therefore mutations in the genes involved in its synthesis, lead to a 
deficit of CoQ and cause severe mitochondrial disorders (Quinzii and Hirano, 2010). 
The function of CoQ is central for the production of ATP in the mitochondria. Hence, 
it has been proposed to be involved in the detection of metabolic alterations via 
changes in the redox state of the ETC (Guaras et al., 2016). Later, I will discuss how 
changes in the CoQH2:CoQ ratio alter the generation of mitochondrial ROS. 
Diagram displaying the 5 individual complexes involved in OXPHOS. Additionally, it 





The other mobile electron carrier of the ETC is Cyt C that transfers electrons between 
CIII and CIV. Similarly to CoQ, Cyt C is found either oxidised or reduced. Cyt C is a 
central regulator of apoptosis and its release from the mitochondrion, to the cytosol, 
has the potential to trigger cell death (Kluck et al., 1997). It has been proposed that 
only the oxidised form can trigger caspase activation and cell death (Pan et al., 
1999), therefore sensing of the ETC redox state, by Cyt C, can be coupled with the 
regulation of apoptosis. However, other reports indicate that both forms, oxidised and 
reduced, trigger apoptosis (reviewed in (Brown and Borutaite, 2008)). Finally, in 
parallel to CoQ, Cyt C can also act as an antioxidant scavenging superoxide 
(Pasdois et al., 2011), or as a pro-oxidant promoting the formation of superoxide 
(Giorgio et al., 2005).  
 
 Complex I (CI) 
CI, otherwise known as NADH:ubiquinone oxidoreductase, is the first and largest 
component of the ETC. It carries out the oxidation of NADH, receiving two electrons, 
which are subsequently donated to CoQ. Alongside the transfer of electrons, it also 
transports a total of four protons across the IMM to the IMS, contributing to the pmf 
(Figure 1.3) (Rhooms et al., 2019) (Zhu et al., 2016) (Sharma et al., 2009). This multi-
domain respiratory enzyme is composed of 45 subunits, which amounts to a weight 
of 980 kDa. Of these 45 subunits, 7 are encoded by mtDNA, whilst the remainder are 
nuclear-encoded (Wirth et al., 2016). 14 out of the 45 subunits are core subunits, 
which are involved in the transfer of electrons from NADH to CoQ, whereas the rest 
are accessory subunits. A small number of the accessory subunits are assembly 
factors, required for the complete assembly of CI (McKenzie and Ryan, 2010). 
However the role of these subunits is yet to be characterised (Carroll et al., 2006). 
Electron microscopy has revealed that CI occupies an L-shaped structure, where the 
embedded long arm spans the IMM and the short arm protrudes into the 
mitochondrial matrix (Parey et al., 2018) (Sanchez-Caballero et al., 2016). The 
hydrophilic matrix domain of CI is the site of electron donation, where the soluble 
carrier; NADH, binds and catalyses the reduction of a flavin mononucleotide (FMN), 
situated at the top of the complex.  Following oxidation of NADH, the electrons are 
passed through CI via a series of redox reactions, involving 7 subunits containing Fe-
S clusters. This transfer of electrons occurs until they reach the ubiquinone-binding 
site (IQ), located near the hydrophobic membrane-bound domain. The binding of CoQ 
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at this site allows the complete transfer of electrons and subsequent reduction of 
CoQ to CoQH2 (Parey et al., 2018) (Murphy, 2009). The traditional CI chemical 
inhibitors, rotenone and piericidin A, are both able to target and prevent the binding 
of CoQ to CI (Parey et al., 2018) (Sharma et al., 2009). Accompanying the electron 
transfer through the hydrophilic region is the transport of protons to the IMS, 
occurring within the hydrophobic domain of CI. Within the hydrophobic arm, there are 
7 core mtDNA encoded subunits, which all participate in the translocation of protons 
across the IMM (Brandt et al., 2003). It has been proposed that the energy produced, 
as a result of the redox reactions during electron transfer, is able to power a 
conformational change in the hydrophobic domain, allowing the passage of protons 
(Sazanov, 2014). CI can be sectioned into three different zones based on their 
distinct activities. The first is the N module, which partakes in the electron flow 
through CI, starting at the FMN site. The second is the Q module, involving the 
ubiquinone-binding site where the reduction of CoQ occurs. The final module, which 
regulates the movement of protons across the membrane, is defined as the P module 











Figure 1.3 Diagram displaying the structure of Complex I. 
 Complex II (CII) 
The second member of the ETC, CII, is the enzyme succinate dehydrogenase (SDH). 
CII is by far the simplest of the respiratory complexes, formed by four subunits 
Electrons from NADH are transferred to the IF site of CI and are passed through the complex 
to the IQ site, indicated by the dotted line). At the IQ site ubiquinone binds and accepts the 






(SDHA, SDHB, SDHC and SDHD), all of which are nuclear-encoded. It is anchored 
into the IMM by the two smaller subunits, SDHC and SDHD. The remaining two 
peripheral subunits, SDHA and SDHB, are situated in the mitochondrial matrix 
(Cecchini, 2003) (Bowman and Birch-Machin, 2016).  SDH possesses a dual 
functionality, as it is the only complex involved in both OXPHOS and CAC. Its 
functional role is catalysing the oxidation of the small metabolite succinate, an 
intermediate from the CAC, into fumarate (Cecchini, 2003). This reaction releases 
two electrons, which are then donated to the CoQ pool. Since this complex does not 
participate in the movement of protons to the IMS, it does not contribute to the pmf. 
The overall mechanism of CII begins with the reduction of covalently bonded FAD 
group, associated with subunit SDHA. From here, the electrons are sequentially 
passed through subunit SDHB, via three integral Fe-S clusters ([2Fe-2S], [4Fe-4S] 
and [3Fe-4S]). The final transfer of electrons occurs when CoQ binds to the 
membrane-bound domain of CII, forming CoQH2 (Figure 1.4) (Rutter et al., 2010). CII 
inhibitors are categorized under two distinct classes, dependent on their targeted 
binding site. These include either the succinate-binding site or the ubiquinone-binding 
site of CII. A highly recognised inhibitor of CII, is malonate, which competes with 










Figure 1.4 Diagram displaying the structure of Complex II. 
 
 Complex III (CIII) 
Coenzyme Q:cytochrome c oxidoreductase also referred to as bc1 complex or CIII is 
the third respiratory enzyme in the ETC. It continues the flow of electrons down the 
Succinate is oxidised to form fumarate and electrons are passed through CII via 3 Fe-S 
clusters, indicated by the dotted line, until being passed to ubiquinone. 
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chain, by oxidising CoQH2 and subsequently reducing Cyt C, through the transfer of 
two electrons. In parallel to electron transfer, it also transports four protons across 
the membrane, contributing to generate the pmf (Xia et al., 2013). In total, there are 
11 subunits that constitute a fully assembled dimeric CIII, one of which is encoded by 
mtDNA (Murphy, 2009). Three of the subunits form a catalytic core, namely 
cytochrome c1, cytochrome b and the Rieske iron-sulphur protein. The redox 
reactions are achieved via the presence of haem groups within the cytochrome c1 
and b subunits as well as the [2Fe-2S] cluster within the Rieske protein. Additionally, 
CIII possesses two quinone (Q) binding sites, Qo and Qi, which are instrumental for 
the movement of electrons and protons through the complex (Crofts, 2004). The Qo 
site is situated towards the IMS and is responsible for accepting electrons from 
CoQH2, in addition to the translocation of four protons into the IMS. The Qi site is 
orientated towards the matrix side of the membrane, where it acquires two protons 
from the matrix and two electrons to reduce CoQ. The movement of electrons and 
protons throughout CIII, relies on the completion of the Q cycle, involving the two 
mentioned Q sites. The electron transfer within CIII is split into two steps, therefore 
the whole process and complete reduction of Cyt C, requires two rounds of the Q 
cycle (Xia et al., 2013). The cycle proceeds with the binding of CoQ to the Qo site, 
which subsequently gains two electrons and two protons. From here, the 2 electrons 
are passed through two distinct pathways, whilst the two protons are shuttled directly 
to the IMS. The first electron is transferred to the Rieske iron-sulphur cluster and then 
sequentially passed to the haem group in cytochrome c1 (cyt c1). Cyt C present in 
the membrane is then able to bind to cyt c1 within CIII and receive this electron, 
becoming partially reduced. In this same cycle, the second electron obtained from 
CoQH2, is passed down to two haem groups of cytochrome b, cytochrome bL and 
cytochrome bH. At the Qi site, a bound CoQ accepts this electron along with a proton 
retrieved from the matrix, to become partially reduced. This cycle is then repeated 
once more to allow the complete oxidation of CoQ at the Qo site, as well as the full 
reduction of both Cyt C and CoQ (at the Qi site) (Larosa and Remacle, 2018). This 
process transports a total of four protons to the IMS, as well as removing two 
additional protons from the matrix, therefore CIII is able to greatly contribute to the 
pmf (Crofts, 2004). The most recognised inhibitors of CIII are antimycin A, 
myxothiazol and stigmatellin. Antimycin A targets the Qi site of CIII (Murphy, 2009), 












Figure 1.5 Diagram displaying the structure of Complex III. 
 Complex IV (CIV) 
CIV, also known as cytochrome c oxidase, is the final enzyme involved in the 
transport of electrons within the ETC. Its role is to catalyse the oxidation of Cyt C, 
transferring the electrons to the final electron acceptor oxygen and terminating the 
flow of electrons. It is also the third complex where electron transport is coupled with 
proton translocation across the IMM to the IMS. Mammalian CIV is composed of 13 
subunits, in which the three largest (COX I, COX II and COX III) are encoded by 
mtDNA (Timon-Gomez et al., 2018). CIV exists as an active dimer embedded into the 
membrane and consists of 3 distinct regions, I, II and III (Li et al., 2006). I and II are 
involved in coordinating the redox reactions carried out by CIV, whilst region III 
stabilises the structure. The electron transfer reactions are achieved by the presence 
of metal centres, in the catalytic site of the enzyme.  Within region I resides a haem 
group, haem a, as well as a binuclear centre formed by haem a3 and the copper 
centre, CuB. Incorporated into region II is another copper centre referred to as CuA 
(Shimada et al., 2017). The first step in the mechanism of CIV is the interaction 
between reduced Cyt C and the CuA centre of region II. Here the transfer of 
electrons occurs from the haem group within Cyt c to the prosthetic copper centre. 
CuA then shuttles the electrons through the two haem groups of region I, reaching 
the second copper centre, CuB. The binuclear centre is the site of water formation 
where molecular oxygen (O2) is split into 2 monooxygen and reduced. The complete 
Ubiquinone binds to the Qo site of CIII and transfers 2 electrons. The first electron is passed 
through CIII until it reaches the cyt c1 and is sequentially transferred to Cyt c. The second 
electron is passed onto the Qi site of CIII, which is then used to reduce ubiquinol. The complete 




reaction requires 4 Cyt C molecules to donate four electrons to O2, along with four 
protons retrieved from the matrix. The overall reaction catalysed by CIV is:  
     
O2 + 4e- + 4H+ ➔ 2H2O 
 
Additionally, a further four protons are transported into the IMS from the matrix 
(Figure 1.6) (Kim et al., 2009). Inhibitors of CIV, such as cyanide (CN), carbon 
monoxide (CO), nitric oxide (NO) and hydrogen sulphide (H2S) all target the oxygen-











Figure 1.6 Diagram displaying the structure of Complex IV.  
 
 The Chemiosmosis Theory 
In the 1960’s Peter Mitchell proposed the chemiosmosis theory, describing the 
mechanism of how ATP is produced within the mitochondria (Mitchell, 1961). Today 
this theory is widely accepted and explains the molecular mechanisms that drive 
OXPHOS. The theory states that an established electrochemical proton gradient 
across the IMM, acts as stored energy that can drive the synthesis of ATP. The pmf 
is generated through the translocation of protons across the membrane, leading to a 
positively charged IMS. As previously discussed, the production of this proton 
gradient is coupled to electron transfer and accomplished by three components of the 
ETC, CI, CIII and CIV. The movement of protons down the gradient, into the matrix, 
Cyt C binds and transfers electrons to CIV. Electrons are passed through the complex via two 
copper centres (indicated by the dotted line), until reaching the final electron acceptor, O2, to 




creates an energy potential, which is then harnessed, by the enzyme ATP synthase, 
to catalyse the phosphorylation reaction and synthesise ATP (Morelli et al., 2019).  
 
The electrochemical proton gradient is used to generate the pmf that is required for 
the production of energy, by mitochondria. The pmf is produced with the energy 
released from transferring electrons between the four respiratory complexes, as 
described in detail below. Pmf has two components, namely, the mitochondrial 
membrane potential and the pH gradient (Brand and Nicholls, 2011). Changes to the 
pmf can affect all the other cellular processes, where the mitochondrion is involved, 
for example, redox and calcium homeostasis, proteostasis and metabolic reactions. 
Thus, the pmf has a strong influence on the signalling occurring between the 
mitochondria and the rest of the cell (Berry et al., 2018).  
 
 ATP Synthase  
ATP Synthase, otherwise known as CV, is the fifth complex involved in OXPHOS. It 
is an IMM proton pump that catalyses the synthesis of ATP from ADP and inorganic 
phosphate (Pi). CV consists of 15 subunits, which are arranged into two central 
domains, F0 and F1 (Walker, 2013), (Neupane et al., 2019). The F0 domain occupies 
a hydrophobic ring-like structure, bound to the IMM and is comprised of 
approximately 8 identical subunits, called the c subunit. The F1 region extends 
outwards into the mitochondrial matrix and is assembled by 5 subunits, α, β, γ, δ and 
ε. Nearest to the membrane is the primary stalk formed by the subunits γ, δ and ε, 
which are attached to a hexamer of 3 alternating α and β subunits. Also attached is 
the peripheral stalk which connects the F0 and F1 domains and is comprised of 
subunits a, b, d, F6 and oligomycin sensitivity-conferring protein (OSCP) as well as 
the accessory subunits e, f, g and A6L (Figure 1.7) (Jonckheere et al., 2012). The 
role of the F0 domain is to pump protons through the complex, whilst the F1 domain 
forms the catalytic head, where the ATP synthesis occurs. CV is able to synthesise 
ATP by harnessing energy from the electrochemical proton gradient. The energy 
released from this gradient, fuels the rotation of CV and catalyses the production of 
energy (Stock et al., 1999). The first step in the mechanism of CV, is the passing of 
protons through subunit c, of the membrane bound region, which deposits the 
protons into the mitochondrial matrix. The movement of these protons causes the F0 
domain of CV to rotate 120°.  This rotation stimulates the rotary mechanism of the 
central stalk, specifically the γ subunit, which induces conformational changes within 
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the catalytic region of F1. Within the 3α3β hexamer, three catalytic sites bind the 
substrate (ADP and Pi) and through a series of three conformational changes (open, 
loose and tight), ATP is released (Figure 1.7) (Stock et al., 1999) (Senior et al., 
2002). A well-studied inhibitor of CV is the antibiotic oligomycin, which binds to the F0 
region, therefore preventing the passage of protons through the enzyme, 













Figure 1.7 Diagram displaying the structure of ATP Synthase. 
 Alternative respiratory enzymes; AOX and Ndi1  
In addition to the five basic respiratory complexes of the OXPHOS system, seen in 
mammalian mitochondria, many organisms such as plants, fungi and bacteria, also 
express alternative respiratory enzymes (McDonald, 2009) (Saari et al., 2019). 
Alternative enzymes can also be found in animals, including some chordates such as 
Ciona intestinalis but not in humans or flies (McDonald et al., 2009) (McDonald and 
Gospodaryov, 2019). The expression of these alternative respiratory systems, in the 
aforementioned organisms, evolved as a survival response to toxins present in the 
surrounding environment that targeted the ETC (McDonald et al., 2009) (McDonald 
and Gospodaryov, 2019). Alternative enzymes function to bypass interrupted 
electron flow that may have occurred as a result of damage to the standard ETC 
The membrane bound region, F0 and peripheral region, F1 are outlined. Protons move from the 
IMS through the c subunit of CV into the matrix, indicated by the dotted line. The movement of 
protons causes a rotary motion the catalytic head, consisting of α and β subunits, which 




components, or environmental stresses that inhibit CI, CIII or CIV (Saari et al., 2019). 
Therefore this evolutionary trait, of possessing alternative respiratory enzymes, 
protects mitochondria from dysfunction, by overcoming the stress of limited electron 
flow. This protective mechanism allows the maintenance of mitochondrial energy 
production (Saari et al., 2019), as well as the maintenance of mitochondrial 
processes coupled with OXPHOS, such as synthesis of Fe-S clusters or nucleotides 
and one-carbon metabolism reactions (Schiff et al., 2012). For unknown reasons, 
alternative respiratory enzymes became redundant in most animals, (including 
humans and flies), during evolution and therefore have been removed from their 
genomes (McDonald et al., 2009) (McDonald and Gospodaryov, 2019).  
 
There are two classes of alternative respiratory enzymes, the alternative NADH 
dehydrogenases and the alternative oxidases, which all possess the ability to recover 
electron flow at specific points of the ETC. Most organisms possess both types of 
enzymes at the same time (McDonald and Gospodaryov, 2019). However, unlike the 
standard respiratory complexes, they do not pump protons into the IMS and therefore 
do not contribute to the pmf, directly. Thus, these alternative respiratory systems 
cannot fully restore ATP synthesis. Another characteristic feature is their structural 
simplicity consisting of a single polypeptide, encoded by the nuclear genome, in 
contrast to the complex multi-subunit structures that form the standard ETC 
components. This contributes to their quick and easy assembly, with less opportunity 
of becoming damaged (Saari et al., 2019). 
 
The Alternative Oxidase (AOX), found in plant and fungi mitochondria, is able to 
reduce O2 to water through the direct transfer of electrons from CoQ, thus bypassing 
CIII and CIV.  AOX is a small integral dimeric polypeptide, bound to the matrix facing 
side of the IMM, where it is activated by accumulation of CAC intermediates and a 
highly reduced CoQ pool (Figure 1.8) (Vanlerberghe, 2013) (Fernandez-Ayala et al., 
2009). Upon activation, a conformational change within its structure elevates its 
affinity for CoQH2, beyond that of CIII. Due to its alternative pathway of electron flow, 
independently of CIII and CIV, AOX also confers cyanide resistance (Hakkaart et al., 
2006). To take advantage of these systems, scientists have been able to express 
AOX in the mitochondria of higher eukaryotes, mainly from the tunicate Ciona 
intestinalis (Hakkaart et al., 2006) but also from the fungus Aspergillus nidulans 
(Perales-Clemente et al., 2008). In mammalian cells and Drosophila melanogaster, 
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the co-expression of AOX was shown to partially rescue the lethal phenotype caused 
by knocking down CIII/CIV subunits or inhibiting CIII/CIV with antimycin and cyanide, 
respectively (Rajendran et al., 2019) (Dogan et al., 2018) (Szibor et al., 2017) (Sanz 
et al., 2010a) (Kemppainen et al., 2014) (Fernandez-Ayala et al., 2009). In addition, 
AOX has been described to rescue pathological phenotypes that are not caused by 
CIII or CIV inhibition, in Drosophila melanogaster. A non-extensive list includes: (i) 
mutations in the antioxidant gene, dj-1β (Fernandez-Ayala et al., 2009), (ii) knock 
down of the catalytic subunit of the mtDNA polymerase (Humphrey et al., 2012), (iii) 
accumulation of β-amyloid protein in the fly brain (El-Khoury et al., 2016) or (iv) 
disruption of Jun N-terminal kinase signalling during development (Andjelkovic et al., 
2018). All of these phenotypes are associated with elevated levels of ROS and/or 
oxidative stress. AOX is a powerful tool to reduce mitochondrial ROS levels when 
ectopically expressed in mammals and insects, which I will discuss in detail later in 
this thesis.  
 
The second class of alternative respiratory enzymes is the alternative NADH 
dehydrogenases.  Examples that belong to this group are the NADH dehydrogenase 
internal 1 (Ndi1), NADH dehydrogenase external 1 (Nde1) and the NADH 
dehydrogenase external 2 (Nde2).  This class of rotenone-insensitive enzymes 
transfers electrons directly to the CoQ pool through the oxidation of NADH, 
subsequently bypassing CI (Matus-Ortega et al., 2015).  Ndi1 is found in plants, fungi 
and the mitochondria of some animals (Gospodaryov et al., 2014), embedded into 
the IMM, facing the matrix (Figure 1.8) (Bahadorani et al., 2010). In some species of 
fungi such as Saccharomyces cerevisiae, CI has been completely lost during 
evolution and Ndi1 is the only NADH dehydrogenase located in the mitochondrial 
matrix (Yagi et al., 2006).  In parallel to AOX, Ndi1 (from Saccharomyces cerevisiae, 
Ciona intestinalis and Aspergillus nidulans) has been inserted into the genome and 
subsequently expressed in the mitochondria, of mouse and human cells, as well as 
flies (Yagi et al., 2006) (Gospodaryov et al., 2014) (Perales-Clemente et al., 2008). 
Ndi1 expression confers resistance to CI inhibitors (e.g. rotenone or metformin), in 
mammalian cells and fruit flies (Seo et al., 1998) (Seo et al., 2004), as well as 
rescuing the lethal phenotype caused by the knockdown of CI subunits (Bai et al., 
2001) (Park et al., 2007) (Marella et al., 2010) (Cho et al., 2012) (Wheaton et al., 
2014). The therapeutic use of Ndi1 has been strongly explored in models of 
Parkinson’s disease, since CI dysfunction is one of the hallmarks of this disease 
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(Schapira et al., 1990). In fact, Ndi1 has been shown to rescue fly and mouse models 
of Parkinson’s disease (Seo et al., 2006) (Barber-Singh et al., 2009) (Sanz et al., 
2010b) (Vilain et al., 2012). Finally, expression of Ndi1 either from Saccharomyces 
cerevisiae or Ciona intestinalis, has been shown to extend lifespan in fruit flies 




Figure 1.8 Schematic diagram showing the expression of alternative respiratory 
enzymes, Ndi1 and AOX. 
1.2 Reactive Oxygen Species (ROS) 
Free radicals are atoms or molecules with one or more unpaired electrons, rendering 
them highly unstable. As a result of this instability, they are able to take single 
electrons from molecules around them. When produced within biological systems, 
free radicals can cause injury, known as oxidative damage (Pamplona and Barja, 
2007). The most common free radicals found in cells are derived from O2 and known 
as reactive oxygen species (ROS). Another group derived from nitrogen, referred to 
as reactive nitrogen species (RNS) and reviewed in (Pacher et al., 2007), are also 
abundant. However, during this thesis, I focus primarily on ROS. O2 is an oxidant due 
to the presence of two unpaired electrons with parallel spins in its external orbital 
(Magder, 2006); therefore, O2 accepts electrons one at a time. The incomplete 
Ndi1 and AOX are both expressed within the matrix facing side of the IMM. Ndi1 directly 
reduces NADH to NAD+ and transfers electrons to the CoQ, thereby bypassing CI. AOX takes 




reduction of O2 mainly occurs during processes consisting of univalent electron 
transfer, such as OXPHOS (Barja, 1999). Accordingly, ROS are formed when O2 is 
incompletely reduced with 1, 2 or 3 electrons. ROS represent a large group of 
molecules, all possessing different stabilities and half-lives. Examples of ROS include 
the free radicals: superoxide anion (O2•−), hydroxyl radical (OH•−), singlet oxygen 
(1O2) and hydroperoxyl radical (HO2•). However, not all ROS are free radicals such as 
the non-radical entity hydrogen peroxide (H2O2) (Lambert and Brand, 2009).  
 
ROS are abundantly generated by mitochondria, however, they are also produced in 
large amounts in other cellular compartments, such as peroxisomes and cytosol, 
discussed in detail below. It has been well established that cells require a basal level 
of ROS, acting as signalling messengers, to maintain cellular homeostasis (Murphy, 
2009). Endogenous antioxidants scavenge the excess ROS and detoxify them into 
less reactive products. When ROS overwhelm the antioxidant defence mechanisms 
and start to deviate from the optimum cellular levels, they can inflict damage onto 
their nearby surroundings (Hekimi et al., 2011). Here they react with other 
components of the cell, resulting in oxidative damage to proteins, DNA and lipids 
(Ray et al., 2012). In recent years, there has been a rise in research behind the 
mechanisms of ROS production and the delicate balance between their beneficial or 
destructive behaviour. 
 
There are numerous types of ROS that can be produced, however, in this section, I 
will focus on discussing the three most common forms of ROS produced, as a result 
of electrons leaking from the ETC (Scialo et al., 2013). These specifically include 
superoxide, hydrogen peroxide and hydroxyl radical.  
 
The most common type of ROS, produced by the ETC (Esterhazy et al., 2008), is 
superoxide (O2-.), which is generated during the univalent reduction of oxygen:  
 
O2 + e- ➔ O2- 
 
This reaction is the first to yield ROS, in the form of superoxide, which can 
subsequently be converted into a variety of other oxidative molecules, via a cascade 
of downstream chemical reactions. Superoxide is highly reactive, due to the 
presence of an unpaired electron and consequently has a short half-life (Esterhazy et 
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al., 2008). This form of ROS is able to react with the Fe-S and modify cysteine 
groups, within proteins. Superoxide on its own can non-enzymatically dismutate into 
H2O2 (Paulsen and Carroll, 2010). However, this is a very slow process therefore, 
cells have evolved specialised antioxidant enzymes, belonging to the family of 
superoxide dismutases (SOD), which specifically target superoxide. SOD converts 
superoxide into the less reactive H2O2 by the following reaction:  
 
                               SOD 
2O2- + 2H+ ➔ H2O2 + O2 
 
The activity of SOD is highly efficient (due to its low Km for superoxide) and 
scavenges free superoxide, almost immediately (Sheng et al., 2014) at a rate of ~109 
M−1s−1 compared to the spontaneous dismutation of superoxide (~105 M−1s−1).  
 
Hydrogen peroxide (H2O2) is produced when O2 receives two electrons. Given that 
H2O2 is not a free radical, it is more stable and possesses a longer half-life (~1 ms), 
in comparison to superoxide (Bak and Weerapana, 2015). H2O2 is considered to be 
the most abundant cellular ROS (Bienert et al., 2006). Due to its stability and neutral 
charge, it can move between cellular compartments and interact with biomolecules 
far away from its site of production (Lee et al., 2011). H2O2 is the product of a 
dismutase reaction involving two molecules of superoxide, which is usually achieved 
by the activity of SOD (Wang et al., 2018). There are three families of antioxidants 
responsible for metabolising H2O2, namely catalases, glutathione peroxidases and 
peroxiredoxins, which catalyse the following reaction; 
          
2H2O2 ➔ 2H2O + O2 
 
The hydroxyl radical (OH) is produced when O2 is incompletely reduced with three 
electrons. It is the most reactive form of ROS and for this reason, is considered the 
most toxic. The reactivity of the hydroxyl radical is so high and unpredictable that 
there is no enzymatic antioxidant dedicated to its detoxification, in contrast to 
superoxide or H2O2 (Scialo et al., 2013). Unlike superoxide and H2O2, it can directly 
interact with DNA, inflicting damage, which subsequently leads to DNA mutations. 
The hydroxyl radical is produced via a two-step reaction involving the encounter of 
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both superoxide and H2O2. These reactions are known as the Haber-Weiss and 
Fenton reactions, which utilise ferrous ions as a metal catalyst (Lipinski, 2011).  
 
Fe3+ + O2-  ➔  Fe2+ + O2 
Fe2+ + H2O2 ➔  Fe3+ + -OH + OH 
O2- + H2O2 ➔ OH + -OH + O2 
 
 Antioxidants  
Antioxidants include a wide range of systems dedicated to the removal of oxidants 
from cells and exist as either enzymes or non-enzymatic organic molecules. Cells 
have specialised enzymatic systems dedicated to maintaining ROS at non-toxic 
levels. In 1969, McCord and Fridovich discovered the first enzymatic antioxidant 
dedicated to detoxifying superoxide in cells, called SOD (McCord and Fridovich, 
1969). This was a historical discovery as it confirmed the production of superoxide in 
vivo and prompted the development of the Free Radical Theory of Ageing, proposed 
by Denman Harman (Harman, 1956). The term antioxidant covers a broad range of 
enzymes and molecules; however in this section I will focus on the enzymes involved 
in the specific detoxification of superoxide and H2O2.  
 
As previously mentioned, SOD is involved in the dismutation of superoxide into H2O2 
and O2. There are three distinct isoforms of mammalian SOD, which differ according 
to their roles, metal association and subcellular location. (Hayyan et al., 2016). The 
first is SOD1 (CuZnSOD), which is in charge of managing cytosolic superoxide 
levels. The second is the manganese-containing SOD2, found exclusively within 
mitochondria. The final SOD, better known as ECSOD, which is also associated with 
Cu and Zn ions, is localised to the extracellular matrix to protect surrounding tissues 
from high levels of superoxide (Sheng et al., 2014). 
 
Detoxification of H2O2 into innate water molecules can occur via three different 
families of enzymes (reviewed in (Veal et al., 2007)). The first is catalase, 
predominantly situated in the peroxisomes, whose activity results in the conversion of 
H2O2 into water and O2. In addition, there are two other major families of enzymes, 
which participate in the degradation of H2O2, including glutathione peroxidases and 
peroxiredoxins. These enzymes are located in the cytosol, mitochondria and other 
cytosolic compartments, such as nuclei, according to their specific isoforms. The 
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glutathione peroxidases require the presence of 2 reduced glutathione (GSH) 
molecules (Mailloux, 2018). This reaction involves the reduction of H2O2 forming a 
glutathione disulphide (GSSG) and water (Handy and Loscalzo, 2012). The reduction 
of GSSG, to restore the pools of GSH and continue the detoxification of H2O2, is 
catalysed by glutathione reductase, which acquires electrons from NADPH to 
complete the reaction (Mailloux, 2018). The peroxiredoxins, use a similar mechanism 
to glutathione peroxidase, where the reduction of H2O2 occurs in the presence of 
another co-substrate, thioredoxin 2 (Trx2) (Handy and Loscalzo, 2012). Within the 
active site of peroxiredoxins are 2 conserved cysteine residues, which are 
responsible for the reduction of H2O2. Following the degradation of H2O2 the oxidised 
cysteine residue forms an intermolecular disulphide bridge, with the second cysteine 
residue. Trx2 then sequentially restores the reductive state of peroxiredoxins. Trx2 
can then be reactivated by thioredoxin reductase, using the reductive properties of 
NADPH. It has been widely established that peroxiredoxins are the major family of 
enzymes involved in the detoxification of H2O2 (Mailloux, 2018). In addition to the 
removal of H2O2, glutathione peroxidases are also implicated in the detoxification of 
lipid peroxides (Ursini and Bindoli, 1987).  
 
 Oxidative stress 
The accumulation of ROS in cells is associated with the damage to proteins, DNA, 
and lipid membranes (Pamplona and Barja, 2007). As previously discussed, cells 
have evolved antioxidant systems whose primary function is to prevent oxidative 
damage (Pamplona and Costantini, 2011). However, when antioxidants become 
overwhelmed with high levels of oxidants, oxidative stress occurs. If it is not 
controlled, oxidative stress will inflict oxidative damage that may cause permanent 
molecular damage (Sies, 1997). Accumulation of oxidative damage has been shown 
during ageing (Forster et al., 1996) (Gan et al., 2012) (Akila et al., 2007) and in many 
degenerative diseases (D'Amico et al., 2013) (Navarro et al., 2009) (Du et al., 2009). 
It is clear that oxidative stress is deleterious and happens during ageing, as well as 
age-related diseases but it remains to be established whether it is a cause or a 
consequence. Here, I will focus on the damage that can be instigated by superoxide, 
H2O2  and hydroxyl radical.  
 
Superoxide cannot directly damage proteins, but it can attack Fe-S clusters, which 
results in the release of iron and H2O2, as well as disruption of protein activity 
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(Esposito et al., 2013). Therefore the attack of Fe-S by superoxide can result in the 
generation of hydroxyl radicals, via Fenton reactions, which accelerate oxidative 
damage. Ageing and age-related diseases are characterised by an increase in ROS 
levels (both superoxide and H2O2), free iron and oxidative damage (Massie et al., 
1985) (Massie et al., 1983) (Hofer et al., 2008) (Forster et al., 1996) (Gan et al., 
2012) (Akila et al., 2007) (Seo et al., 2008). It is possible to speculate that the age-
related increase in superoxide causes the release of iron. Increased iron levels, 
together with accumulation of superoxide and H2O2, would produce the hydroxyl 
radical, which in turn would initiate the oxidative damage, observed in old individuals. 
Supporting the former hypothesis, are the observations from feeding an enriched iron 
diet to Caenorhabditis elegans, which increased oxidative stress (Valentini et al., 
2012). Furthermore, in a Drosophila model of Alzheimer’s disease, chelating free iron 
or reducing ROS levels restored lifespan to normal (Rival et al., 2009), which further 
supports the role of iron and hydroxyl radical in triggering oxidative stress. 
 
ROS with high reactivity, such as hydroxyl radical and peroxynitrite, are able to attack 
any biological molecule, of the cell. These specific types of ROS can react with lipid 
membranes, initiating lipid peroxidation (Bielski et al., 1983). Polyunsaturated fatty 
acids (PUFAs), within membranes, are particularly sensitive to oxidative attack, due 
to the presence of structural double bonds (Pamplona et al., 1996). Lipid peroxidation 
has two main characteristics; first of all, it operates as a chain reaction where 
oxidised fatty acids perform electrophilic attacks on non-oxidised fatty acids to take 
their electrons, causing the oxidation of the attacked fatty acids. Secondly, reactive 
carbonyl species (RCS) are generated as by-products of lipid peroxidation. These 
RCS can spread oxidative damage long distances from their site of generation 
(reviewed in (Pamplona, 2011). Lipid peroxidation is stopped by the presence of fat-
soluble antioxidants such as vitamin E (Wang and Quinn, 2000) or the neutralisation 
of lipid hydroperoxides, by glutathione peroxidases (Ursini and Bindoli, 1987).  
 
The most harmful consequence of ROS is damage inflicted onto DNA. This is due to 
the fact that DNA contains the information needed to synthesise all cellular 
components and cannot be replaced, once it is irreversibly damaged (Sanz et al., 
2006). In vitro, hydroxyl radical, peroxynitrite and other highly reactive free radicals, 
can attack DNA directly and cause different lesions including: single- and double-
strand breaks, point mutations and deletions. mtDNA has been proposed to be 
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particularly vulnerable to oxidative damage due to its proximity to the ETC, which is 
supported by data demonstrating that levels of oxidative damage detected in mtDNA, 
are higher than in nuclear DNA (Richter et al., 1988). Similarly, mtDNA accumulates 
mutations at a higher rate in comparison to nuclear DNA (Ladoukakis and Zouros, 
2017).  Mutations in mtDNA increase during ageing and have been linked to the 
onset of ageing and age-related diseases (Greaves et al., 2012) (Su et al., 2018). 
However, some studies indicate that mutations in mitochondria are not caused by 
oxidative damage but by errors during replication and subsequent clonal expansion 
(Larsson, 2010) (Lefevre-Borg et al., 1988) (Kauppila et al., 2018).  
 
Free radicals can inflict damage to proteins in a heterogeneous manner (reviewed in 
(Stadtman, 2006) (Stadtman and Levine, 2003)). For example, oxidative damage can 
affect the whole protein (e.g. protein fragmentation and cross-linking with other 
proteins) or specific amino acids. As I have discussed above, proteins containing Fe-
S clusters are particularly sensitive to oxidative attack by superoxide (Imlay, 2006). 
Additionally, cysteine and methionine are the two amino acids more prone to 
oxidative modifications (Stadtman et al., 2003) (Held and Gibson, 2012). These 
modifications can be either irreversible or reversible. Irreversible oxidation reactions 
include the carbonylation of several amino acid residues, nitration of tyrosine 
residues and the over-oxidation of cysteine forming sulfinic and sulfonic acids, all of 
which have been implicated in oxidative damage (Cai and Yan, 2013). Overall, 
ageing is characterized by the accumulation of oxidised proteins (Forster et al., 
1996), which can be caused either by the increase in oxidative stress associated with 
ageing or by an age-related decline in the mechanisms of protein quality control 
(Sohal and Weindruch, 1996) (Higuchi-Sanabria et al., 2018).   
 
 ROS as signalling molecules 
Over the past decade, the role of ROS as cellular signalling messengers has been 
under a lot of scrutiny, within the scientific community (Holmstrom and Finkel, 2014). 
In light of the overwhelming amount of evidence that exists today, ROS are now 
widely recognised as redox signalling molecules that can orchestrate multiple 
different signalling pathways, essential for maintaining cellular health and viability.  
 
The general mechanism of signal transduction is through ROS-mediated redox 
reactions, with key cysteine residues (Ray et al., 2012). Both superoxide and H2O2 
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can react with the thiol groups of cysteine, to induce oxidative modifications. Cysteine 
residues are highly conserved and account for only 2% of amino acid content (Bak 
and Weerapana, 2015). In addition, they are the only amino acid to possess a thiol 
functional group; collectively making cysteine residues unique and effective for signal 
transduction (Kettenhofen and Wood, 2010).  Oxidative modifications to the thiol 
groups within cysteine residues can induce structural changes, which alters protein 
activity. As previously mentioned, these cysteine oxidation reactions can be either 
irreversible, where they are predominantly associated with damage, or reversible, 
where they are involved in redox signalling. Reversible modifications of the cysteine 
residues can include S-sulfenation, S-nitrosylation, S-glutathionylation and disulphide 
bond formation. These redox-related modifications can alter the catalytic activity and 
function of the protein, to initiate specific signalling pathways, within the cell, 
discussed in detail below (Paulsen and Carroll, 2010). 
 
S-sulfenation of cysteine residues yields the formation of the sulfenic acid. Following 
this reaction, sulfenic acid can then be oxidised further to produce more stable forms 
of oxidative modifications, both reversible (i.e. S-glutathione) and irreversible (i.e. 
sulfinic and sulfonic acid). Thus, the formation of sulfenic acid can lead to divergent 
downstream consequences (Poole et al., 2004). S-sulfenation is mostly achieved 
through the interaction with H2O2, however, can also occur through oxidation with 
peroxynitrite and other forms of ROS (Cai and Yan, 2013). This form of cysteine 
oxidation has been associated with numerous signalling pathways, involving the 
activity of various proteins and transcriptions factors, such as Fos and Jun (activator 
protein-1) (Claiborne et al., 1999), as well as Nf-ĸB (Pineda-Molina et al., 2001). For 
example, some studies have reported that the formation of sulfenic acid within aldose 
reductase, provides protection against cardiac ischemia reperfusion in rats 
(Kaiserova et al., 2006). In addition, S-sulfenation is needed for the initiation of T-cell 
growth and proliferation (Michalek et al., 2007). Protein S-nitrosylation is carried out 
by RNS, such as NO and peroxynitrite. This modification can occur on tyrosine, 
serine and threonine residues, as well as cysteine residues. There is evidence that 
S-nitrosylation can provide cardio-protection during ischemia reperfusion (Murphy et 
al., 2012) (Sun et al., 2007). However, the excessive nitrosylation of specific proteins 
has also been observed in multiple diseases, such as neurodegenerative disorders 
and cardiovascular disorders (reviewed in (Foster et al., 2009)). S-glutathionylation 
occurs as a result of ROS and RNS, during oxidative stress. It can also be achieved 
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by the endogenous antioxidant glutathione, under low GSH/GSSG ratios. This form 
of modification leads to a mixed disulphide bond and can protect proteins from 
downstream irreversible oxidative modifications, to form sulfinic and sulfonic acids 
(Cooper et al., 2011). Similarly to other types of cysteine oxidation, glutathionylation 
has been implicated in both physiological and pathological processes. In terms of cell 
signalling, glutathionylation has been shown to regulate proteins kinases such as 
mitogen-activated protein kinase (MAPK) (Templeton et al., 2010) as well as 
transcription factors, including Nf-ĸB (Reynaert et al., 2006). These support the role 
of glutathionylation in a wide range of processes such as proliferation, differentiation 
and apoptosis. However, this oxidative modification has also been associated with 
neurodegenerative disease, cancer and type 2 diabetes (Cooper et al., 2011). 
Disulphide bond formation through ROS or RNS in proteins is different to the mixed 
disulphide produced during glutathionylation, between proteins and GSH. Disulphide 
bonds are produced between two cysteine residues, within the structure of a protein, 
causing structural and functional changes, which can regulate cellular stress 
responses. For example, a disulphide bond created in Keap1, in response to 
oxidative stress, leads to the activation of NF-E2-related factor 2, which elevates the 
expression of antioxidants (Cai and Yan, 2013). 
 
The two forms of ROS that are predominantly associated with redox signalling are 
H2O2 and superoxide. This is due to their higher stabilities, compared to other more 
harmful ROS entities, such as the hydroxyl radical. Additionally, H2O2 and superoxide 
predominantly target proteins or Fe-S groups within proteins and cannot directly 
target DNA and lipids, in contrast to the hydroxyl radical. H2O2 is particularly effective 
as a signalling molecule as it can diffuse across membranes and travel long 
distances, from where it was originally produced, due to its long half-life (Bak and 
Weerapana, 2015). The activity of superoxide as a signalling molecule is subject to 
controversy, due to its chemical properties. The short half-life of superoxide means 
that it is not able to travel far and therefore reacts primarily with proteins in close 
proximity to its site of generation (Wang et al., 2018). However, recent studies have 
discovered channels within the OMM of the mitochondria, specifically for the 
transport of superoxide, thus supporting its role as a signalling molecule, (Hayyan et 
al., 2016). 
The first encounter of ROS as a signalling molecule was during the 1990s, where an 
increase in cellular proliferation was detected, upon addition of H2O2, triggered by the 
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activation of pathways regulated by NF-kB (Schreck et al., 1991). NF-kB is involved 
in a wide range of cellular survival pathways, including immune responses, 
autophagy, proliferation, differentiation and apoptosis. Since then, the interaction 
between ROS and other signalling pathways has been extensively studied. Specific 
pathways include, the MAPK cascade, which is able to regulate many critical cellular 
processes, through downstream phosphorylation events, such as survival, cell 
growth, differentiation and cell death (Dhillon et al., 2007). The hypoxia inducible 
factor (HIF-1), which is stabilised by ROS, is primarily involved in triggering a 
response under low oxygen conditions and promotes cellular survival (Jung et al., 
2008).  As I mentioned above, the Keap1-Nrf2-ARE signalling pathway, regulated by 
ROS-mediated-oxidation of cysteine residues, is involved in the activation of an 
antioxidant response to counteract oxidative stress. The phosphoinositide-3-kinase-
Akt pathway (PI3K-Akt), is also activated by ROS to initiate downstream processes 
responsible for protein synthesis, cell proliferation and cell growth. In addition, ROS 
can also participate in the regulation of Ca2+ ions through the opening of channels, 
such as mPTP (in the IMM) (Zhang et al., 2016). Recently, there has been evidence 
that H2O2 can also induce redox signalling through peroxiredoxins or the co-substrate 
thioredoxin, which are able to relay the signal directly to target proteins (Netto and 
Antunes, 2016).  
 
 Cellular ROS 
As discussed above, mitochondria are an important source of ROS; however there 
are also enzymes that reside in the cytoplasm and distinct cellular compartments that 
contribute to the generation of ROS. These can be categorised according to their 
location within the cell, for example (i) the plasma membrane, (ii) cytosol, (iii) 
peroxisome and (iv) endoplasmic reticulum (Brown and Borutaite, 2012), discussed 
in detail below. 
 
One of the most prevalent non-mitochondrial sources of ROS originates from the 
plasma membrane generated by the trans-membrane NADPH oxidases, otherwise 
known as the NOX family. In mammals, there are seven tissue specific NOX isoforms 
in total, all with the primary role of producing ROS (superoxide or H2O2) (Krause, 
2004). In fact, NOX are the only family of enzymes whose primary function is the 
generation of ROS (Drummond et al., 2011), whereas in other enzymes it can be 
argued that ROS are produced as by-products. One of the main roles of NOX-
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derived ROS is triggering an innate immune response. For example, in macrophages 
the integral NOX enzymes can produce and release a burst of superoxide outside of 
the cell, which can target and kill harmful microbes (Panday et al., 2015). Within the 
cytosol there are the NO synthase (NOS) enzymes and lipoxygenases (LOX). In 
normal conditions, NOS enzymes are responsible for the production of the essential 
signalling molecule, NO. Conversely, under conditions of limited substrate or cofactor 
availability, the enzyme’s activity can shift to the production of superoxide (Xia and 
Zweier, 1997). In addition, studies have revealed that cytosolic superoxide and H2O2 
can promote further ROS production by NOS, by shifting NO production to 
superoxide production (Sun et al., 2010). Cytosolic LOX enzymes catalyse the 
oxidation of the unsaturated fatty acid arachidonic acid, released from the plasma 
membrane. A by-product of this redox reaction is the formation of superoxide. Further 
research has shown a possible interaction between the metabolites produced by 
LOX and the NOX enzymes, in which these LOX metabolites trigger ROS production 
from NOX (Cho et al., 2011b). Also found in the cytosol are the xanthine oxidase 
enzymes, typically involved in the metabolism of hypoxanthine, to produce uric acid. 
However, due to their oxidase properties, they are also able to participate in the 
direct transfer of electrons to oxygen, leading to the generation of superoxide, H2O2 
and NO. ROS produced as a result of Xanthine oxidase enzymes possess both 
negative and positive consequences. For example, the activity of xanthine oxidase 
has been reported to be higher in carcinogenic tissues compared to healthy tissue. In 
this model, it was been proposed that ROS produced by xanthine oxidase has 
promoted the progression of cancer by stimulating cell proliferation. However, ROS 
produced via xanthine oxidases has also been associated with cell signalling, 
including pathways linked to apoptosis and cell differentiation (Battelli et al., 2016).  
 
Peroxisomes are small cytosolic organelles, residence to many enzymes that are 
involved in catalysing the oxidation of substrates such as long-chain fatty acids, 
polyamines or D-amino acids. During these metabolic reactions, electrons from the 
oxidised substrates are passed to O2 to form ROS (Sandalio et al., 2013).  A few 
examples of enzymes, present in the peroxisome that generate ROS, include acyl-
CoA oxidase (for β-oxidation of fatty acids), urate oxidase, xanthine oxidase and D-
amino acid oxidase (Schrader and Fahimi, 2006). To neutralize the high amounts of 
H2O2 generated, the antioxidant catalase is highly expressed in the peroxisome 
(Schrader and Fahimi, 2006). Another subcellular compartment, involved in the 
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production of ROS, is the endoplasmic reticulum (ER). Amongst many of the ROS 
generating enzymes found in the ER, is the cytochrome P450 heme-containing 
polypeptide, which resides in the ER membrane. These enzymes are responsible for 
the oxidation of a broad range of substrates, in which the acquired electrons are 
simultaneously passed to oxygen (Zangar et al., 2004). Oxidative enzymes such as 
Ero1 and the NOX family are important for the production of ROS, to achieve folding 
of newly-synthesised nascent proteins, through the formation of disulphide bonds 
(Yoboue et al., 2018).  Overall, there are multiple ways, in which ROS can be 
produced in the cytosol, excluding the mitochondria. Similarly to mitochondrial ROS, 
these have also been linked to signalling pathways as well as numerous disease 
pathologies (Zhang et al., 2016).  
 
 Mitochondrial ROS 
Mitochondria have been considered for a long time as the main generators of ROS 
(Barja, 2019). However, this is due to the lack of comprehensive studies measuring 
ROS generation from different sources in the same experimental conditions (Sanz, 
2016). A recent study by Martin Brand’s laboratory addressing this question showed 
that in C2C12 human myoblasts only 45% of the ROS produced by the cells come 
from the mitochondrion (Wong et al., 2019). Similarly, previous studies have 
suggested that peroxisomes produce higher levels of ROS than mitochondria, in the 
liver (reviewed in (Brown and Borutaite, 2012)). 
 
In any case, mitochondria are one of the most important generators of ROS within 
the cell. Furthermore, mitochondrial ROS remain the most studied and the only free 
radicals that have shown a direct connection with ageing and age-related diseases, 
in multiple independent studies and several animal species, including humans 
(reviewed in (Sanz, 2016) (Barja, 2019) (Wallace, 2005)). Given that respiration 
requires a vast amount of the overall O2 supply, the mitochondrial matrix is rich in O2, 
which is therefore vulnerable to reduction via escapee electrons from the ETC. The 
extent of electrons leaking from the ETC during OXPHOS is unclear, particularly in 
vivo. Early estimations suggested that, during normal conditions, 1-4% of electrons 
leak and generate ROS (Barja, 2007). However, a more conservative updated 
estimation reduces this amount, to less than 0.1% of electrons (Larosa and Remacle, 
2018). Within the mitochondria, there are 11 acknowledged sites where electrons can 
escape and reduce O2, with one electron to produce superoxide (reviewed in (Wong 
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et al., 2017)). However, only CI and CIII have been shown to produce ROS under 
relevant physiological conditions, where independent approaches, such as chemical 
and genetic in vivo inhibition of the complex have been utilised to confirm the source 
of ROS (reviewed in (Murphy, 2009) (Stefanatos and Sanz, 2011) (Wong et al., 
2019), (Chandel, 2010) (Weinberg et al., 2015) (Sanz, 2016) (Chouchani et al., 
2016)).  
 
Within CI, there are two established sites of ROS production, namely the IF 
(Chouchani et al., 2016) and the IQ (Treberg et al., 2011) sites. A minority of reports 
have also suggested the Fe-S N2 cluster of CI, as a site of ROS production (Genova 
et al., 2001) (Herrero and Barja, 2000). The IF site represents the FMN region of CI, 
where NADH binds and donates two electrons. The IQ site is the site where CoQ 
binds to and receives two electrons, from CI. All the sites in CI contribute to the 
generation of mitochondrial matrix superoxide (Zhao et al., 2019). Inhibitors of the IQ 
site within CI, such as rotenone and piericidin A, both lead to an increase in 
superoxide production at the IF site. This is the consequence of a highly reduced IF 
site, when the downstream electron flow is blocked, which increases the 
NADH/NAD+ ratio and leads to the increased production of superoxide (Murphy, 
2009). Superoxide production at the IQ site has been proposed to occur during the 
process of reverse electron transport (RET) when the CoQ pool is highly reduced 
(Murphy, 2009). However, others have proposed that only the IF site produces ROS 
in both a forward and reverse direction (Pryde and Hirst, 2011). Strong support for 
the IQ site comes from the development of a new class of antioxidants calls S1QELs 
(suppressors of site IQ electron leak) (Brand et al., 2016). S1QELs scavenge 
superoxide exclusively produced at the IQ site and have been shown to protect 
against ischemia-reperfusion (IR), in vivo (Brand et al., 2016). As I will discuss in 
detail below, IR is characterised by the production of ROS by CI via RET (Brand et 
al., 2016) and therefore the protection of S1QELs against IR injury, supports the IQ 
site as the location of electron leakage. 
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At present, there is only one recognised site of electron leakage and superoxide 
production within CIII, the Qo site, where CoQH2 binds and undergoes oxidation 
(Muller et al., 2003) (Muller et al., 2004). At this site, superoxide can be deposited 
into both the matrix and the IMS.  Mitochondria from rat and mouse skeletal muscle, 
showed that around 63% and 50% of superoxide ends in the matrix, respectively 
(Treberg et al., 2010) (Muller et al., 2004). The inhibitor antimycin A binds to the Qi 
site of CIII and leads to a dramatic increase in superoxide production at the Qo site. 
This is due to an accumulation of electrons upstream of the Qi site, leading to the 
formation of a ubisemiquinone radical (QH-) and the univalent reduction of O2 
(Murphy, 2009). Another condition, which is known to affect superoxide generation at 
the Qo site is the mitochondrial membrane potential. It has been proposed that RET 
also occurs within CIII when electrons, at the Rieske iron-sulphur cluster, move back 
towards the Qo site and produce superoxide (Bleier and Drose, 2013).  
Figure 1.9 Schematic diagram demonstrating the sites of ROS production from CI and 
CIII of the ETC. 
 
CII is usually overlooked as an important generator of ROS (Drose, 2013). However, 
mutations in CII that increase superoxide generation have been related to cancer 
(Ishii et al., 2005), neurodegeneration (Ackrell, 2002) and reduced lifespan (Walker et 
al., 2006). Electrons can leak from the IIF site of CII, where the FAD cofactor oxidises 
CI possesses two sites (IQ and IF) which both generate ROS into the mitochondrial matrix. CIII 




succinate, when both CI and CIII are inhibited (Quinlan et al., 2012). Superoxide 
production from IIF can occur with electrons flowing in forward or reverse direction but 
superoxide is always directed to the mitochondrial matrix. Aside from the major 
respiratory complexes, mitochondrial superoxide generation can also occur via 
NADH/NAD+ linked enzymes, collectively known as 2-oxoacid dehydrogenase 
complexes. During the oxidation of their specific substrates, this group of enzymes 
form ROS at their flavin sites. These metabolic enzymes include alpha-ketoglutarate 
dehydrogenase, pyruvate dehydrogenase, branched-chain-2-oxoacid dehydrogenase 
and 2-oxoadipate dehydrogenase (Quinlan et al., 2014). Another group of enzymes 
that can generate ROS include those that interact with the CoQ pool. For example, 
G3PDH, DHODH and ETF:CoQ, which all participate in the reduction of CoQ. 
G3PDH oxidises G3P and feeds the electrons directly to the CoQ pool. The Q 
binding site of this enzyme has been proposed to be the site of superoxide 
production (Mracek et al., 2014). The DHODH enzyme executes the oxidation of 
dihydro-orotate and subsequently donates the electrons to CoQ. Similarly to G3PDH, 
superoxide can be generated at the CoQ binding site (Hey-Mogensen et al., 2014). 
Lastly, the ETF:QO passes electrons to the CoQ, derived from β oxidation of fatty 
acids. Studies suggest that superoxide production occurs as a result of the singular 
electron transfer from the flavin site to the CoQ binding site (Watmough and Frerman, 
2010). 
 
In addition, there are two other reported families of proteins that contribute to the 
production of mitochondrial ROS. The first is the p66Sch adaptor protein, which upon 
cytosolic stress signals is imported to the mitochondria, where it mediates the direct 
reduction of O2 molecules with electrons from Cyt C (Kaludercic and Giorgio, 2016). 
The final example is the mitochondrial monoamine oxidases (MAO) found in the 
OMM (Edmondson, 2014). These enzymes catalyse the oxidation of amines, which 
consequentially produces a significant amount of ROS, associated with a few 
disease pathologies, such as Parkinson’s disease (Fitzgerald et al., 2014). 
 
 Methods of measuring mitochondrial ROS levels; resolution vs physiological 
relevance  
Measuring ROS levels is challenging due to their high reactivity and short half-lives. 
For these reasons, the hydroxyl radical, which is extremely reactive and unstable, is 
the hardest form of ROS to study. This is particularly true for in vivo measurements; 
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thus the majority of studies regarding mitochondrial ROS production have been 
performed using in vitro techniques and mainly in isolated mitochondria. The use of 
isolated mitochondria has revealed important evidence surrounding how and where 
ROS can be produced. For example, the ETC complexes, where electrons leak from 
specific sites to incompletely reduce oxygen and generate ROS. However, in vitro 
studies cannot provide information about how ROS are produced in vivo and which 
enzymes generate ROS, in relevant physiological circumstances.  
 
The use of isolated mitochondria has many drawbacks; however it has been 
extremely useful in allowing the high-resolution study of how mitochondrial ROS are 
generated (Sanz, 2016). Through these high-resolution techniques, it has been 
possible to identify specific enzymes and the sites within those enzymes, where ROS 
are produced. For example, it has facilitated the distinction between the production of 
ROS through forward electron transport or RET. High-resolution is achieved by the 
use of specific substrates and inhibitors to manipulate the redox state of the ETC and 
the pmf (Wong et al., 2018). Using this approach, it is possible to study the sites of 
ROS production, exclusively at CI, by feeding mitochondria with CI-linked substrates 
(e.g. pyruvate and glutamate), in combination with rotenone. The major disadvantage 
of using isolated mitochondria is the lack of physiological relevance, caused by 
removing mitochondria from the cell for ROS measurements. Under these 
circumstances, mitochondria lose the ability to interact with other intracellular 
components and are exposed to unnaturally high levels of O2. Thus, measurements 
are performed using saturated concentrations of substrates that are rarely observed 
in vivo. Working with cells in vitro eliminates certain disadvantages that isolated 
mitochondria possess (Sanz, 2016). However, the conditions under which cells are 
generally cultured i.e. high O2 and glucose levels also limits the physiological 
relevance of ROS measurements. The following two examples illustrate the 
limitations of using cells to study mitochondrial ROS. Firstly, fibroblasts from muscle 
biopsies of patients suffering from mitochondrial diseases, in some cases, have no 
mitochondrial phenotypes, when cultured in vitro (Rodenburg, 2011). Secondly, 
human fibroblasts become senescent after a few rounds of replication, when cultured 
in high O2 levels (20%). This phenotype is dependent on the levels of mitochondrial 
ROS and can be prevented when they are reduced (Passos et al., 2007). However, 
senescence does not occur in the same fibroblasts if they are cultured under 
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physiological O2 levels (~3%) (Busuttil et al., 2003). These examples further 
emphasise why in vitro experiments should be interpreted with caution.  
 
In vivo ROS measurements are much more limited in number and current studies 
using in vivo techniques possess two major drawbacks (Wang et al., 2013). First of 
all, they lack the resolution achieved by studies using isolated mitochondria and 
secondly the conflict surrounding the quantification versus visualisation of ROS 
levels. In this section, I will briefly discuss different approaches available to overcome 
these disadvantages and allow high-resolution in vivo ROS measurements.  
 
It is possible to measure ROS in vivo in the presence or absence of specific 
inhibitors, to increase the resolution of the measurements. The inhibitors are fed or 
injected into the animal model, to determine where and how ROS are produced. The 
typical example is the administration of rotenone to prevent RET (Scialo et al., 
2016a) (Chouchani et al., 2014a). Here one of the main problems is the toxicity of the 
drug for the animal, the difficulties of targeting specific tissues or cell types and 
undesirable side effects of the inhibitor. To obtain tissue specificity, genetic 
approaches can be used to target specific subunits of the respiratory complexes, 
leading to reduced levels of the specific complex. An example of this is the 
knockdown of CI subunits to prevent RET, in Drosophila (Scialo et al., 2016a) or the 
knockdown of CIII subunits to abolish ROS production at the Qo site (Diebold et al., 
2019). Finally, the use of alternative respiratory enzymes allows the redox state of 
the CoQ pool to be manipulated, which subsequently leads to an increase or 
decrease, in the production of superoxide (Scialo et al., 2017). In summary, chemical 
and genetic inhibition of the respiratory complexes, as well as the expression of 
alternative respiratory enzymes, increases the resolution of mitochondrial ROS 
measurements, performed in vivo or ex vivo.  
 
One method of measuring ROS in vivo and ex vivo is using microscopy, which allows 
the visualisation of ROS that can be subsequently quantified. However, the 
quantification of ROS levels using microscopy can be quite challenging (Xu and Xu, 
2016). On the other hand, techniques available for allowing the precise quantification 
of ROS, such as, Mass Spectrometry (MS), measure the reduced and oxidised state 
of a ROS probe but they do not allow the visualisation of ROS, in vivo. An example is 
the MitoB/MitoP method, developed by the laboratory of Mike Murphy in Cambridge, 
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which takes advantage of a ratiometric approach to precisely detect H2O2, in the 
mitochondrial matrix (Cocheme et al., 2011). An advantage of this technique is the 
reduction of experimental variability that may occur through autoxidation of the probe 
or differential accumulation, within the mitochondria. However, one of the drawbacks 
of MitoB/MitoP and other approaches that rely on MS for detection, is that they are 
highly invasive and require a significant amount of sample.  
 
The visualisation of ROS levels can be achieved using chemical probes, which 
fluoresce once oxidised and can be measured using fluorescence microscopy. 
However, the use of fluorescent probes can be impossible to correlate with real 
values of ROS levels and ROS levels are usually reported as arbritary units. 
Alternatively, the oxidation of the same probes can be measured by flow cytometry 
(Kauffman et al., 2016) or using liquid chromatography together with MS (LC-MS) 
(Zielonka et al., 2009). These methods make quantification more reliable and 
reproducible between experiments.  
 
There are many different fluorescent probes for specific types of ROS (reviewed in 
(Xu and Xu, 2016)). The probes most commonly used are 2',7'-
dichlorodihydrofluorescein diacetate (H2DCF), for total ROS levels and 
dihydroethidium, for superoxide. H2DCF belongs to a group of cell-permeable 
compounds called dihydroflourescein (H2F). Once H2DCF enters cells, the acetate 
group, which allows the entry of H2DCF into the cell, is cleaved via cellular esterases.  
Upon oxidation H2F is converted to the highly fluorescent 2',7'-dichlorofluorescein 
(DCF). H2DCF is normally used to measure H2O2 within cytosolic compartments of 
cells. The main advantage of this probe is its high sensitivity. However, H2DCF has 
low specificity towards peroxides, as it also reacts with other ROS and RNS. In 
addition, it also has high autoxidation rates (Kalyanaraman et al., 2012). Another 
fluorescent probe is Dihydroethidium (DHE), which is commonly used to detect 
superoxide (Robinson et al., 2006). The variant of DHE, known as MitoSOX, allows 
DHE to be targeted to mitochondria using tri-phenyl-phosphonium (TPP). MitoSOX 
has become the most popular probe to detect mitochondrial ROS. However, DHE 
and therefore MitoSOX, have many drawbacks including lack of specificity, where 
other ROS and RNS are also able to oxidise MitoSOX. Additionally, MitoSOX 
increases fluorescence upon intercalation into DNA, both nuclear and mitochondrial, 
as well as the potential of auto-oxidation, thus is not always a direct indicator of 
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superoxide and can produce misleading results (Zielonka and Kalyanaraman, 2010). 
The lack of specificity can be addressed by using MS to allow the specific detection 
of 2-hydroxyethidium, which is formed as a result of superoxide oxidation (Zhao et 
al., 2003). Despite all these problems, MitoSOX remains a quick and inexpensive 
way of studying mitochondrial superoxide levels, particularly considering the lack of 
reliable alternatives for measuring superoxide.  Recently, an improved version of 
MitoSOX, called MitoNeoD, has been developed (Shchepinova et al., 2017). It has 
been reported that MitoNeoD can overcome the two main problems of MitoSOX 
previously discussed, including the lack of specificity and increased fluorescence 
upon intercalation into DNA.  
 
To achieve in vivo ROS measurements, using the probes discussed above, they can 
be either fed or injected into the animal model. However, due to their high 
autoxidation rates, this can be challenging and increases variability, thus reducing 
reproducibility among experiments (Sanz, 2016). A partial solution is to use these 
probes ex vivo, taking advantage of their cell permeability. Alternatively, it is possible 
to utilise genetically encoded fluorescence detectors that can be expressed in 
specific tissues or cells (Sanz, 2016). For the detection of H2O2, the two most 
commonly used options are the redox-oxidation Green Fluorescent Protein (roGFP) 
(Albrecht et al., 2011) and Hydrogen Peroxide protein (Hyper) (Choi et al., 2001). 
Unfortunately, there is no reliable alternative for specifically measuring superoxide. 
The circularly permuted Yellow Fluorescent Protein (cpYFP) was previously 
proposed as a superoxide sensor (Wang et al., 2008), however, has since been 
shown not to specifically detect superoxide (Muller, 2009). All of these 
aforementioned methods are ratiometric detectors, similar to MitoB/MitoP. In these 
cases, the ratiometric system is based on two different excitations wavelengths, one 
for the oxidised and the other for the reduced form of the protein. Here, the 
fluorescent protein is fused to a peroxide sensor, which confers their specificity and 
determines their sensitivity. Genetically encoded sensors have an important 
advantage over chemical probes, as they can be targeted to specific organelles 
within the cell. For example, the laboratory of Tobias Dick has produced roGFP 
proteins fused to the oxidant receptor peroxidase 1 (Orp1, roGFP-Orp1), which 
detects H2O2, in the mitochondria or the cytosol (Albrecht et al., 2011).  roGFP allows 
fixation of the samples, which increases the potential number of samples examined 
and in vivo estimations of ROS levels. Genetically encoded sensors are generally 
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more specific but less sensitive, in comparison to chemical probes. However, new 
and more sensitive roGFP probes fused to peroxiredoxin proteins have been 
developed to detect basal levels of H2O2, in both the mitochondria and cytosol 
(Morgan et al., 2016). Another disadvantage of the genetically encoded sensors 
versus the chemical probes, is that they require the transformation of cells or whole 
animals. This could be technically challenging and very expensive, in the case of 
mice and other mammal models.  
 
Finally, it is recommended to confirm the specificity of any ROS signal measured. 
ROS measurements could be repeated in the presence of specific antioxidants that 
must reduce the intensity of the signal. For example, during the detection of 
superoxide, the overexpression of SOD would significantly reduce the signal. 
Conversely, overexpression of catalase must reduce a H2O2 signal without altering 
any superoxide signal being measured.  
 
All the probes and sensors described above have advantages and disadvantages 
that need to be considered carefully. The use of chemical probes offers a quick, 
sensitive and inexpensive way of detecting ROS levels and allows performing 
multiple experiments, in parallel. However, they possess issues with the specificity of 
the ROS detected and are prone to technical artefacts. Genetically encoded sensors 
are more specific but less sensitive and require complex systems of expression that 
increase the time and resources invested in ROS measurements, thus limiting the 
number of experiments. Therefore the use of one or another approach will depend on 
the experimental design and the resources available.  
 
 The physiological relevance of site-specific ROS production at CIII 
It is now apparent that ROS can behave as signalling molecules in cells, as well as 
contributing to oxidative damage. It has been established that ‘good’ ROS participate 
in signalling and have low or moderate reactivity, i.e. H2O2 and superoxide. In 
contrast to ‘bad’ ROS, which are highly reactive and cause oxidative damage, e.g. 
hydroxyl radical or peroxynitrite. The physiological effect of ROS is determined by 
three factors, namely (i) where and when they are produced, (ii) the amount 
generated and (iii) the type of ROS (Sanz, 2016). As discussed before, ROS involved 
in signalling are produced at specific times and places, in moderate amounts and 
have low reactivity. Conversely, oxidative stress is characterised by uncontrolled 
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production of ROS, with high reactivity that leads to oxidative damage. As 
mitochondria have a central role in metabolism, a lot of research has focused on this 
organelle as a potential site for the creation of signalling ROS messengers. As 
discussed above, the two major sites of ROS production detected in isolated 
mitochondria, are respiratory complexes I and III (Wong et al., 2017). Thus, both CI 
and CIII derived ROS have been implicated in vital physiological processes, as well 
as being associated with ageing and age-related diseases, by in vivo studies 
(Stefanatos and Sanz, 2018).  
 
CI possesses two sites that generate ROS into the mitochondrial matrix (St-Pierre et 
al., 2002). An intriguing mechanism of CI is that it can produce ROS, with electrons 
flowing in both a forward and reverse direction (Robb et al., 2018). Paradoxically, 
reports showing a role of CI ROS in cellular signalling indicate that ROS are mostly 
produced in the reverse direction. I will discuss in detail the mechanism and 
physiological pathways behind ROS produced via RET (ROS-RET), in the following 
section. In this section, I will focus on the physiological relevance of ROS produced 
by CIII. 
 
So far, only the Qo site of CIII has been shown to produce ROS (Brunelle et al., 
2005). CIII ROS production is bidirectional, with approximately half of the ROS being 
generated into the IMS and the other half into the mitochondrial matrix (Treberg et 
al., 2010) (Muller et al., 2004). The production of ROS into the IMS can be 
particularly useful for transmitting mitochondrial information directly to the cytosol. 
Here the ROS act as signalling messengers and have the potential to interact with a 
vast array of redox-regulated proteins (reviewed in (Sena and Chandel, 2012)). 
Studies from the laboratory of Navdeep Chandel have established an association 
between ROS generated at the Qo site of CIII and multiple physiological processes 
(Schieber and Chandel, 2014). For example, Chandel’s work has shown that CIII 
ROS are required to stabilise HIF-1α, in response to hypoxia (Chandel et al., 2000). 
Upon CIII inhibition, using the Qo site inhibitors myxothiazol and stigmatellin, or the 
genetic depletion of the Rieske-iron sulphur protein, the stabilisation of HIF-1α was 
prevented, thus supporting the role of CIII ROS production within this process 
(Brunelle et al., 2005) (Bell et al., 2007). In addition, CIII derived ROS has also been 
shown to regulate the differentiation of adipocytes from mesenchymal stem cells. 
This process requires an increase in OXPHOS, which subsequently increased 
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electron leak and superoxide production at CIII (Tormos et al., 2011). Suppressing 
the increased ROS levels, using similar techniques described earlier, prevented 
differentiation, therefore demonstrating its dependence on the production of ROS. 
Finally, CIII derived ROS have also been affiliated with the activation of T cells (Sena 
et al., 2013) as well as TGF-β signalling (Jain et al., 2013).  
 
ROS produced at CIII have also been associated with negative effects during 
pathological situations. For example, a link between air pollution and ROS has been 
suggested, which promotes death of alveolar epithelial cells (Soberanes et al., 2009). 
In this model, ROS produced at the Qo site of CIII were responsible for triggering 
apoptosis, by activation of the redox-sensitive kinase ASK1 (Apoptosis signal-
regulating kinase 1). It is known that air pollution causes the release of pro-
inflammatory cytokines, such as IL-6, which induces lung inflammation. The release 
of IL-6 by alveolar macrophages occurs in response to the increase in ROS produced 
by CIII (Soberanes et al., 2019).  Furthermore, in a Kras-driven mouse model of lung 
cancer, CIII derived ROS were shown to be required for both proliferation and 
tumorigenesis in cancer cells (Weinberg et al., 2010). The anti-proliferative effects of 
metformin on cancer may be caused by the inhibition of ROS generated by CIII 
(Wheaton et al., 2014). Accordingly, expression of Ndi1 in metformin-treated cells 
restores both ROS production at CIII (but not at CI) and the proliferation capacity of 
the cells, when injected into mice (Wheaton et al., 2014).  
 
 The physiological relevance of site-specific ROS production via Reverse 
Electron Transport (RET) at CI 
In 1961, Chance and Hollunger demonstrated that feeding the CII-linked substrate, 
succinate, to isolated mitochondria resulted in the reduction of NAD+ back to NADH, 
a process that they termed reverse electron transport (RET) (Chance and Hollunger, 
1961). For many years, RET was dismissed as an in vitro artefact. However, in the 
last 10 years, evidence has accumulated supporting the occurrence of RET in vivo, 
thus re-establishing its scientific interest. RET is a phenomenon observed at CI of the 
respiratory chain, where electrons move in the reverse direction back to CI, from 
CoQH2. Coinciding with the process of RET, there is a significant rise in ROS 
production from CI. The exact site of electron leak during RET is unclear, and both 
the IF and IQ sites have been proposed as the source of ROS (Pryde and Hirst, 2011) 
(Quinlan et al., 2013). For RET to occur there are two required conditions: a highly 
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reduced CoQ pool and a high pmf, both of which are essential to make the reverse 
flow of electrons possible. Previous studies have shown that the use of the inhibitor, 
FCCP, to abolish the polarised membrane prevented the occurrence of RET (Robb et 
al., 2018). Additionally, preventing the binding of CoQ to CI, via targeted IQ site 
inhibitors, such as rotenone, also prevents the process of RET. In each case, the 
dramatic increase in ROS associated with RET, was also abolished. ROS-RET has 
since been recognised in a number of physiological processes, discussed in detail 
below (Scialo et al., 2016a). 
 
The physiological occurrence of ROS-RET was first reported during IR 
(Paraidathathu et al., 1992) (Lesnefsky et al., 2004) (Chen et al., 2006). A paper from 
Michael Murphy’s laboratory at Cambridge (Chouchani et al., 2014a) showed that O2 
starvation during ischemia leads to the rapid accumulation of succinate. During 
reperfusion and restoration of O2, CII starts metabolising the abundant supply of 
succinate, leading to a highly reduced CoQ pool and sustained high membrane 
potential. In combination, these two conditions, stimulate RET and the extensive 
production of ROS associated with it (Chouchani et al., 2014a). 
 
Since 2014, ROS-RET has been implicated in many other physiological processes 
(Scialo et al., 2017). In contrast to the IR model, ROS produced during RET in these 
cases are not detrimental. Instead they have been shown to play an essential role in 
activating specific signalling pathways, required for maintaining cellular homeostasis. 
For example, the differentiation of myoblasts into myotubes requires the generation 
of ROS-RET (Lee et al., 2011). Genetically silencing CI subunits or culturing cells in 
rotenone, prevented differentiation. The role of ROS during this process was further 
confirmed by adding antioxidants, which also prevented cellular differentiation. 
Another function of ROS-RET is the regulation of CI levels and its integration into 
respiratory supercomplexes (Guaras et al., 2016). When cells were cultured in a 
sugar-rich medium, rotenone increased ROS production, indicating forward electron 
flow. However, when fatty acids were used as the primary fuel to supply electrons to 
mitochondria, ROS-RET was observed, indicating the reverse flow of electrons 
(Guaras et al., 2016). Interestingly, the occurrence of ROS-RET caused oxidation of 
CI subunits, which subsequently reduced both CI levels and its integration into 
supercomplexes. This demonstrates an adaptation affecting the assembly of 
supercomplexes, depending on the type of substrates available for oxidation. When 
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electrons from the oxidation of substrates enter the ETC downstream of CI, the 
complex is degraded and supercomplexes are restructured, to favour CIII/CIV 
association versus CI/CIII/CIV (Cogliati et al., 2013).   
 
Altering the respiration rate to the levels of O2 in the blood is an essential task. In 
mammals, cells located in the carotid body are responsible for this process. When O2 
levels are low, the chemoreceptors of the carotid body trigger a response that 
increases the respiration rate. The former response requires both the activity of CI 
and the presence of ROS, to occur (Fernandez-Aguera et al., 2015) (Arias-Mayenco 
et al., 2018). In the absence of CI, the presence of rotenone or high concentrations of 
antioxidants, the cells of the carotid body are unable to respond to changes in O2 
levels and mouse models cannot increase respiration, during hypoxia. Furthermore, 
CI ROS seems to also play an essential role in the immune response, similarly to CIII 
derived ROS. Macrophages react to the presence of pathogenic bacteria by 
triggering a pro-inflammatory response, characterised by the generation of several 
types of cytokines. This immune response requires mitochondrial ROS, which is 
triggered by exposing or injecting lipopolysaccharides (LPS) in macrophages and 
experimental animals, respectively (West et al., 2011). A comprehensive study from 
the laboratory of Luke O’Neill at Trinity College has shown that the metabolism of 
macrophages is reprogrammed, in the presence of bacteria. Mitochondrial respiration 
was manipulated to produce ROS instead of ATP and these ROS triggered the 
expression of pro-inflammatory cytokines. The pro-inflammatory response was 
abolished in the presence of rotenone, FCCP or expressing AOX, indicating that 
ROS were produced by RET.   
 
Finally, our laboratory has shown that ROS-RET can also be induced in vivo by the 
expression of the alternative Ndi1, described before. RET is stimulated by the 
expression of Ndi1, due to the direct transfer of electrons from the oxidation of 
NADH, to the CoQ pool. Thus, leading to a highly reduced CoQ and a dramatic 
increase in ROS, observed in the fly brain (Scialo et al., 2016a). As expected, this 
increase in ROS was abolished by blocking the IQ site with rotenone or by dissipating 
the membrane potential with FCCP. In addition, preventing the reduction of CoQ with 
AOX or knocking down subunits of CI, also abolished ROS, supporting RET as the 
source. Surprisingly, Ndi1-induced ROS-RET has also been shown to significantly 
extend the lifespan of Drosophila melanogaster, irrespective of diet or the 
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background (Sanz et al., 2010b) (Scialo et al., 2016a) (Bahadorani et al., 2010) (Hur 
et al., 2013)).  Furthermore, NDX, an alternative NADH dehydrogenase found in 
Ciona intestinalis, has also been reported to lead to lifespan extension (Gospodaryov 
et al., 2014). Due to the fact that Ndi1 can bypass CI, it can rescue CI subunit 
mutations (Sanz et al., 2010b) (Cho et al., 2012), thus, Ndi1 expression protects 
mitochondrial function against the effects of ageing and several other stress 
conditions. Evidence, in support of the former, includes the increase in mitochondrial 
respiration in old flies expressing Ndi1 (Sanz et al., 2010b), as well as an increase in 
mitochondrial ATP production, in models of Parkinson’s disease (Vilain et al., 2012). 
More surprisingly, Ndi1 can also protect against the knockdown of Sod2, which 
increases mitochondrial superoxide levels (Scialo et al., 2016a). In the Sod2-KD 
model, flies expressing Ndi1 lived longer and their mitochondria respired more 
efficiently than the controls, despite having higher levels of mitochondrial ROS. This 
indicates that ROS-RET can act as a signal, which activates pro-survival pathways 
over the background noise of ROS, caused by knockdown of Sod2 or the age-related 
progressive increase in ROS.  
 
In light of the recent evidence, there has been speculation that ROS-RET plays a 
pivotal role in signal transduction and maintaining cellular homeostasis. ROS-RET is 
connected to two central components of metabolism, including both the redox state 
of the CoQ pool (which provides information about electron flow through the ETC) 
and the pmf (which is essential in regulating mitochondrial ATP production). In 
addition, ROS generated during the process of RET can be modulated in intensity 
and duration. For these reasons, ROS-RET is an ideal signalling system responsible 
for communicating information from the mitochondria, to the rest of the cell (reviewed 
in (Scialo et al., 2017)). Thus, research dedicated to understanding the mechanisms 
behind ROS-RET, may be pivotal in understanding the role ROS play in health and 
disease. 
 
1.3 Mitochondrial ROS and age-related diseases 
The ageing process is a universal phenomenon in all animals, characterised by 
inevitable deterioration, which ultimately leads to death (Lopez-Otin et al., 2013). 
Over the past decade, the importance of researching the mechanisms behind ageing 
has been established by the evident increase of the elderly population, which 
currently shows no indication of slowing down. Coinciding with the ageing population 
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is the corresponding increase of age-related disease prevalence (LeBrasseur et al., 
2015). Excessive mitochondrial ROS production has been repeatedly implicated in 
the ageing process and has also been observed in numerous age-related 
pathologies (Vos et al., 2010). This is particularly observed in neurodegenerative 
diseases such as Alzheimer’s and Parkinson’s diseases (Kim et al., 2015). In 
Alzheimer’s disease, enhanced oxidative stress has been reported, resulting in 
damaged neurons, within the brain. In addition, different studies have shown 
decreased levels of antioxidants in patients of Alzheimer’s disease (Zhao and Zhao, 
2013). Parkinson’s disease has been associated with a decrease in the activity of 
respiratory CI, which leads to excessive production of ROS (Schapira, 2008). This 
was later supported by the parkinsonism phenotype induced by the CI inhibitors, 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or rotenone (Betarbet et al., 
2000). Although both these neurodegenerative disorders present an increase in 
oxidative stress, it is still unclear if mitochondrial ROS is the cause or consequence of 
Alzheimer’s and Parkinson’s disease (Kim et al., 2015). Elevated mitochondrial ROS 
production can also be observed in the pathology of cancer (Rodic and Vincent, 
2018). It has previously been established that DNA damage induced by oxidative 
stress can increase the risk of cancer (Moloney and Cotter, 2018). Recently, 
mitochondrial ROS have also been shown to possess a regulatory role in cancer 
progression. Here, the cancer cells can maintain ROS at precise concentrations, 
enough to stimulate growth and proliferation but low enough to avoid apoptosis and 
autophagy. Therefore allowing the rapid growth and progression associated with 
cancer cells (Idelchik et al., 2017). Type II diabetes is another age-related disorder, 
where patients have been identified to have increased ROS production. It has been 
proposed that the sustained ROS-dependent activation of downstream insulin 
signalling pathways, can lead to insulin resistance (Abdul-Ghani et al., 2009). A final 
example of heightened mitochondrial ROS production is in cardiovascular diseases. 
Here it has been shown that the oxidation of low density lipoproteins (LDLs), by ROS, 
is a direct cause of atherosclerosis (Panth et al., 2016). 
 
In most of these cases, the source of ROS observed in these pathologies has not 
been investigated. For example if the ROS are generated at specific sites, such as CI 
or CIII, or produced non-specifically, as a result of a defective metabolism. Answering 
this question may help the development of more specific therapies that prevent 




 Historical importance of MFRTA; evidence for and against  
In the 1950’s Denman Harman proposed the free radical theory of ageing, describing 
free radicals as the primary cause of ageing (Harman, 1956). This was later modified 
in 1972 to the mitochondrial free radical theory of ageing (MFRTA), which 
characterised mitochondria as biological clocks. In this updated version of the theory, 
free radicals produced exclusively in the mitochondria accumulate, leading to 
oxidative stress, which induces the ageing process (Harman, 1972). Since this theory 
was first introduced, extensive research exploring the relationship between ageing 
and mitochondrial ROS has been instigated. The evidence from these studies has 
accumulated, both supportive and contradictory (reviewed in (Sanz et al., 2006) 
(Sanz and Stefanatos, 2008) (Barja, 2019)).  Although this theory is still popular, it 
does not take into consideration the recent advancements surrounding the role of 
ROS in redox signalling ((Lapointe and Hekimi, 2010) (Sanz, 2016).  Below I 
describe in detail the evidence for and against the MFRTA.  
 
The first line of evidence, supporting the MFRTA, revealed a positive correlation 
between ROS and age, (Toroser et al., 2007) (Sanz et al., 2010a) (Cocheme et al., 
2011) as well as a correlation between short-lived animals and higher ROS levels, 
compared to long-lived species (Barja et al., 1994). This was further supported by an 
increase in oxidative stress and mitochondrial dysfunction, a classic hallmark of 
ageing in old individuals and short-lived species (Chistiakov et al., 2014). Additionally 
in many age-related diseases, such as Parkinson’s disease (Kim et al., 2015), cancer 
(Idelchik et al., 2017), cardiovascular diseases (Garcia et al., 2017b) and diabetes 
(Abdul-Ghani et al., 2009), high levels of ROS and oxidative stress could be 
detected. All the previously described evidence, supporting the MFRTA, are 
observational in nature and based on correlations. Contradictory evidence started to 
accumulate when alternative experimental approaches were used, to test the 
predictions of the theory. The experimental manipulation of antioxidant levels brought 
about inconsistent data, which began to challenge the integrity of MFRTA. Studies 
were able to demonstrate that the overexpression of antioxidants and the 
administration of non-enzymatic antioxidants, such as vitamin E and C, to decrease 
ROS levels showed no beneficial effects on longevity (Ernst et al., 2013). 
Furthermore, diminishing antioxidant levels did not shorten lifespan as expected 
either (reviewed in (Sanz et al., 2006)). For example in C.elegans, the knockdown of 
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all SOD enzymes, did not lead to a decrease in longevity, despite a rise in 
superoxide levels (Van Raamsdonk and Hekimi, 2012) (Yang et al., 2007) (Van 
Raamsdonk and Hekimi, 2009) (Yang et al., 2007) (Doonan et al., 2008). Similarly, in 
a heterogeneous SOD2 knockdown mouse model, no effect on lifespan was 
observed, although mice suffered from higher levels of ROS and oxidative damage 
(Van Remmen et al., 2003). Additionally, in Drosophila melanogaster it has been 
demonstrated that the overexpression of MnSOD and the expression of a 
mitochondrial targeted catalase have no effect or negative effects on lifespan, 
respectively (Mockett et al., 2010). The direct manipulation of mitochondrial ROS 
production was then used to test the validity of the MFRTA. Reducing the production 
of superoxide from the ETC did not extend lifespan in fruit flies (Sanz et al., 2010a). 
In fact, in flies and worms an increase in mitochondrial ROS was shown to extend 
lifespan (reviewed in (Ristow and Schmeisser, 2011) (Sanz, 2016) (Hekimi et al., 
2011)). For example the clk-1 mutation in worms, targeting CoQ, increased both 
mitochondrial ROS and lifespan (Wong et al., 1995). In addition, administration of CI 
inhibitors, rotenone or paraquat, as well as mutations in ETC subunits, were 
associated with an increase in ROS production, which positively affected longevity in 
worms (Yang and Hekimi, 2010). In Drosophila melanogaster, there is no positive 
effect on lifespan associated with feeding rotenone or paraquat (Scialo et al., 2016a). 
However mutations in CI, which increase ROS in the muscle (Owusu-Ansah et al., 
2013) and the aforementioned expression of Ndi1, which increases mitochondrial 
ROS production, both extend lifespan. All these manipulations that increase ROS 
and extend lifespan are reverted by overexpression or administration of antioxidants, 
showing that these beneficial effects are ROS dependent.  
 
Despite the accumulation of contradictory evidence, overall, the MFRTA has been 
pivotal in advancing the field of ageing and ROS. Research surrounding this theory 
has enabled a deeper understanding of the physiological processes that ROS 
participate in, providing the tools to understand the dual role that ROS play in redox 
signalling and oxidative stress. 
 
 The concept of hormesis 
It has been established that damaged mitochondria produce higher levels of ROS 
and accumulate during ageing. Paradoxically to this, are studies demonstrating that 
boosting mitochondrial ROS levels, in young individuals, extends lifespan. The 
45 
 
concept of hormesis has been used to provide an explanation for these contradictory 
facts. Hormesis is defined as an adaptive response in which mild stress in early life 
will induce resistance to higher levels of stress, in later life. In the case of 
mitochondrial ROS, increasing their levels would stimulate protective survival 
mechanisms to counteract the stress and produce antioxidant systems, capable of 
removing the ROS signal (Luna-Lopez et al., 2014). Mitochondrial hormesis is known 
as mitohormesis (Yun and Finkel, 2014) and has been used to explain how 
mitochondrial ROS regulate lifespan (Ristow and Schmeisser, 2011). From the point 
of view of mitohormesis, the exposure of ROS in early life can induce the expression 
of antioxidants that protect against oxidative stress, in later life (Schulz et al., 2007). 
The problem with this explanation is that fails to explain why the overexpression of 
the same antioxidants does not extend lifespan, as discussed previously. 
Additionally, mitohormesis also fails to explain why ROS produced at different sites 
can impose different downstream effects, through targeting distinct physiological 
pathways (Luna-Lopez et al., 2014). 
 
 Importance of studying mitochondrial ROS signaling 
It has been well established that cells rely on healthy and active mitochondria to 
provide cellular energy, as well as maintaining cellular homeostasis, through the 
activation of numerous signalling pathways. At the forefront of mitochondrial 
signalling is the controlled production of mitochondrial ROS, a by-product of 
OXPHOS. Mitochondrial ROS can diffuse across the double membrane, as signalling 
messengers, in response to stress and regulate the redox state of key cysteine 
residues in target proteins. Once homeostasis has been restored, antioxidant 
systems are activated to remove the ROS signal (Shadel and Horvath, 2015). 
However, the unregulated and excessive production of mitochondrial ROS has been 
implicated in a wide range of pathologies, including the ageing process. It appears 
that during early life mitochondrial ROS protects cells and promotes cell viability, 
which is ultimately lost in later life, where ROS drives oxidative stress. It has been 
shown that three factors can determine the behaviour of ROS. Firstly, the type of 
ROS, in which low reactive molecules such as H2O2 participate in signalling and 
highly reactive molecules as the hydroxyl radical, cause oxidative damage. Secondly, 
the location and duration of ROS production. As previously discussed, ROS 
produced by CI activate different downstream targets, in comparison to ROS 
produced by CIII. Similarly, ROS produced in response to stress can help cells to 
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cope with that stress, whereas ROS produced continually will cause oxidative stress.  
Finally, the amount of ROS produced, where low amounts modulate the activity of 
signalling pathways and high amounts contribute to ageing and the onset of age-
related diseases (Hekimi et al., 2011).  
One of the important unanswered questions in the field of redox biology, is how ROS 
signalling is lost during ageing and how oxidative stress takes a leading role 
(Stefanatos and Sanz, 2018). The two major sites of mitochondrial ROS production 
within the mitochondria are CI and CIII, which can both regulate superoxide 
production depending on the electron flow through the ETC and the pmf. As I 
discussed for ROS-RET, changing ROS levels in response to alterations in 
mitochondrial respiration, is one of the characteristics that makes mitochondrial ROS 
suitable to participate in redox signalling. However, mitochondria fail to communicate 
information in the presence of a dysfunctional ETC, which is observed during ageing 
and in mitochondrial diseases. For example, in Drosophila, CI levels and activity 
declines in aged flies, compared to early adulthood (Scialo et al., 2016a). It has been 
previously shown that CI inhibition prevents RET (Scialo et al., 2016a), therefore the 
reduction of CI activity during ageing would gradually lead to the inhibition of RET 
and the alteration of any physiological processes, which ROS-RET regulate. It is 
possible that during early life, ROS are produced specifically through regulated 
processes, which are ultimately lost during ageing. Thus, in later life, there is a switch 
in ROS production, to create non-specific, unregulated ROS, which drives the 
oxidative stress, we see in older individuals (Stefanatos and Sanz, 2018). To 
understand how ROS signalling fails, it is essential to measure mitochondrial ROS 
levels across all ages and test whether the place, time and intensity of ROS, changes 
during ageing. In the future, this could be central to developing treatments, which 
ameliorate age-related diseases and facilitate healthy ageing.  
 
1.4 Drosophila melanogaster as a model system 
The common fruit fly, also known as Drosophila melanogaster, was first introduced to 
scientific research as a model organism in the 1900s. Since then, research on 
Drosophila has contributed to understanding further, a wide range of scientific topics 
such as ageing, behaviour, genetics and human disease (Fernandez-Moreno et al., 
2007).  A total of six Nobel prizes have been awarded to researchers working with 




The Drosophila genome consists of only 4 pairs of chromosomes; X/Y, II, III and IV. 
Although due to the notably small size of chromosome 4, the majority of genes are 
encoded on the first three chromosomes (Kaufman, 2017).  In 1910, Thomas Hunt 
Morgan discovered the Drosophila white-eyed mutant (Morgan, 1910), which was the 
catalyst for the deep understanding of fruit fly genetics we hold today (Fernandez-
Moreno et al., 2007). At present, the entire fruit fly genome, of approximately 13,600 
genes, has been characterised, making them an obvious choice for carrying out 
genetic studies (Adams et al., 2000). One of the advantages of using Drosophila 
melanogaster as a model organism is the existence of public stock centres where fly 
lines carrying drivers, transgenes or mutations, are available for the whole 
community. Two of the most important stock centres are the Bloomington Drosophila 
Stock Centre (BDSC, https://bdsc.indiana.edu/) and the Vienna Drosophila Resource 
Centre (VDRC, https://stockcenter.vdrc.at/control/main).  
 
The life cycle of Drosophila melanogaster is short, consisting of an approximate 10-
day developmental period, categorised into 4 distinct stages: embryo, larva, pupa 
and adult. The Drosophila life cycle begins with the fertilisation of an embryo encased 
in an egg, which undergoes embryogenesis for 24 hours. From embryos, they 
develop into larvae, starting with the first instar larva, which feeds on the 
carbohydrate-protein-based food media. Following on from first instar larva, they 
moult into second instar larva, which burrow into the culture medium and enter a 
second moulting phase. The mature 3-day-old third instar larvae start to migrate up 
the surfaces of the containers and here they develop into pupae. During pupation, 
metamorphosis occurs to develop fully formed adult flies, from the coordinated 
assembly and maturation of imaginal disks and histoblasts, present in the larvae. 
After a pupation period of 4 days, the adult flies eclose from their pupae and can 
survive for an approximate 2 – 3 months at 25°C (Figure 1.10).  As Drosophila are 
poikilothermic, their rate of development and longevity can be controlled using 
temperature. At 25 °C, it will take an average of 10 days to produce adult flies 
however at a lower temperature of 18 °C, the process is much slower, taking up to 20 


















Figure 1.10 Diagram of the Drosophila life cycle. 
 
 Advantages of using Drosophila as a model organism   
There are many reasons that make the fruit fly an advantageous model organism. 
The first is that they allow in vivo experimentation to study an entire organism, 
therefore can overcome the limitations associated with in vitro studies, such as the 
artificial conditions in which cells are cultured. Secondly, working with Drosophila is 
cost-effective due to their low maintenance costs. In addition, fruit flies have a short 
lifespan, when compared to the average 3-year lifespan of mice, and produce a high 
number of offspring. Furthermore, fruit flies are small 3 mm long invertebrates, 
available in much higher numbers than bigger animals and can be reared in confined 
spaces, allowing many biological repeats in a short time frame, to confirm results 
(Hirth, 2010). One of the tools that makes Drosophila an extremely valuable model 
organism is its powerful genetics. Since their first introduction to laboratories more 
than 100 years ago, scientists have been able to map out the entire fly genome and 
develop an extensive range of genetic techniques, allowing the effortless 
manipulation of targeted genes (Sun et al., 2013). There are two defined categories 
of genetic manipulation: (i) loss-of-function (LOF) and (ii) gain-of-function (GOF). LOF 




includes the partial or complete removal of a targeted gene, whilst GOF involves 
strategies to increase the expression of a specific gene. There are different strategies 
that individually or in combination allow modification of gene expression in 
Drosophila, including the use of (i) P-element insertional mutagenesis, (ii) gene 
silencing through RNA interference (RNAi), (iii) FLP-FRT recombination, (iv) 
CRISPR-Cas9 genome editing and (v) PhiC31 mediated site-specific recombination 
(reviewed in (Cooley et al., 1988) (Theodosiou and Xu, 1998) (Bier et al., 2018) (Gao 
et al., 2008) (Heigwer et al., 2018)). Another advantage is the similarity of the human 
and fly genome, where 75% of disease-related genes in Drosophila possess 
homologues in humans (Pandey and Nichols, 2011). This offers the potential to study 
the effects of human diseases in flies, to elucidate their biological mechanisms and 
discover future therapies.  
 
 GAL4/UAS system to control gene expression  
The GAL4/UAS (upstream activator sequence) system is a highly used tool that 
allows the manipulation of targeted gene expression in Drosophila (Brand and 
Perrimon, 1993). The basis of this system consists of two elements; the first is the 
functional incorporation of the yeast GAL4 transcription factor and secondly the 
presence of a UAS sequence which GAL4 binds to, neither of which are 
endogenously present in fruit flies (Scialo et al., 2016b). Each of these components is 
distributed between two separate lines. The yeast transcription factor GAL4 is 
expressed in the presence of a promoter, whilst the targeted gene is expressed 
downstream of the UAS sequence. When these two lines are crossed the 
transcription factor GAL4 is able to bind to the UAS, thus driving expression of the 
downstream gene of interest. The resulting progeny will express the transgenes of 
interest (Figure 1.11). This system allows the spatial and temporal control of gene 
expression depending on the chosen promoter. To achieve spatial control, the 






































(A) GAL4-UAS system; Virgin female flies carrying the GAL4 promoter are crossed with male 
flies carrying the transgene. This leads to the binding of GAL4 to the UAS-transgene, resulting 
in the expression of the transgene. (B) GeneSwtich GAL4 (GS) system; Similarly to GAL4-
UAS virgin female flies are crossed with male transgene flies however the GAL4 transcription 
factor is only induced in the presence of RU-846 leading to the expression of the transgene.    
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The GeneSwitch GAL4 (GS) system is a modified GAL4 protein that is only active in 
the presence of the synthetic progesterone analogue, mifepristone (RU486). This 
allows control over when and where the modified expression is activated (Nicholson 
et al., 2008). Thus, in theory, it allows work with an identical background in both 
experimental and control group where the only difference is the presence of RU486 
in the fly food. However, GS has many drawbacks including its leakiness, where the 
transgene can be expressed even in the absence of RU486 (Poirier et al., 2008). GS 
is particularly problematic when working when RNAi transgenes designed for 
depleting endogenous Drosophila genes (Scialo et al., 2016b). In the former case, 
genes are also depleted in the control, (without RU486) when strong drivers are 
used. Therefore GS requires appropriate controls and confirmation that the control 
group has normal levels of expression of the gene of interest.  
 
 Genetic screening 
Further demonstrating the advantages of Drosophila’s genetic tool kit is the ability of 
performing large-scale genetic screens, to characterise gene function and their 
respective biological mechanism (Perrimon et al., 2010). In Drosophila, the most 
common method used to perform screens is the targeted silencing of genes using 
RNA interference (RNAi). This is achieved by the integration of double-stranded 
RNAs, transported in a transgenic vector. These double-stranded RNAs cause 
targeted degradation of individual mRNA strands, thereby inhibiting gene expression 
(Mohr, 2014). RNAi provides an in vivo genetic platform to observe links between 
genotype and phenotype easily. This genetic technology has enabled the execution 
of large scale, unbiased, high-throughput genetic screens allowing the analysis of 
approximately 12,500 gene targets, equating to 91% of the Drosophila genome 
(Heigwer et al., 2018). To date, genetic screens in Drosophila have played an 
essential role in understanding metazoan development, circadian rhythm, cellular 
signalling pathways and a range of disease mechanisms (Mohr et al., 2010). 
 
 Drosophila and ageing studies  
Drosophila melanogaster is a convenient model for the research of ageing and age-
related diseases. The most valid reason is the short lifespan, of approximately 2-3 
months, (depending on genetic background and temperature where flies are 
cultured), making them ideal candidates for carrying out in vivo lifespan studies 
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quickly and easily (Sun et al., 2013). Their short lifespan allows ageing researchers 
to quickly identify genetic mutations, drugs or environmental interventions that can 
lead to the extension or reduction of longevity, within a whole organism. Thus, 
making fruit flies extremely valuable within ageing studies (He and Jasper, 2014). 
The powerful genetics of Drosophila allows manipulating the expression of any gene 
suspected to be implicated in the ageing process (Clancy et al., 2001) or expressing 
genes that do not exist in Drosophila but can modify its lifespan (Humphrey et al., 
2009). Drosophila has greatly contributed to our knowledge about age-related 
diseases such as Parkinson’s disease. For example, the genetic association between 
Pink1 and parkin was first described in fruit flies (Park et al., 2006). Pink1 and parkin 
mutants display reduced lifespan, male sterility and abnormal flight and climbing 
abilities (Guo, 2012). These phenotypes can be quantified and studied to discovery 
specific therapies that can recuse the phenotypes (Tufi et al., 2014). The former is 
true for other diseases such as cancer (Dar et al., 2012) and ageing (Brandt and 
Vilcinskas, 2013), where the ability of the flies to display disease phenotypes 
provides us with the tools to investigate and identify new therapeutic agents. 
 
 Studying mitochondrial function in Drosophila  
Over the years, experiments using Drosophila have contributed a vast amount to the 
field of mitochondrial disease and studying the role of mitochondria in ageing. In 
parallel to humans, flies accumulate defective mitochondria during ageing and in 
models of neurodegeneration (Cho et al., 2011a). One advantage of using 
Drosophila for mitochondrial studies is that mitochondrial proteins are highly 
conserved between humans and flies. In addition, the nuclear-encoded mitochondrial 
proteins are also highly conserved, allowing for the genetic manipulation of these 
genes to study specific mitochondrial diseases. Detailed information about these 
nuclear-encoded mitochondrial proteins, such as their functions, ontology and 
respective human homologues, can be easily found in the Mitodrome database 
(Fernandez-Moreno et al., 2007). Due to the variety of different genetic tools that flies 
have to offer, there have been many mitochondrial mutation models reported in the 
literature. For example, mutations that affect the OXPHOS subunits (Walker et al., 
2006) (Frolov et al., 2000) (Kemppainen et al., 2014) (Da-Re et al., 2014) (Chen et 
al., 2015) or other mitochondrial proteins (Vos et al., 2010) (Dorn et al., 2011) 
(Phillips et al., 1989). These allow us to observe the phenotypes associated with 
individual mutations. An example is the fly mutant technical knockout (tko), which 
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carried a point mutation in the mitoribosomal protein S12 gene. This tko fly mutant 
mimics the phenotype seen in the corresponding human mitochondrial disease, such 
as ETC deficiency, developmental delay, seizures and hearing loss (Jacobs et al., 
2004). Another example is the Leigh Syndrome (LS) fly model caused by mutations 
in the CI subunit ND2. In this model flies experience CI deficit, abnormal flight, 
mechanically induced paralysis, metabolic defects, neurodegeneration and 
decreased lifespan (Burman et al., 2014). An important advantage of being able to 
observe phenotypes in these Drosophila mitochondrial disease models is the ability 
to find therapeutics, which can reverse the disease pathologies in the flies (Foriel et 
al., 2015). For example, in the previously discussed LS mitochondrial disease model, 
a study reported that the administration of rapamycin was able to extend lifespan by 
rescuing metabolic defects. Drosophila are also highly important for the study of 
mitochondrial dysfunction during ageing. During ageing, Drosophila mitochondria 
exhibit alterations in morphology and functionality (Cho et al., 2011a). Using flies we 
can examine, in vivo, the effect of ageing on the activity of the individual ETC 
components and ROS production, as well as observing the global effect of 
mitochondrial dysfunction. Fruit flies, therefore, provide us with the potential to 
analyse the link between mitochondria and ageing. Finally, age-related disease can 
be studied in flies, including the Parkinson’s model discussed earlier, which exhibits 













Over the past decade, it has been widely established that ROS possess two distinct 
behaviours, within cells. Firstly, they are described as toxic by-products that trigger 
oxidative stress and drive the progression of ageing (Barja, 2014). Conversely, ROS 
are also recognised as signalling molecules, which are instrumental in maintaining 
cellular homeostasis (Ray et al., 2012). At present, it is not clear how these 
contrasting identities are determined. However, it has been speculated that signalling 
ROS messengers are characterised by site- and time-specific production, under 
controlled conditions, involving ROS with low reactivity, such as H2O2 and 
superoxide. On the other hand, harmful ROS involved in oxidative damage is 
generated at non-specific sites, in uncontrolled circumstances and involves highly 
reactive ROS, such as the hydroxyl radical (Sanz, 2016). The most acknowledged 
example of site-specific ROS production, which takes into account all of the previous 
criteria, is ROS-RET, occurring at CI. This process occurs under specific conditions, 
as a result of redox changes in the ETC, including a highly reduced CoQ pool and a 
sustained increase in the pmf. In addition, RET triggers a significant increase in ROS 
production, specifically at CI, which can subsequently be neutralised (Chance and 
Hollunger, 1961) (Chouchani et al., 2014a). Recent studies have reported the 
occurrence of RET in specific cell signalling pathways, reviewed in (Scialo et al., 
2017). However, despite all the evidence surrounding the occurrence of ROS-RET in 
vivo and its physiological importance, it is still unclear how the conditions required for 
RET initiation are reached. Therefore, the aims for my thesis were to investigate the 
mechanisms responsible for triggering ROS-RET, to establish (i) how it can be 
stimulated in vivo, (ii) how altering electron flow through the ETC can effect ROS-
RET and (iii) which cellular components are involved in the regulation of ROS-RET. 
The specific aims of each Chapter were; 
 
1) To identify if and how ROS-RET can be stimulated, physiologically in the fly 
brain (Chapter 3). 
2) To study the effects of blocking electron entry into the ETC on ROS-RET, 
through CI and CII inhibition (Chapter 4). 
3) To study the effects of blocking electrons from exiting the ETC on ROS-RET, 
through CIII, CIV and CV inhibition (Chapter 5) 
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4) To identify novel genes involved in the regulation of ROS-RET, by performing 
a Genome-Wide RNAi screen using AOX expression to prevent ROS-RET 




Chapter 2 Materials and Methods 
 
2.1 Reagents  
All of the reagents used during the experiments included in this thesis are listed in 
Table 2.1, along with their providers and catalogue numbers. 
Table 2.1 List of chemical reagents.   
Reagent  Company Catalogue number 
Active Dried Yeast  Dutscher Scientific 789093 
Adenosine 5’-diphosphate Sigma A2754-5X1G 
Antimycin A Santa Cruz 
Biotechnology 
Sc-202467A 
Bovine Serum Albumin (BSA) Sigma  A7906-100G 
Bradford Reagent Sigma B6916-500ML 
Chloroform  Sigma 288306 
Nuclease free dH2O Qiagen 129112 
Dichlorofluorescin (H2DCF) Sigma D6883-50MG 





DNase I  Fisher Scientific 10649890 
DNase I 10x Buffer Fisher Scientific 10202730 
Drosophila agar Type II Dutscher Scientific 789150 












HEPES Sigma 50046-1KG 





Isopropanol Sigma 190764 
Magnesium Chloride, Hexahydrate Santa Cruz 
Biotechnology 
Sc-203126A 
Maize meal TRS / 
MitoSOX Life Technologies M36008 
Nipagin (Methyl 4-hydroxybenzoate) Sigma H5501-100G 
Sodium Acetate (NaAc pH 5.2 3M) Life Technologies AM9740 
Phosphate Buffered Saline (PBS) tablets Cambio MC-09-9400-100 
Potassium Chloride (KCl) Sigma P9333-500G 
Potassium cyanide (KCN) Sigma 60178-25G 
Potassium Hydroxide (KOH) Sigma 484016-1KG 





L-Proline Sigma P5607-25G 
Propionic acid  VWR 8.00605.2500 
Pyruvic acid monopotassium salt Sigma 860077-1G 





Rotenone Santa Cruz 
Biotechnology 
Sc-203242 
Saccharose (sucrose) Sigma 27480.294 
SensiFAST SYBR Hi-ROX Kit Bioline BIO-92020 
(+)-Sodium L-ascorbate Sigma A4034-100G 
Sodium pyruvate Sigma P2256-25G 
Sodium succinate dibasic hexahydrate Sigma S9637-500G 






Treacle Bidvest 90028S 
Tris-HCl Promega H5121 
Trizol/TRIreagent  Fisher Scientific 11312940 










2.2 Fly Husbandry  
All flies were maintained on standard media, (1% agar, 1.5% sucrose, 3% glucose, 
3.5% dried yeast, 1.5% maize, 1% wheat, 1% soya, 3% treacle, 0.5% propionic acid, 
0.1% nipagin), prepared as described below and kept in 12 hours light:dark cycle 
incubators. Incubators were set to different temperatures depending on the 
experiment. Due to the fact that flies are poikilothermic they adapt to environmental 
temperature (Dillon et al., 2009), therefore in higher temperatures they develop faster 
than in lower temperatures. In normal conditions, flies were kept at 25°C whereas 
stocks were maintained at 18°C. For heat stress experiments flies were exposed to 
32°C for 3-4 hours, unless otherwise indicated. All experimental flies were female 
flies unless otherwise stated.  
For collection, flies were anaesthetised using CO2 and placed in vials containing 2 ml 
of standard fly food with 20 flies per vial. Vials were changed every 2-3 days. Two 
different strains were used as controls; white Dahomey strain (wDAH) and w1118. All 
lines were backcrossed, for at least 6 generations, into wDAH or w1118, or they were 
used in the original w1118 background in the case of RNA interference (RNAi) lines 
from the Vienna Drosophila Resource Centre (VDRC) used in the screen. Two 
different drivers were used to express UAS-transgenes: daughterless-Gal4 (daGAL4) 
and tubulin-Gene-Switch (tubGS). For experiments using RNAi lines of the ETC 
subunits the following strategy was used. First of all the daGAL4 driver was used to 
achieve expression throughout development. However, if this driver caused lethality 
or a weak phenotype resulting in mortality soon after eclosion, the tubGS driver was 
used, restricting expression during adulthood only.  These particular drivers were 
picked due to the level of expression induced. For example, tubulin drivers are 
considered to induce stronger levels of expression, where as daughterless are 
considered to have milder effects. Therefore, the daGAL4 driver was used instead of 
the stronger tubGAL4 driver, to lower the possibility of lethality when expressed 
during development however, the stronger tubGS driver was used instead of the 
daGS to maximise expression of the RNAi during adulthood. The control lines, driver 
lines and UAS-lines used in this thesis are summarised in Table 2.2. Expression of 
UAS-transgenes was achieved by crossing virgin females, carrying one of the two 
drivers, with males carrying the UAS-transgene. Appropriate controls were generated 
by crossing female virgins carrying the driver, (daGAL4 or tubGS), with male control 
flies, of the same background, (i.e. wDAH or w1118). Fly crosses were made in bottles 
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with 30 ml of fly food or 5 ml vials and flipped every 2-3 days for a maximum of 4 flips 
to avoid contamination and whilst virgins were still young. Each bottle reached a 
density of approximately 100 – 300 flies depending on the genotype. For example, 
less flies eclosed from bottles containing KD of the ETC complexes, which were 




Table 2.2 List of fly stocks. 
Fly Strain Source Details 
wDAH Prof Linda Partridge/University College London White Dahomey, white-eye control type background 
w1118 VDRC w1118, white-eye control type background 
wDAH; UAS-Sod2 Bloomington Drosophila Stock Centre (BDSC) Superoxide dismutase 2 (Mn) under UAS control on the 
2nd chromosome (24494) 
wDAH; UAS-mtCat 8M Prof William Orr / Southern Methodist University 
Dallas 
Catalase targeted to the mitochondrion under UAS 
control on the 2nd chromosome.  
wDAH; daGAL4 
 
BDSC GAL4 under the control of the daughterless promoter on 
the 3rd chromosome. 
w1118; UAS-ND-75 VDRC RNAi against NADH dehydrogenase (ubiquinone) 75 kDa 
subunit (CI subunit) on 2nd chromosome. (CG2286, 
100733/KK) 
w1118; UAS-ND-42 VDRC RNAi against NADH dehydrogenase (ubiquinone) 42 kDa 
subunit (CI subunit) on 2nd chromosome. (CG6343, 
110787/KK) 
wDAH; tubGS Prof Scott Pletcher/University of Michigan Gene-Switch GAL4 under control of the tubulin promoter, 
White Dahomey background, 3rd chromosome. 
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w1118; tubGS Prof Scott Pletcher/University of Michigan GeneSwitch GAL4 under control of the tubulin promoter, 
w1118 background, 3rd chromosome. 
wDAH; UAS-SdhD VDRC RNAi against Succinate dehydrogenase, subunit D (CII 
subunit) on 2nd chromosome. (CG10219, 101739/KK) 
w1118;UAS-UQCR-Q VDRC RNAi against UQCR-Q on the 2nd chromosome. 
(CG7580, 101371/KK) 
wDAH; UAS-AOX F6 Prof Howy Jacobs/ University of Tampere AOX from C.intestinalis under UAS control (allele F6) on 
the 2nd chromosome.  
wDAH; UAS-AOX F6; 
tubGS 
 AOX from C.intestinalis under UAS control (allele 
F6),Gene-Switch GAL4 under control of the tubulin 
promoter, 
wDAH; UAS-Ndi1B20 Prof Howy Jacobs/University of Tampere Ndi1 from S.cerevisae under UAS control (allele B20) on 
the 2nd chromosome. 
w1118; UAS-empty VDRC Landing site VIE-260B, insertion on the 2nd chromosome 
at position 22019296 (5’ to CR33987) 
w1118;UAS-VhaPPA1-1 VDRC RNAi against Vacuolar H+ ATPase PPA1 subunit 1on the 
2nd chromosome. (CG7007, 47188/GD) 
w1118; UAS-CG30373 VDRC RNAi against CG30373 on the 2nd chromosome. 
(CG30373, 104802/KK) 
w1118; UAS-ABCB7 VDRC RNAi against ATP binding cassette subfamily B member 
7 on the 2nd chromosome. (CG7955, 106039/KK) 
w1118; UAS-Mitofilin VDRC RNAi against Mitofilin on the 2nd chromosome. (CG6455, 
106757/KK) 
w1118; UAS-Cchl VDRC RNAi against Cytochrome c heme lyase on the 2nd 





w1118; UAS-mRpS25 VDRC RNAi against mitochondrial ribosomal protein S25 on the 
2nd chromosome. (CG14413, 101443/KK) 
w1118; UAS-CG11200 VDRC RNAi against Carbonyl reductase on the 2nd 
chromosome. (CG11200, 101697/KK) 
w1118; UAS-CG7071 VDRC RNAi against CG7071 on the 2nd chromosome. (CG7071, 
110726/KK) 
w1118; UAS-Cul3 VDRC RNAi against Cullin 3 on the 2nd chromosome. (CG42616, 
109415/KK) 
w1118; UAS-Ppn VDRC RNAi against Papilin on the 2nd chromosome. (CG33103, 
108005/KK) 
w1118; UAS-CG9853 VDRC RNAi against CG9853 on the 2nd chromosome. (CG9853, 
107346/KK) 
w1118; UAS-crb VDRC RNAi against crumbs on the 2nd chromosome. (CG6384, 
39177/GD) 
wDAH ; UAS-levy VDRC RNAi against levy on the 2nd chromosome. (CG17280, 
101523) 
w1118; UAS-ATPsynδ VDRC RNAi against ATP Synthase, δ subunit on the 2nd 
chromosome. (CG2968, 100621) 
64 
 
 Preparation of the fly food 
The fly food was prepared using the ingredients described in Table 2.3. The 
ingredients were weighed into a glass beaker, according to the required volume and 
mixed. To prepare a litre, approximately 750 ml of deionized water was added to the 
mixture and heated to 37°C, on a hot plate, under continuous agitation with a 
magnetic stirrer. Once the mixture had reached 37°C, the yeast undergoes 
fermentation for 10 minutes, after which the temperature was further increased to 
80°C and left to boil for 25 minutes. The remaining deionized water was added, to 
reach the total desired volume. The food was then allowed to cool to 70°C before the 
addition of propionic acid and nipagin (diluted in EtOH to a 10% (w/v) stock solution). 
 
The cooled mixture was then dispensed into vials (2 ml or 5 ml) or bottles (30 ml) and 
left at room temperature to set, for approximately 60 minutes. Food was stored at 
4°C and used within 14 days. Before use, food was left at room temperature to warm 
up, for approximately 60 minutes. Activation of the modified GAL4 protein GS was 
achieved by adding mifepristone (RU-486) into the standard fly food mixture. A 100 
mM stock solution of RU-486 was prepared in EtOH and diluted to the final 
concentration to which 200 μL was added to molten food (1 μM during development 
and 500 μM during adulthood). Adult flies were fed the drug (500 μM) from eclosion 
for up to 10 days before being used for experiments unless otherwise stated. A fresh 
Table 2.3 List of fly food ingredients. 
Standard medium for 1000ml 
% in food Quantities Component 
1% (w/v) 10g Drosophila agar Type II 
1.5% (w/v) 15g Saccharose (sucrose) 
3% (w/v) 30g D-(+)-Glucose 
3.5% (w/v) 35g Active Dried Yeast 
1.5% (w/v) 15g Maize meal 
1% (w/v) 10g Wheat germ 
1% (w/v) 10g Soybean flour 
3% (w/v) 30g Treacle 
0.5% (v/v) 10ml Propionic acid 
0.1% (w/v) 5ml Nipagin M 
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stock of RU-486 was prepared every 2 weeks and the appropriate volume was added 
to the standard food, to reach desired concentration.  
 Addition of ETC inhibitors to the fly food 
I prepared stock solutions for the different ETC inhibitors in EtOH, except for cyanide, 
which was dissolved in water. After diluting the stock solution, to reach the desired 
final concentration of inhibitor, I added 100 μl onto the surface of the set pre-made fly 
food. The inhibitors were added on top of the 2 ml vials of food and left on a shaker 
at 4°C overnight, to allow even distribution and absorption into the food. Vials were 
covered in aluminium foil to prevent contamination. Control vials were prepared 
concurrently, where the vehicle without drug was added on top of the food. Table 2.4 
lists the different ETC inhibitors and concentrations used in this thesis. The flies fed 
inhibitors were starved before being transferred onto the food with the ETC inhibitors. 
Starvation was achieved by transferring the flies into empty vials for 1 hour.  
 
Table 2.4 List of ETC inhibitors and their concentrations 








EtOH 8.750 M 600 µM 
Myxothiazol (CIII) EtOH 1 mM 10 µM, 50 µM, 100 
µM, 500 µM or 1 mM 
Cyanide (CIV) H2O 1 M 12 mM or 18 mM 
Oligomycin (CV) EtOH 1 mM 10 µM or 50 µM 
FCCP (uncoupler) EtOH 1 mM 600 µM, 900 µM or 1 
mM 
 
 Heat Stress model 
Female flies of approximately 3 days old were transferred from a 25°C incubator, 
(non-stressed conditions), to a 32°C incubator, (heat stress, HS), for 3-4 hours, 
unless otherwise stated. Flies were used immediately for experiments, (e.g. ROS 
measurements in the fly brain), after HS. This model is outlined in Figure 3.4. During 
the HS signalling experiment, studying the effect of HS during 1-6 hours, flies were 
exposed to HS and measured after every hour.  In experiments where flies subjected 
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to HS were also fed inhibitors, the flies were starved for 1 hour before being 
transferred onto drug food and placed in 32°C incubators. This included the control 
flies fed the vehicle, which were also starved for 1 hour.  The implementation of the 
HS model during the lifespan experiments is detailed below.  
 Lifespan Experiments  
For the lifespan experiments, female wDAH flies were used. 20 flies were collected 
one day after eclosion and transferred to 2 ml vials of standard fly food. Each 
experimental condition had 5 independent replicates of 1 vial, (100 flies in total per 
condition) and each experiment was repeated twice. All vials were maintained at 
25°C in a 12 hours light:dark cycle controlled incubator with the exception of the 
period of time during which experimental flies received their treatments. Flies were 
changed into fresh food vials every 2-3 days and the number of dead flies was 
scored. The goal of the lifespan experiments used in this thesis was to test whether 
induction of ROS-RET using HS could extend lifespan. HS was induced as described 
above to the experimental group and one control group, fed with 600 μM of rotenone 
as described in Section 2.2.3. HS was repeated three times a week. The other two 
control groups were kept at 25°C, where one was fed with 600 μM of rotenone. Three 
different experimental designs were used; (1) HS 3 times per week during the first 25 
days of life, (2) HS 3 times per week from day 25 to day 50 and (3) HS 3 times per 
week constantly throughout the lifespan of the flies. Figure 3.15-3.16 contains a 
summary of the experimental plan.  
 Genome-Wide RNAi Screen 
For the screen, 12,719 RNAi lines were acquired from VDRC (Dietzl et al., 2007) 
(https://stockcenter.vdrc.at/control/main). The laboratory acquired all the lines from 
the KK library (~9,646 lines) and then lines from the GD library for those genes that 
were not covered in the KK library. Integration of the transgenes in the GD lines is 
achieved via  P-element transposition, which results in random integration, unlike the 
KK RNAi lines which use PhiC31 site-specific integration (Dietzl et al., 2007) (Bischof 
et al., 2007). The specific integration site of the KK RNAi library, where the hairpin 
constructs are targeted to is the 30B landing site. However, recently it has been 
demonstrated that in fact there are two possible integration sites (Green et al., 2014). 
Studies have revealed that 75% of KK lines possess the 30B insertion site and the 
remaining 25% possess both the intended 30B site as well as the 40D landing site 
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(Vissers et al., 2016). This produces the potential for off target and non-specific 
phenotypes for the approximate 25% of KK RNAi lines that possess both integration 
sites, which is documented for on the VDRC website. A total of 12,372 different fly 
genes covering >91% of protein-coding genes in the Drosophila melanogaster 
genome were studied. The screen was initiated in Tampere (Finland) and finished in 
Newcastle (United Kingdom) and took over 5 years to be completed. The selected 
dose of RU-486 (1 µM), added to the fly food to induce the expression of the RNAi 
construct and/or AOX, was chosen based on preliminary experiments performed by 
Essi Kiviranta and Alberto Sanz in Tampere (Finland). In these experiments, it was 
established that 1 μM of RU-486 in the fly food was the optimal dose to rescue the 
lethal phenotype, caused by the knock-down of 4 different genes encoding subunits 
of CIV (COX4, COX5A, COX5B, COX7A). Dr Rhoda Stefanatos and I completed the 
screen in Newcastle where all lines were screened at least once.  
The 12,719 RNAi lines were analysed in batches of 100-300 lines per week. In most 
cases, males carrying the UAS-RNAi transgene were selected directly from the vials 
received from VDRC. Males were crossed with virgin females carrying the tubGS 
driver, (control group), or females carrying both the driver and UAS-AOX construct 
(AOX group). Crosses were performed in vials of food containing 1 μM of RU-486 at 
25°C. Flies mated and laid eggs for 5 days, after which adult flies were discarded 
from the vials. After 10 days, vials were scored for the presence of larvae, pupae or 
adult flies, during 3 consecutive days. I defined lethality as the absence of flies 3 
days after the expected eclosion time, (10 days), in the control group. Then, I 
established three different lethal phenotypes; (1) lethal at embryo stage, where no 
larvae was observed in the vial, (2) lethal at larval stage, where larvae were observed 
but no pupae and (3) lethal at pupal  stage, where pupae were observed but no adult 
flies. Within the list of scored lethal genes, I identified a gene as an AOX rescue gene 
when larvae, pupae or adults were observed in the AOX group but not in the control 
group. Negative and positive controls were included in each batch of screened flies, 
to identify potential problems with either the quality of food or the concentration of 
RU-486. These controls were used to select which lines needed to be rescreened. 
The negative and positive controls were virgin tubGS crossed with wDAH males and 
virgin tubGS>AOX crossed with UAS-COX4-KD flies, respectively. I rescreened a 
total of 189 RNAi lines that were originally scored as rescue AOX genes, as 
described above. The rescreen was performed in the same conditions as the original 
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screen, (including reordering of the flies from VDRC), with the exception that vials 
were scored for 5 days instead of 3 days after eclosion. AOX rescue was confirmed 
only when the knock-down caused a lethal phenotype in the control group that was 
rescued, (i.e. flies eclosed), or alleviated, (e.g. no larvae or pupae in the control but 
larvae or pupae in the AOX group), by the presence of AOX. I performed data 
analysis of the results of the screen in collaboration with Dr Alberto Sanz. First of all, I 
used data from the original screen. For this analysis, I selected the list of genes that 
were scored as lethal, as described before. Secondly, I used data from the rescreen 
of 189 RNAi lines. For this analysis, I used only the list of confirmed AOX rescue 
genes as indicated before. The analysis was performed using Gene Ontology (GO) 
analysis with the Database for Annotation, Visualization and Integrated Discovery 
(DAVID) (Huang da et al., 2009) (https://david.ncifcrf.gov/summary.jsp). I also 
performed network analysis of protein-protein associations among the AOX rescue 
genes using STRING (Szklarczyk et al., 2017) (http://string-db.org/). For DAVID, the 
Function Annotation Clustering Analysis tool was selected with default settings. 
STRING analysis was performed using default setting followed by kmeans clustering 




2.3 Quantitative real-time PCR (qPCR) 
 RNA Extraction  
For each sample, a total of 10 whole flies were anaesthetised on ice and stored 
immediately at -80°C in 1.5 ml tubes. Once frozen, flies were mechanically 
homogenized in 50 µl of cold TRIreagent, and a further 250 µl of TRIreagent were 
added, which was mixed by inversion. The homogenized samples were then 
incubated at room temperature for 5 minutes. Following incubation, 50 µl of 
chloroform were added to the samples and mixed thoroughly, before being incubated 
again for 3 minutes, at room temperature. Samples were then centrifuged for 15 
minutes at 12,000 g at 4°C. The upper aqueous phase was then transferred to a new 
tube, where a 1:1 volume of isopropanol was added and mixed vigorously. Then 
samples were incubated at room temperature for 10 minutes, to allow the RNA to 
precipitate out of solution and centrifuged again for 10 minutes. The residual 
supernatant was removed by pipetting and the pellet was washed by adding 500 µl of 
75% EtOH in DEPC and centrifuged for 5 minutes at 7,500 g at 4°C.  The EtOH was 
removed and the pellet was left to air dry for 5 minutes, at room temperature. To 
remove any DNA contamination, the RNA pellet was first re-suspended in 89 µl of 
DNAse/RNAse free H2O. Then 1 µl of DNAse1 and 10 µl of DNAse1 buffer were 
added to each sample. Tubes were mixed gently by pipetting and incubated in a 
water bath for 60 minutes at 37°C, to allow the reaction to take place. After 
incubation 10 µl of 3 M sodium acetate (pH 5.2) were added, followed by 275 µl of 
95% EtOH in DEPC water and mixed thoroughly. Samples were then stored at  -
20°C overnight to allow the RNA to precipitate. Following precipitation, the samples 
were centrifuged at 16,000 g for 20 minutes at 4°C and the remaining supernatant 
was then removed. The pellet was then washed using 1 ml of 75% EtOH in DEPC 
and centrifuged again. EtOH was removed and one final wash step took place before 
drying the pellet at room temperature for 5 minutes. Depending on the size of the 
pellet, 10-20 µl of DEPC water were added to resuspend the pellet, and then the 
RNA concentration was measured using a Nano-Drop 2000C, (Thermo Scientific, 
Wilmington, USA). The concentrations of RNA were then adjusted to no more than 2 
µg/µl with DEPC water and stored at -80°C for cDNA synthesis.  
 cDNA Synthesis 
To ensure there was enough cDNA for multiple qPCR measurements, cDNA 
synthesis was performed in triplicate for each sample. Finally, the cDNA from the 
70 
 
triplicates was pooled in one single tube. Each cDNA synthesis had a final volume of 
20 µl, consisting of 10 µl master mix and 10 µl of the sample. All samples and 
reagents were defrosted on ice and samples were diluted with Nuclease-free H2O to 
achieve an RNA maximum concentration of 2 µg. The master mix was prepared 






PCR tubes were used to carry out cDNA synthesis. 10 µl of the sample were added 
first to the PCR tube, followed by 10 µl of the master mix. The tubes were spun down  
and placed in the PCR Thermocycler, (Applied Biosystems, California). The following 
programme was used: 25°C for 10 minutes, 32°C for 120 minutes, 85°C for 5 
minutes and finished at 4°C. 
 q-PCR using the Standard Curve Method 
Primers were designed using the Primer 3 web designing software (Untergasser et 
al., 2012) (http://primer3.ut.ee/), for each gene. For the SYBR green reagent used 
the recommended amplicon length is <200 base pairs. In addition, the Tm was set at 
60°C and GC content was set at 50%.  
To create the standard curve a serial dilution was made using four points. The cDNA 
samples were thawed on ice and 5 µl of every sample were added to a new tube to 
make a stock solution. This stock was then diluted 1:1, using nucleic acid-free water, 
making the first point of the standard curve. Serial dilutions were then prepared by 
taking 20 µl of the solution and diluting with 80 µl of nucleic acid-free water, this was 
repeated three times to obtain four standard dilutions in total. The four points of this 
standard curve were 1, 1:10, 1:100 and 1:1000. cDNA samples were diluted 1:20 to 
ensure they would sit in the linear part of the standard curve. 
All plates were prepared with a standard curve for each set of primers, (each target 
genes and the housekeeping gene), as well as the samples for each set of primers. 
Table 2.5 List of reagents used during cDNA synthesis. 
Reagents MM 1x (10 µl) 
10x RT Buffer   2.0  µl 
25x dNTP Mix (100mM) 0.8  µl 
10x Random Primers  2.0  µl 
MultiScribe Reverse Transcriptase 1.0  µl 
Nuclease-free H20 4.2  µl 
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The house-keeping gene acted as a control and gave a baseline to which the target 
gene expression was compared to. Standards and samples were run in triplicates in 
fast optical 96 well plates, (Applied Biosystems, San Francisco, USA), for qPCR. A 
master mix containing nuclease-free H2O, SYBR green and the forward and reverse 
primers was prepared for each primer set, using the amounts shown in Table 2.6. 
 
 
The plate was prepared by pipetting 4 µl of standards and samples and then 16 µl of 
the master mix, containing primers specific to either target gene or house-keeping 
gene, to obtain 20 µl of reaction mix in each well in total. The plate was then sealed 
using a clear cover and inserted in the StepOne, qPCR machine (Applied 
Biosystems, San Francisco, USA). The programme used followed a cycle of 95°C for 
2 minutes, then 95°C for 5 seconds, 60°C for 10 seconds and 72°C for 10 seconds.  
The last three steps were repeated for 40 cycles. Measurements were taken during 
the 72°C extension stage. The obtained values were quantified using the StepOne 
v2.1 software.  Raw values obtained from the quantification of target genes were 
normalised against the raw values from the quantification of the house-keeping gene. 








Table 2.6 List of reagents used for qPCR.  
Reagents MM 1x (16 ul) 
Nuclease-free H2O 5.2  µl 
2x SYBR Green SensiFast Hi-Rox buffer                    10  µl 
20µM Forward Primer   0.4  µl 






Table 2.7 List of Primers.  
Gene/Primer Name Primer Sequence 
SdhD Forward 5’- CTCTGGACTGTGGAGCGAATT-3’ 
SdhD Reverse 5’- GGATGACGACAGAGATGGCC-3’ 
VhaPPA1-1 Forward 5’- AACGTTCCTGTGGCTCTTCC-3’ 
VhaPPA1-1 Reverse 5’- GTTTGAGGAGGCCAGGAACC-3’ 
Ppn Forward 5’- ATTTAGGACCTTGGACGCCG-3’ 
Ppn Reverse 5’- GCTTCTCCTCCACGCAATCT-3’ 
Cchl Forward 5’ GCAATACAGCCATCACCCGA-3’ 
Cchl Reverse 5’- AGGCCGATTTTGCATCTCCA-3’ 
Rpl32 Forward 5’- AGCATACAGGCCCAAGATCGTGAAGAA-3’ 
Rpl32 Reverse 5’- CACGTTGTGCACCAGGAACTTCTTGAA-3’ 
Act88f Forward 5’- AGGGTGTGATGGTGGGTATG-3’ 
Act88f Reverse 5’- CTTCTCCATGTCGTCCCAGT-3’ 
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2.4 High-Resolution Respirometry measurements 
Measurements of mitochondrial oxygen consumption were performed by high-
resolution respirometry in homogenates from whole flies or fly heads (Sperl et al., 
1997). 10-20 female flies, (whole flies), or 20-30, (fly heads), were immobilised on ice 
and transferred to a mortar at 4°C to which 500 µl of ice-cold isolation buffer without 
BSA, (250 mM sucrose, 5 mM tris-HCl, 2 mM EGTA, pH 7.4), were added. Flies were 
then gently homogenised with a pestle to minimise mitochondria damage, caused by 
rupture of the mitochondrial external membrane. Fly homogenates were collected in 
a beaker, after being filtered through a polyamide net to remove debris. An additional 
500 µl, (for whole flies), or 300 µl, (for fly heads), of isolation buffer without BSA was 
added and the homogenate was collected into a tube. Samples were prepared every 
time just before making oxygen consumption measurements.  
The Oxygraph 2-K, (Oroboros Instruments, Innsbruck, Austria), was used to measure 
mitochondrial oxygen consumption of fly homogenates. The Oxygraph 2-K is 
specially designed to perform high-resolution respirometry measurements with small 
amounts of sample (Hutter et al., 2006). Before adding the samples, the chambers of 
the oxygraph machine were cleaned thoroughly, with 70% EtOH and distilled water, 
to ensure any residual inhibitors or substrates from previous runs were removed. In 
between runs, the chambers were washed thoroughly 3 times with EtOH and water. 
A total of 1.9 ml of assay buffer with BSA, (120 mM KCl, 5 mM KH2PO4, 3 mM 
HEPES, 1 mM EGTA, 0.5 mM MgCl2, 0.2% (w.v) BSA, pH 7.2), were added to the 
chambers, followed by 100 µl of the homogenate. For each run, one chamber would 
contain the control group whilst the other would contain the experimental group. To 
reduce variability between the chambers, the groups were alternated between every 
run. The chambers were closed after adding the samples and the run was initiated. 
Substrates and ETC inhibitors were added only after the O2 flux signal was stable. 
Hamilton Gastight syringes, (Hamilton Bonaduz AG, Bonaduz, Switzerland), were 
used to add the substrates and inhibitors. To initiate CI+CIII+CIV respiration the 
following substrates were added to the chambers: 5 µl of 2 M pyruvate, 5 µl of 2 M L-
proline and 4 µl of 0.5 M ADP. Once a stable reading was obtained, CI-linked 
respiration, (i.e. CI+CIII+CIV), was inhibited using 1 µl of 1 mM rotenone stock. Then 
60µl of 0.65M sn-glycerol-3-phosphate (G3P) were added to stimulate CIII+CIV 
respiration and after a stable reading was obtained, 1 µl of 5 mM antimycin A was 
added to inhibit CIII. Finally, 5 µl of 0.8 M ascorbate and 4 µl of 0.25 M TMPD were 
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added to the chambers to initiate CIV respiration, through the donation of electrons to 
Cyt C. Once the O2 flux signal was stable, 1 µl of 1 M cyanide was added to inhibit 
CIV respiration. A minimum of 3 independent biological samples, per group were 
used in each experiment.  
Quantification of oxygen consumption was performed using the Oroboros DataLab 
5.0 software. Raw values were measured by recording the stabilised rate of O2 flux 
after the addition of appropriate substrates. For CI-linked respiration, (also referred to 
as CI+CIII+CIV respiration), the rate after the addition of pyruvate+proline+ADP was 
taken. CIII-linked, (also known as CIII+CIV respiration), was quantified by recording 
the stabilised rate after addition of G3P. Finally, CIV-linked respiration, (also known 
as CIV respiration), was measured by taking the stabilised rate of respiration after 
addition of ascorbate+TMPD and subtracting the residual respiration after cyanide 
was added. When head homogenates were used, only CI+III+IV respiration was 
measured. This was due to the fact that preparing head homogenates is very time 
consuming and these homogenates have fewer mitochondria, therefore it is difficult 
to get good estimations for CIII+CIV linked respiration. Oxygen flux raw values were 
normalised to the amount of fly protein added to the chamber. The protein 
concentration measurements were carried out using the Bradford assay. Final values 














2.5 ROS Measurements in the Drosophila Brain 
Approximately 5-10 female flies were used for each genotype/condition. 10-20 flies 
were transferred to an ice-cold vial and anesthetised then kept on chilled aluminium 
foil to maintain immobilisation. A minimum of 5 brains were imaged per experimental 
condition but additional brains were dissected, incase of any damage occurring to the 
brains during dissection. Using forceps the immobilised flies were placed one by one 
in 70% EtOH for 30 seconds to remove the hydrophobic layer surrounding the flies, 
which may have caused them to float, making dissection difficult. Once cleaned, flies 
were then dried and transferred to a glass dissecting dish well, containing chilled 1X 
PBS. Under a light microscope the brains of flies were carefully dissected, using 
dissection forceps, ensuring that the brain was fully intact without damage, which 
could lead to the presence of outliers in the measurements. Each experimental group 
was dissected in less than 10 minutes to minimise damage to the brain. All trachea 
and tissue surrounding the brain was removed, to allow clean staining and imaging. 
A minimum of 5 brains was used for each group. After dissection, the brains were 
gently transferred to fresh PBS to be cleaned and then relocated to a small glass 
dish well. A Pasteur pipette coated in silicon was used, to avoid any brains attaching 
to the inside wall of the pipette during transfer. The excess PBS was removed, and 
100 µl of PBS solution containing the appropriate fluorophore were added at the 
concentrations indicated in Table 2.8. 
 
 
The working concentration of the fluorophore was prepared at the desired 
concentration in 1X PBS, prior to dissection.  The same preparation was used for all 
of the different groups within the experiment to reduce variability. MitoSOX was used 
to measure mitochondrial superoxide levels whilst H2DCF was used to measure total 
cellular peroxide levels. Experiments using MitoSOX were carried out in collaboration 
with Filippo Scialo. Once the chosen fluorophore was added, forceps were used to 
Table 2.8 List of fluorophores used to measure ROS. 
Fluorophore Stock in DMSO Working Concentration Wavelength 
MitoSOX  2.5 mM 30 µM 510/580 nm 
H2DCF 10 µM 30 µM 495/529 nm 
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carefully attach the brains to the bottom of the dish well facing upwards. The dish 
well was then placed onto a shaker at speed 50 rpm at room temperature and 
incubated for 10 minutes in the dark, due to light sensitivity of the probes. After 
incubation, the fluorogenic dye was removed, and the brains were washed with 300 
µl of 1X PBS using a pipette to gently mobilise the brains. Once washed the fly brains 
were transferred to a poly-lysine coated 35 mm glass-bottom culture dish containing 
1X PBS. The fly brains were mounted to the bottom of the dish well, using the 
forceps, with the antennal lobe facing towards the glass in a line. The dish well was 
then transferred onto the microscope stage of the SP8 confocal microscope, (Leica 
Microsystems, Wetzlar, Germany). The microscope was set with a 10x 0.3 NA 
objective and an argon laser with the required wavelength needed to excite the 
respective dyes was used, (noted in the table above). To acquire Z stack images, 
LasX software was used. The same number of stacks was used for each sample to 
minimize variability. The average total intensity was quantified for each individual 
brain using FIJI/ImageJ software (https://imagej.net/Fiji). 
2.6 Statistical Analysis 
All data were analysed with GraphPad Prism 8, (GraphPad Software, California), using 
one-way ANOVA or the unpaired Student’s T-test as appropriate. Lifespan survival 
curves were analysed using the log-rank Mantel Cox Test. Values shown represent 
means ± SEM unless otherwise indicated. p<0.05 was taken as statistically significant 











Chapter 3 Heat Stress Induces ROS-RET physiologically in 
Drosophila Melanogaster 
 
3.1  Reverse Electron Transport 
RET is the flow of electrons from the CoQH2 to CI, reducing NAD+ to NADH (Scialo 
et al., 2016a). For RET to occur, two conditions are required, including a highly 
reduced CoQ pool and a high pmf (Robb et al., 2018). Once triggered, studies have 
shown that a dramatic increase in ROS production from CI occurs, as a result of RET 
(Robb et al., 2018). 
The dual nature of ROS has been extensively explored in the past decade, where 
studies have shown that ROS possess roles in both oxidative stress and redox 
signalling (Sanz, 2016). Results from previous experiments using the alternative 
respiratory enzyme, Ndi1, showed that RET produces a ROS-dependent beneficial 
effect on lifespan in Drosophila. Ndi1 mediated ROS production has also been 
shown to protect mitochondrial function in both SOD2-KD and PINK1-KD models, 
which under normal circumstances cause mitochondrial dysfunction (Scialo et al., 
2016a). This suggests that ROS produced specifically via RET may possess 
signalling properties, capable of initiating downstream protective pathways in order 
to promote healthy ageing. Thus leading to the increase in lifespan, observed in the 
Ndi1 flies. Understanding the mechanisms behind RET will allow us to induce 
beneficial ROS-RET that in theory can extend lifespan and protect mitochondrial 
function.  
The Ndi1 model provides us with stimulation of RET, in vivo, however Ndi1 isn’t 
endogenously expressed in either humans or flies. Therefore in this Chapter, I 
attempt to determine if RET can occur physiologically, in Drosophila.  
  RET Under Physiological Conditions 
RET was first discovered in the 1960’s in isolated mitochondria but was considered 
to be an in vitro artefact lacking physiological relevance (Chance and Hollunger, 
1961). However, recently, RET has been recognised in a number of cell signalling 
processes as well as having a significant role within ageing (Scialo et al., 2017).  
The most frequently documented occurrence of RET is during ischemia-reperfusion 
(IR). IR occurs when tissue is re-oxygenated after a period of oxygen starvation. 
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During ischemia, succinate levels rise rapidly causing RET to be stimulated when 
oxygen is re-introduced. This leads to a dramatic increase in ROS production and 
causes injury to the surrounding tissue (Chouchani et al., 2014a). This example of 
RET, in physiological conditions, shows that when ROS is produced in a disorderly 
and uncontrolled manner it can be detrimental. Other cases that require a ROS-RET 
signal include the differentiation of myoblast into myotubes (Lee et al., 2011), hypoxia 
response in carotid bodies (Fernandez-Aguera et al., 2015) and during bacterial 
infection, where macrophages stimulate ROS-RET in order to produce an 
inflammatory response against the infection (Mills et al., 2016a). At present, it is 
uncertain how the highly reduced CoQ pool and high pmf, needed for RET to occur, 
can be generated and sustained physiologically. 
To achieve physiological stimulation of RET; I subjected Drosophila melanogaster to 
a stress condition. Here I hypothesised that under stress, mitochondria would need to 
adapt and produce a beneficial ROS signal, via RET, to protect mitochondrial 
function during the stress condition. Therefore the stress would need to create both a 
highly reduced CoQ and high pmf to promote CI to switch ROS production from a 
forward direction, in non-stressed conditions, to a reverse direction in order to initiate 
RET. For these reasons I selected heat stress (HS). HS triggers a rise in energy 
demands and causes mitochondria to consume more O2. This increases the flow of 
electrons, into the ETC, to allow mitochondria to respire more. This boost of electrons 
could lead to the production of a high CoQH2:CoQ ratio, thereby stimulating RET and 
the corresponding ROS signal, to counteract the HS (Figure 3.1). Therefore the 
characteristic increase in ROS production, seen in all RET models, would be the first 







Figure 3.1 Schematic diagram illustrating the differences in ROS production at CI 




During FET, in non-stressed conditions (top panel), electrons move from complex I to 
ubiquinone down the electron transport chain. ROS production occurs at CI when electrons 
escape and react with nearby O2 molecules. However when the ubiquinone pool becomes highly 
reduced and a high-membrane potential is established, RET is initiated (bottom panel). Thus 
electron transport shifts to the reverse direction, from ubiquinol back to CI, leading to a large 




  Validating RET at Complex I 
To validate the induction of a physiological RET-ROS signal; two inhibitors, rotenone 
and FCCP were used.  
The well-established CI inhibitor, rotenone, works by binding to the CoQ-binding site 
of CI, therefore, preventing the transfer of electrons to CoQ (Murphy, 2009). In non-
stressed conditions, during forward electron transport, interrupting the flow of 
electrons down the chain would lead to increased ROS production at CI due to 
electron leakage (Figure 3.2A). However, during RET, rotenone binding blocks the 
flow of electrons back to CI, leading to the prevention of RET. For this reason it was 
anticipated that ROS would decrease following the addition of rotenone, if RET was 
occurring (Figure 3.2B). 
FCCP uncouples the electron transport chain from OXPHOS by forming pores in the 
IMM, thereby releasing protons and subsequently dissipating membrane potential 
(Brennan et al., 2006). RET is dependent on achieving a high pmf, therefore 
administration of FCCP would prevent the stimulation of RET. Similarly to rotenone it 
was also expected that feeding FCCP during RET would lead to a decrease in ROS 
production (Figure 3.3). 
Previous experiments using the Ndi1 fly model confirmed the prevention of RET, with 
both rotenone and FCCP (Scialo et al., 2016a). Therefore in this chapter, I took 
advantage of these inhibitors to help determine if a RET-ROS signal could be 











Figure 3.2 The effects of rotenone during FET and RET. 
(A) In non-stressed conditions rotenone binds to CI preventing the transfer of electrons to 
ubiquinone, therefore leading to an increase in ROS production at CI. (B) During RET, 
electrons move backwards from ubiquinol to CI therefore in the presence of rotenone a 
decrease in ROS is observed, due to rotenone preventing the flow of electrons and subsequent 

















The uncoupler FCCP works by forming pores in the inner mitochondrial membrane, leading to 




3.2  Results 
 
 Heat stress increases ROS production 
I wanted to study the effect of exposing flies to 32°C for several hours. To do this I 
transferred flies from 25°C (non-stressed conditions) to 32°C (HS) for 6 hours and 
then measured ROS levels in dissected fly brains, after every hour, using two 
different fluorescent probes, H2DCF and MitoSOX. H2DCF was used to measure total 
cellular ROS in the form of peroxides, as it emits fluorescence when oxidised by 
H2O2 and other peroxides. To then further confirm a change in ROS, I used MitoSOX, 
which fluoresces when oxidised by superoxide. Due to MitoSOX possessing a 
positive charge, it is able to detect superoxide produced specifically in the 
mitochondrial matrix (Pavelescu, 2015). Experiments using MitoSOX were performed 
in collaboration with Dr Filippo Scialo. During the experiments I found that H2DCF 
gave a strong signal throughout the brain, which also localised at the antennal lobe. 
The MitoSOX signal was weaker in comparison to H2DCF, however also appeared to 
localise at the antennal lobe, therefore supporting that both dyes are successfully 
absorbed into the fly brain.  As Drosophila are ectothermic animals they rely on the 
temperature of their immediate surroundings to adjust their metabolic rate, making 
them ideal for carrying out HS experiments (Figure 3.4).  
HS had no effect on ROS production after 1 and 2 hours, where no change was 
observed in comparison to the control at 25°C. After 3 hours of HS, ROS levels 
significantly increased, which was detected using both dyes. ROS levels stayed 
elevated at 4 hours; however, after 5 hours ROS decreased back down to those seen 
at 1-2 hours (Figure 3.5). This indicates the presence of a dynamic ROS signal 
induced by HS, which is switched on at 3 hours and terminated at 5 hours.  
Once I had established a specific time point, in which HS was able to increase ROS 
production, I repeated HS for 4 hours to confirm an increase when compared to 
control flies at 25°C. As expected, after 4 hours ROS production was increased 
(Figure 3.6). Between the two experiments shown in Figure 3.5B and 3.6D there was 
shown to be a larger response to HS in the latter. This could be due to the fact that 
these experiments were performed on separate occasions, which could affect the 
magnitude of ROS response between experiments. For example, using different 
aliquots of fluorescent dye, a different pool of flies, different controls and variations 
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Flies are transferred to 32°C for 4 hours. Fly brains are then dissected and incubated 
in either MitoSOX or H2DCF for 10 minutes. ROS levels are measured using confocal 







Figure 3.5 ROS measurements of flies subjected to heat stress over a 6 hour time 
course. 
 (A) ROS measurements in the brain using H2DCF after 2 hours of heat stress compared to 
normal conditions, demonstrating that there is no change in ROS occurring (N = >8) (B) H2DCF 
(N = >8) and (C) MitoSOX time course over 6 hours of HS (N = >8). Flies were approximately 
3 days old. P Values were calculated using One-Way ANOVA. Data are shown as mean ± 
SEM. p < 0.05 was taken as statistically significant and represented by *, p<0.01 was represent 
by ** and p<0.001 was represented by ***. MitoSOX data was carried out in collaboration with 









Figure 3.6 ROS measurements of flies subjected to 4 hours of heat stress. 
Representative images of dissected fly brains stained with (A) H2DCF (N = >6) and 
(C) MitoSOX (N = >9) from control flies (25°C) and flies subjected to thermal stress (32°C for 
4 hours). Quantifications of (A) and (C) are shown in (B) and (D), respectively. Flies were 
approximately 3 days old. P Values were calculated using unpaired Student’s T-test. Data are 
shown as mean ± SEM. p < 0.05 was taken as statistically significant and represented by *, 
p<0.01 was represent by ** and p<0.001 was represented by ***. MitoSOX data was carried 







 Heat Stress changes the way CI produces ROS 
I tested that rotenone was able to reach the brain and inhibit mitochondrial respiration 
in the fly brain after 4 hours of feeding. Lower doses, (600 μM), did not show any 
major alteration in respiration but high doses, (900 μM and 1 mM), significantly 
reduced respiration rate, by approximately 50% (Figure 3.7A). Following confirmation 
of CI inhibition with rotenone after 4 hours, ROS measurements were conducted. As 
expected, rotenone increased ROS production during forward electron transport 
when flies were in non-stressed conditions (25°C). This increase was detected even 
using lower doses (600 μM) where no inhibition in respiration was observed, using an 
in vitro approach (Figure 3.7B – E). 
I then measured the effect of rotenone on the ROS levels during HS. As shown 
previously, an increase in ROS was observed after 4 hours of HS. However, upon 
addition of rotenone, this increase was abolished and ROS levels were similar to 
those seen in non-stressed conditions (Figure 3.8). These results support the 





Figure 3.7 The effect of rotenone on ROS production in normal conditions. 
 
 
(A) Mitochondrial respiration of fly head mitochondria after feeding flies with differing 
concentrations of rotenone (600 µM, 900 µM and 1 mM) (N = >9). Images of dissected fly 
brains stained with (B) H2DCF (N = >7) and (D) MitoSOX (N = >7), showing control flies fed 
the vehicle (EtOH) (left panel) and CI inhibitor rotenone (right panel) for 4 hours.  (C) 
Quantification of B. (E) Quantification of D. Flies were approximately 3 days old. P Values were 
calculated using unpaired Student’s T-test. Data are shown as mean ± SEM. p < 0.05 was 
taken as statistically significant and represented by *, p<0.01 was represent by ** and p<0.001 





Figure 3.8 The effect of rotenone on ROS production during heat stress. 
 
Images of dissected fly brains stained with (A) H2DCF (N = 8) and (B) MitoSOX (N = >9) 
showing the effect on ROS production after feeding flies rotenone under HS (32°C). 
Quantifications of (A) and (B) are shown in (C) and (D), respectively. Flies were approximately 
3 days old.  P Values were calculated using One-Way ANOVA. Data are shown as mean ± 
SEM. p < 0.05 was taken as statistically significant and represented by *, p<0.01 was represent 
by ** and p<0.001 was represented by ***. MitoSOX data was carried out in collaboration with 





 Dissipating proton motive force with FCCP prevents RET during heat stress.  
After using rotenone to confirm RET, I then used FCCP to prevent a high membrane 
potential from being achieved. Feeding flies with FCCP did not alter mitochondrial 
respiration in fly brain mitochondria (Figure 3.9A). However, in normal conditions, 
FCCP was capable of increasing ROS production using both H2DCF and MitoSOX 
(Figure 3.9 C-F).  
When transferred to HS, an increase in ROS could be seen, which was then 
abolished in the presence of FCCP (Figure 3.10). Therefore by dissipating the RET 
stimuli; membrane potential during HS, RET was prevented. 
It has been previously shown that dissipating the mitochondrial potential can lead to 
the relocation of MitoSOX from the mitochondria and into the cytosol, 
resulting in an increased ROS signal (Roelofs et al., 2015). 
However, due to the fact that we observe an increase in ROS in normal conditions in 
the presence of FCCP and a contrasting decrease in ROS during HS, which 
correspond to the H2DCF results, these data suggest this is not occurring during 


















Figure 3.9 The effect of FCCP on ROS production in non-stressed conditions. 
 
 
(A) Oxygen consumption of fly head mitochondria after feeding flies with varying 
concentrations of FCCP (600 µM, 900 µM and 1 mM) (N = 5). Representative images of 
dissected fly brains stained with (B) H2DCF (N = >7) and (C) MitoSOX (N = >6) after feeding 
the flies with FCCP in non-stressed conditions (25°C). Quantifications of (B) and (D) are shown 
in (C) and (E), respectively. Flies were approximately 3 days old. P Values were calculated 
using unpaired Student’s T. Data are shown as mean ± SEM. p < 0.05 was taken as statistically 
significant and represented by *, p<0.01 was represent by ** and p<0.001 was represented by 
***. Same control used for Figure 3.7D as 3.9D, due to these 3 groups being measured in the 









Representative images of dissected fly brains stained with (A) H2DCF (N = >6) and (B) 
MitoSOX (N = 9) after feeding flies with FCCP in non-stressed conditions (25°C). 
Quantifications of (A) and (B) shown in (C) and (D) respectively. Flies were approximately 3 
days old. P Values were calculated using One-Way ANOVA. Data are shown as mean ± SEM. 
p < 0.05 was taken as statistically significant and represented by *, p<0.01 was represent by 
** and p<0.001 was represented by ***. MitoSOX data was carried out in collaboration with Dr 




  ROS produced during heat stress originates from mitochondria  
To confirm the location of ROS being produced during HS, I took advantage of the 
antioxidants SOD2 and Catalase, by overexpressing them in the fly. SOD2 resides in 
the mitochondrial matrix and converts superoxide into the less reactive ROS, H2O2. 
Catalase is then able to completely detoxify H2O2, to produce inert water and O2. For 
these experiments, I over-expressed a mitochondrial-targeted catalase (Kwong et al., 
2000) (Figure 3.11). I predicted that by overexpressing both these mitochondrial 
antioxidants I would be able to manipulate the levels of ROS produced during HS, to 
determine whether or not it originates from mitochondria. These experiments were 
done in collaboration with Dr Filippo Scialo.  
When measuring ROS using MitoSOX, SOD2 overexpression revealed a decrease in 
mitochondrial superoxide during HS. These results support the ability of SOD2 to 
convert superoxide into H2O2, which was further confirmed by an increase in H2DCF 
signal, indicating more peroxides (Figure 3.12). 
Overexpression of the mitochondrial-targeted catalase enzyme showed a significant 
decrease in total cellular H2O2 levels, after 4 hours in 32°C. However, no change in 
mitochondrial superoxide levels were observed when measured with MitoSOX. 
These data are consistent with the fact that Catalase converts H2O2 into water, 
thereby leading to the decrease in ROS but without altering superoxide levels 
(Figure 3.13). 
The results obtained using the expression of antioxidants, SOD2 and catalase, 
demonstrated that MitoSOX and H2DCF successfully detect mitochondrial 
superoxide and cytosolic peroxides, respectively. Therefore, due to the ROS 
fluctuating specifically in the mitochondria, these results identified mitochondrial ROS 













SOD2 catalyses the dismutation of superoxide into H2O2. Whereas mitochondrial targeted 




Figure 3.12 The effect of SOD2 overexpression on ROS production during heat stress.  
(A) ROS measurements using H2DCF to measure H2O2 levels in flies overexpressing SOD2 (N 
= >8). (B) ROS measurements using MitoSOX to measure superoxide levels in flies 
overexpressing SOD2 (N = >9). Quantifications of (A) and (B) shown in (C) and (D) 
respectively. Flies were approximately 3 days old. P Values were calculated using One-Way 
ANOVA. Data are shown as mean ± SEM. p < 0.05 was taken as statistically significant and 
represented by *, p<0.01 was represent by ** and p<0.001 was represented by ***. MitoSOX 






Figure 3.13 The effect of mitochondrial-catalase expression on ROS production during 
heat stress. 
 
(A) ROS measurements using H2DCF to measure H2O2 levels in flies overexpressing Catalase 
(N = >10). (B) ROS measurements using MitoSOX to measure superoxide levels in flies 
overexpressing Catalase (N = >8). Quantifications of (A) and (B) shown in (C) and (D) 
respectively. Flies were approximately 3 days old. P Values were calculated using One-Way 
ANOVA. Data are shown as mean ± SEM. p < 0.05 was taken as statistically significant and 
represented by *, p<0.01 was represent by ** and p<0.001 was represented by ***. This 






 Heat stress cannot stimulate RET in old flies 
It has been previously shown that CI activity decreases with age. In Drosophila, 
mitochondrial respiration at day 50 is strongly decreased, particularly CI-respiration 
(Scialo et al., 2016a). Since I have confirmed in this chapter that the CI inhibitor, 
rotenone, is able to prevent RET from occurring I wanted to test if this age–related 
loss of CI activity, would affect the stimulation of RET.  
Consistent with prior studies (Scialo et al., 2016a), which show that ROS increases 
with age, ex vivo ROS measurements using H2DCF increased significantly at 25 and 
50 days in non-stressed conditions (25°C) (Figure 3.14A). In support of results 
reported previously in this chapter, when 25-day-old flies were subjected to HS for 4 
hours there was an increase in ROS, which was restored to control levels upon the 
addition of rotenone (Figure 3.14B). Therefore indicating the stimulation of ROS-RET 
in the 25-day-old flies. However, when conducting the same experiment with 50-day-
old flies no increase was observed in the flies exposed to HS. These results suggest 
















Figure 3.14 The effect of heat stress on ROS production in young and old flies. 
 
 
(A) Representative images of brains stained with H2DCF comparing ROS levels in young flies 
(2 – 3 days old), 25 day old flies and 50 day old flies (N = >8). (B) ROS measurements from 
25 day old flies subjected to HS and rotenone (600 µM) (N = >8).  (C) ROS measurements 
from 50 day old flies subjected to HS and rotenone (600 µM) (N = >7). (D) Quantification of A 
(E) Quantification of B (F) Quantification of C. Due to these three experiments being performed 
on separate occasions it is difficult to interpret the different intensities between the different 
images. P Values were calculated using One-Way ANOVA. Data are shown as mean ± SEM. 
p < 0.05 was taken as statistically significant and represented by *, p<0.01 was represent by 




  Intermittent induction of ROS-RET and its effect on lifespan  
I developed the HS model to test whether RET could be physiologically stimulated in 
flies and if this RET-ROS would provide the same lifespan extension, as the Ndi1 
model. After confirming the stimulation of RET, I wanted to see if the beneficial effect 
on longevity could be repeated using HS.   
To conduct these lifespan experiments, I designed three different groups. In each 
group, the flies were exposed to HS at different stages, to determine an optimal 
period of time that could promote lifespan extension. The groups were as follows; HS 
throughout the entire lifespan (hereafter referred to as intermittent HS), HS from the 
1st day of eclosion to the 25th day (hereafter referred to as 1-25) and HS from the 25th 
day to the 50th day (hereafter referred to as 25-50) (Figure 3.15). All three groups 
were kept at 32°C for 4 hours, 3 times per week.  
Intermittent HS was chosen to see if consistent stimulation of ROS-RET, for 4 hours 
3 times per week, could extend lifespan. 1-25 was selected due to previous studies 
showing that manipulation involving mitochondria or metabolism, such as fasting, or 
induction of mitochondrial fission, extend lifespan only when implemented during a 
brief period of time in early adulthood of the fly (Rana et al., 2017) (Catterson et al., 
2018). The last group, 25-50, was chosen to see the effect of HS on longevity, in 
older flies.  However, due to previous results showing that CI eventually loses the 
capacity to create ROS-RET, HS was stopped at 50 days.  
Within each group, I had 4 different conditions to help resolve any changes in 
lifespan that might occur. The first condition was 25°C (non-stressed conditions) 
which acted as the primary control. These flies were kept in the same incubator and 
transferred to normal fresh food every 2 days. The second condition was 32°C (heat 
stress), where flies were kept in 32°C incubators 3 days a week for 4 hours and 
transferred to normal food every 2 days. The third condition was 32°C + ROT. Here 
flies were flipped onto food containing rotenone and transferred to 32°C for 4 hours, 
3 times a week, before being flipped back onto normal food and placed in 25°C. This 
condition acted as a control for the HS condition, as the addition of rotenone would 
prevent RET, therefore in theory, if HS were successful in increasing lifespan, we 
would expect this to be abolished in the presence of rotenone. The fourth group was 
25°C + ROT, where flies were constantly kept in 25°C. However they were also fed 
102 
 
rotenone for 4 hours, 3 times per week. This condition acted as a control for the 32°C 
























































Figure 3.15 Diagram outlining the 3 different groups of the lifespan experiments as 
well as the 4 conditions used during the lifespan experiments and how this was 
applied on a weekly basis. 
(A) As shown, intermittent HS occurs throughout the Drosophila’s lifespan. The 1-25 group is 
subjected to HS from eclosion to 25th day, whilst the 25-50 groups is subjected to HS from 
the 25th to the 50th day. (B) The flies were subjected to the different conditions three times 
per week, namely Monday, Wednesday and Friday. The four different conditions included (i) 
25°C, (ii) 25°C + ROT, (iii) 32°C and (iv) 32°C + ROT. 
104 
 
 Heat stress does not extend lifespan in Drosophila melanogaster 
Exposing WDAH flies to 32°C for 4 hours 3 times per week throughout adulthood did 
not extend Drosophila lifespan.  In comparison to the control (25°C), both treatments 
(32°C and 25°C + ROT) decreased lifespan. However, flies showed greater 
sensitivity when both treatments were delivered together (32°C + ROT group), which 
decreased lifespan even further by approximately 20 days (Figure 3.16A). This 
decrease may be explained by the changes in ROS production we see in later life of 
the flies (Figure 3.16B). Therefore, once CI can no longer produce RET-ROS, the 
stress of 32°C and rotenone has detrimental effects on lifespan.  
During the first 25 days of adulthood, neither rotenone feeding nor HS had an effect 
on the lifespan (Figure 3.16C). This indicates that throughout early adulthood the 
flies can adapt to overcome stress conditions, more sufficiently than in later life.  
HS was not able to extend lifespan when flies were exposed during the 25th to the 
50th day of adulthood either. No significant difference was observed between the 
control, 32°C and 25°C + ROT. However, similarly to intermittent HS, exposing flies 
to both HS and rotenone during later adulthood led to a significant decrease in 
lifespan (Figure 3.17A). Since this sensitivity towards 32°C +ROT was specific to the 
groups exposed in late adulthood and was not seen in the early adulthood group, it 
further confirms an age-specific inhibition of RET. Thus, indicating that mitochondria 
can no longer adapt to counteract both HS and rotenone, ultimately leading to the 
significant decrease in lifespan. 
Analysis of the different experimental groups, exposed to conditions at different time 
periods, revealed clear correlations. Figure 3.17A shows all of the control groups 
(25°C) together, where as expected, no change in lifespan was observed between 
the 3 different conditions. The 25°C + ROT group lifespans were not affected when 
exposed to rotenone during only 1-25 and 25-50 days (Figure 3.17B). However there 
was a slight decrease detected in longevity, when exposed to rotenone 3 days per 
week, throughout the whole lifespan. A similar trend was observed in the 32°C 
group, where flies exposed to HS from 1-25 and 25-50 days, showed no difference in 
lifespan, whilst flies exposed to intermittent HS, observed a decrease in lifespan 
(Figure 3.17C). These data clearly show that flies can adapt to a stress condition, i.e. 
rotenone feeding or HS, in early adulthood more effectively than in later life. 
Interestingly, the 32°C + ROT group lifespans were significantly reduced when flies 
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were exposed constantly and during 25-50 days to HS (Figure 3.17D), in comparison 
to 1-25 days which were not affected (Figure 3.17B).  
Supporting previous observations, this indicates that the flies subjected to stress in 
later life, i.e. intermittent HS and 25-50 were not able to adapt and overcome stress 
conditions as well as the flies subjected to stress in early lie i.e. 1-25. It is possible 
that this lack of adaptation is caused by a depletion of CI activity, in older adult flies. 
As previously shown in Drosophila, CI levels are dramatically decreased at day 50. 
Additionally when 50-day-old flies were subjected to HS, no ROS-RET response was 
observed. These data together suggest that the loss of CI activity, as the flies age, 
leads to the inability of CI to switch to RET, from forward electron transport. In doing 
so it prevents the stimulation of downstream adaptation pathways that can 
counteract the stress condition, thereby leading to a decrease in longevity. This is in 
contrast to the 1-25 lifespan studies, in which a fully functioning CI can switch to 










Figure 3.16 The effect of heat stress throughout the Drosophila lifespan. 
 (A) Survival curve data displaying the effect of intermittent HS throughout lifespan. (B) Survival 
curve data displaying the effect of subjecting flies to HS from 1-25. (C)  Survival curve data 
displaying the effect of subjecting the flies to HS from 25-50 days. HS (32°C) is indicated in 
red and HS + rotenone (32°C + ROT) is indicated in blue. (N = 200). Lifespan survival curves 
were analysed using the log-rank Mantel Cox Test. p<0.05 was taken as statistically significant 











 (A) Survival curves displaying data of the control (25°C) conditions from each group. Group 
25-50 are indicated in red. (B) Survival curves displaying data of the 25°C+ROT conditions 
from each group. (C) Survival curves displaying data of the 32°C conditions from each group. 
(D) Survival curve data of the 32°C +ROT conditions from each group. Group 1-25 are 
indicated in blue and group 25-50 are indicated in red. (N = 200). Lifespan survival curves were 
analysed using the log-rank Mantel Cox Test. p<0.05 was taken as statistically significant and 





3.3 Discussion  
In summary, I have been able to demonstrate that RET can be stimulated 
physiologically in the brain of the fly, using HS. Results displayed an increase in 
ROS production after 3 hours of HS, which was detected using both H2DCF for 
cellular ROS and MitoSOX for mitochondrial superoxide. I confirmed ROS were 
produced via RET using rotenone and FCCP, established inhibitors of RET stimuli, 
which were both able to terminate RET. Additionally, the over-expression of 
antioxidants SOD2 and a mitochondrially-targeted Catalase indicated that ROS 
produced during HS originates from the mitochondria, in agreement with MitoSOX, 
providing further evidence of RET in vivo. 
I observed that under HS, ROS production is dynamic and behaves as a transient 
signal, which is initiated at 3 hours and terminated after 5 hours. To characterise the 
site of ROS production, occurring during 3 and 4 hours of HS, I used rotenone and 
FCCP, which were both able to abolish the ROS signal, indicating ROS-RET. The 
use of rotenone as an inhibitor of RET has previously been shown in numerous 
studies. For example, during Ndi1 expression in Drosophila, both rotenone and 
FCCP were able to reduce the levels of ROS-RET (Scialo et al., 2016a). Additionally, 
CI inhibition using rotenone was also able to decrease ROS-RET-induced injury 
during IR (Chouchani et al., 2014a). Thus further supporting the elevated ROS levels 
observed during HS, as being RET-induced. Interestingly, rotenone and FCCP both 
resulted in opposing effects when introduced in non-stressed conditions compared to 
HS. At 25°C, rotenone and FCCP both caused an increase in ROS, in contrast to the 
decrease in ROS under HS. The contrasting effects on ROS production, using 
rotenone and FCCP, dependent on the direction of CI activity, i.e. forward or reverse 
electron transport, provided a reliable and reproducible method of identifying the 
presence of ROS-RET. 
The characteristic features of this ROS signal make it distinctive from other sources 
of ROS production. The data showed that HS-induced-ROS, is site-specific at CI, 
resulting from the process of reverse electron transport, which is triggered under 
specific circumstances i.e. highly reduced CoQ and high membrane potential. In 
addition, the signal was shown to be transient, as ROS production was terminated 2 
hours after initiation. This evidence suggests that under stress, such as HS, 
mitochondria respond by altering metabolic activity to establish both a high 
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CoQH2:CoQ ratio and a pmf, promoting CI to switch to a reverse direction and 
stimulate a ROS-RET signal. This ROS can then diffuse through the cell, interacting 
with target proteins and stimulating downstream survival pathways, to counteract the 
stress condition. After 2 hours of ROS-RET the signal is switched off causing ROS to 
return back to basal levels. The restoration of ROS levels after this period of time 
under HS could be caused by the reestablishment of cellular homeostasis, therefore 
leading to the ROS-RET signal being switched off. Here, ROS-RET may stimulate 
beneficial processes such as proteostasis and autophagy, which would ultimately 
remove any damage caused by HS, allowing the return of normal cellular function. 
Under such circumstances the ROS-RET signal would no longer be required and 
therefore would be switched off, leading to the reduction of ROS back down to basal 
levels. This process describes a highly controlled system, where site-specific ROS is 
produced through a distinct process and removed after a certain period of time, in 
order to prevent over-oxidation of cellular components, which would lead to damage.  
The age-dependent decline in CI activity has been reported in multiple animal 
models (Tatarkova et al., 2016), more specifically in Drosophila (Scialo et al., 
2016a). Given that RET is dependent on the uninterrupted activity of CI, which my 
results demonstrate in the following chapter, I wanted to confirm whether CI 
depletion in older adult flies, would affect the stimulation of ROS-RET. My data 
indicated that between 25 and 50 days CI levels are altered, leading to a change in 
how ROS are produced. In early adulthood of flies, HS triggered a ROS-RET 
response, which was abolished upon the addition of rotenone. However, under the 
same experimental techniques, the 50-day-old flies showed no significant changes in 
ROS levels, under HS or in the presence of rotenone. These results clearly showed 
that RET was not being stimulated by HS in the 50-day-old flies, as no increase in 
ROS was observed in 32°C and rotenone was not able to decrease ROS production. 
Due to similar ROS levels being observed in non-stressed conditions and HS, this 
indicated that ROS was being produced either in the forward direction or 
unspecifically elsewhere. Interestingly, rotenone had no effect on ROS production 
either. In previous results of this chapter, I was able to show that rotenone has 
contrasting effects on ROS production, depending on the activity of either forward or 
reverse electron transport. In early life during forward electron transport rotenone 
was able to elevate ROS levels, therefore, based on these results an increase in 
ROS would have been expected, upon the addition of rotenone if forward electron 
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transport was occurring. This indicates that ROS levels are already elevated due to 
CI depletion in later life, which causes an increase in ROS through the same 
mechanisms as CI inhibition, via rotenone. The elevated ROS levels in the 50-day-
old flies, compared to early adulthood flies, support this suggestion.  
To study the downstream consequences of a physiological ROS-RET signal 
triggered during HS, I designed a lifespan experiment to observe the effects of 
intermittent HS-derived-RET and if it could elicit beneficial effects on lifespan, 
reflecting the Ndi1-RET model (Scialo et al., 2016a). The results from the lifespan 
experiments established that HS could not extend longevity, using the selected 
periods of time. Firstly, this could be due to the fact that the Ndi1 model is stimulating 
RET constantly within the fly, leading to a dramatic increase in ROS. Therefore in the 
HS lifespan study, the stimulation of RET for 4 hours, 3 times a week may not have 
been enough to produce the beneficial effect on longevity, observed in the Ndi1 
expressing flies. Alternatively, previous lifespan studies carried out in Drosophila 
have described a small window of opportunity in early adulthood, in which 
manipulating mitochondrial function, can lead to lifespan extension (Rana et al., 
2017). Therefore, it is possible that different time points may be more effective at 
achieving an increase in lifespan through HS-derived-RET e.g. development (when 
Ndi1 is active). The lifespan results obtained, suggest that after 25 days there is an 
age-related decline in CI activity, which prevents the stimulation of ROS-RET. In 
which case, future studies should take this into consideration when selecting 
alternative time periods. Despite not observing an increase in lifespan, the results 
from these experiments supported the age-dependent change in ROS production. 
Here, the flies subjected to HS in early life (1-25), showed no change in lifespan, 
compared to controls in non-stressed conditions. Whereas both groups in later life 
(intermittent HS and 25-50), exhibited decreased longevity, when subjected to both 
HS and rotenone feeding. Previous results of this chapter revealed a change in the 
ability of CI to switch from a forward to a reverse direction between 25 and 50 days 
in Drosophila. This suggests that the two later-life groups exposed simultaneously to 
both rotenone and HS, were unable to trigger ROS-RET to counteract the stress 
conditions, thereby leading to an accumulation of damage, detrimental to the flies. In 
contrast to the early life group (1-25), which could stimulate adaption responses 
through ROS-RET, to protect mitochondrial function and maintain longevity. In 
regards to the lifespan results it is also important to consider differences that occur to 
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feeding rates during ageing. As flies age they tend to eat less food, which could 
therefore impact how much drug the flies are consuming for the two groups fed 
rotenone. However due to the fact that in both groups (intermittent HS and 25-50) 
where rotenone is fed to the flies in later life a decrease in lifespan is observed when 
flies are subjected to both HS and rotenone, this suggests that the flies are eating 
the drug food in later life. Age related changes to mitochondrial density and function 
would also likely cause a change to ROS production. Here, the increase in 
dysfunctional mitochondria and mutations could have an effect on the ability of CI to 
produce ROS-RET, as previously discussed.  
Finally, I have shown that the ROS changes occurring during HS can be measured 
using both H2DCF and MitoSOX. Due to previous studies suggesting H2O2 as the 
primary source of ROS produced during RET, I chose to use H2DCF to study ROS in 
the following chapters. 
In conclusion, the results from this chapter have provided me with a method of 
stimulating ROS-RET physiologically in the fly brain, using HS. I can now take 
advantage of this system to gain a deeper understanding of the mechanisms behind 
RET i.e. factors essential for its stimulation or modulation. Additionally, I was able to 
show that the progressive age-related loss of CI can prevent ROS-RET from 












Chapter 4 Effect of limiting the entry of electrons into the 
mitochondrial ETC on ROS-RET. 
 
4.1 Manipulating the Redox State of CoQ 
A highly reduced CoQ pool is essential for triggering RET (Robb et al., 2018). The 
discovery of RET occurred when Chance and Hollunger observed that feeding the 
ETC with succinate, (a CII substrate), lead to the production of NADH from NAD+ 
and a rise in ROS generation (Chance and Hollunger, 1961). We now know that RET 
was achieved as a result of high concentrations of succinate feeding the 
mitochondrial ETC, causing the CoQ pool to become extremely reduced. 
There are multiple different routes in which electrons can enter the ETC and 
contribute to the reduction of CoQ. One of the major sources being via CI, where 
soluble NADH, produced through the oxidation of sugars, proteins and fats, is 
oxidised to NAD+. This process donates two electrons that are transferred down the 
ETC to generate energy (Zhao et al., 2019). Equally important is CII, which oxidises 
succinate into fumarate via a prosthetic FAD and transfers the electrons directly to 
CoQ (Sousa et al., 2018). In fact, increased oxidation of succinate, by CII, is 
responsible for triggering ROS-RET during IR (Chouchani et al., 2014a). Although CI 
and CII are considered the main entry points for electrons, there are other 
dehydrogenases that also introduce electrons downstream of CI and CII.  For 
example, G3PDH, which oxidises G3P, through the reduction of FAD into FADH2 and 
then carries the electrons to ubiquinone (Mracek et al., 2013). The ETF-QO also 
contributes to the reduction of the ubiquinone pool, by directly passing electrons to 
Co-Q from another mitochondrial matrix flavoprotein (Chokchaiwong et al., 2019). 
Lastly, the enzyme DHODH transfers electrons to the CoQ pool, acquired from 
catalysing the mitochondrial oxidation step in pyrimidine biosynthesis (Singh et al., 
2017).  
All electrons entering the ETC, via these different pathways, pass through CoQ, thus 
making CoQ a central component of the ETC. For this reason the redox state of CoQ 
allows the rest of the cell to sense the metabolic activity of the mitochondria. For 
example, if the flow of electrons has been interrupted, the CoQ will be over-reduced, 
or if there are not enough electrons in the ETC, CoQ will be highly oxidised. 
Therefore it is possible that the CoQ is part of a system, which allows the sensing of 
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mitochondrial state to be coupled with the generation of a signal that can activate 
changes to fine-tune mitochondrial respiration and metabolism. When mutations 
arise in any of the 10 genes encoding the synthesis and assembly of CoQ, it causes 
chronic dysfunction that phenocopies mitochondrial disease (Bentinger et al., 2010). 
Additionally, mitochondrial diseases caused by mutations in genes not involved in the 
assembly or structure of CoQ can also causes depletion in CoQ levels (Yubero et al., 
2016). This highlights the importance of CoQ and its potential role in promoting RET. 
In Chapter 3, I was able to confirm that RET occurs under physiological conditions 
after exposing flies to HS. This provided a physiological model, in which I could take 
advantage of, to further understand the mechanisms that trigger RET. Using a 
hypothesis-driven approach to identify components involved in the generation of 
RET, I decided to manipulate the five respiratory complexes of the mitochondrial 
ETC. First of all, I decided to study how preventing the entry of electrons into the 
ETC and therefore the reduction of CoQ, would affect the generation of a ROS-RET 
signal. To achieve this, I used both chemical and genetic inhibition of CI and CII in 
order to test the effects of short term and long term inhibition, respectively. It was 
important to use both short and long term to provide two models of inhibition. Firstly, 
short term inhibition, allows me to observe the acute effects after 4 hours of blocking 
the respiratory complexes. Secondly, long term genetic inhibition, allows the 
observation of adaptations including changes in the expression of transcripts and 
proteins occurring over long periods of inhibition.  
Here I predicted that blocking the entry of electrons into the ETC, via inhibition of CI 
and CII, would prevent the occurrence of a highly reduced CoQ pool and therefore 
inhibit the stimulation of RET.  
In order to achieve a more comprehensive vision of how manipulation of CI and CII 
activity affects ROS signalling, I decided to perform experiments under conditions 
where electrons flow through CI in the forward direction, (25°C), and conditions 
where electrons also flow in a reverse direction, (after exposure to 32°C for 4 hours, 





4.2 Reduction of CI activity 
CI, the largest of the respiratory chain complexes, occupies an L-shaped structure, 
which consists of a long hydrophobic arm embedded into the IMM and a hydrophilic 
arm that protrudes into the mitochondrial matrix (Zhu et al., 2016). As previously 
shown in Chapter 3, the CI inhibitor, rotenone, was able to increase ROS production 
in non-stressed conditions. However under a stress condition (HS), rotenone 
decreased ROS production. This indicated that during HS, CI can switch to produce 
ROS via RET, which was validated using the membrane potential dissipater, FCCP. 
After testing chemical inhibition using rotenone, I wanted to genetically inhibit CI to 
observe the effect of reducing the levels of CI, the primary site of ROS-RET 
generation. Therefore, I tested two genetic knockdown models of the CI subunits, 
ND-75 and ND-42.  
The core subunit ND-75 (NDUFS1) resides in the hydrophilic region of CI. Here it 
participates in electron transfer between the flavin, where NADH is oxidised, to the 
CoQ pool (Brandt, 2006) (Figure 4.1). Thus I anticipated that silencing ND-75 would 
stop the movement of electrons through CI and decrease the amount of electrons 
contributing to the reduction of CoQ. Previous papers using the same CI subunit had 
reported a clear KD (Garcia et al., 2017a). 
 
In addition, I studied an accessory subunit of CI; ND-42 (NDUFA10) found in the 
hydrophobic region of CI (Stroud et al., 2016) (Figure 4.1). Although its role within CI 
is unclear, ND-42 seems instrumental for the reduction of ubiquinone. The KD of ND-
42 has previously been shown to phenocopy mutations in Pink1. Conversely, when 
overexpressed, ND-42 was able to partially rescue Pink1 mutants, corresponding to 
results from the Ndi1 fly model (Pogson et al., 2014). These data suggest that 
alterations in mitochondrial morphology associated with Pink1 and ND-42 depletion, 




































ND-75 is found in the hydrophilic arm, where transfer of electrons to CoQ occurs, 
therefore its knockdown prevents the entry of electrons into CI. ND-42 resides in the 
hydrophobic region, near to the CoQ binding site where electrons are passed to CoQ. 
Knockdown of both genes blocks the transfer of electrons to the CoQ pool, therefore 




4.3 A fully functional CI is required for ROS-RET. 
I checked that the KD of ND-75 effectively decreased CI function by measuring 
mitochondrial respiration in whole fly lysates. As expected, a significant decrease, 
specific to CI-linked respiration alone, was observed in ND-75-KD flies, 
(DaGAL4>ND-75-KD), when compared to wild type control flies, (DAH>ND-75-KD) 
(Figure 4.2A). This is in agreement with the phenotype observed after knocking down 
two different CI subunits, ND-39 and ND-19 (Sanz et al., 2010b) (Scialo et al., 
2016b). Additionally, I performed qPCR to quantify the RNAi line (Figure 4.2B), which 
also confirmed the presence of CI KD. After confirming, that CI-linked respiration was 
specifically decreased, I then measured ROS levels in non-stressed conditions 
(25°C), where electrons flow through CI in the forward direction. At 25°C, no 
significant difference was observed between the KD flies and their respective control 
flies (Figure 4.2B). I then transferred the flies into HS to test whether reduction in CI-
linked respiration altered the stimulation of ROS-RET. As shown previously, a clear 
increase in ROS levels was observed in control flies exposed at 32°C, when 
compared to the control flies at 25°C. Interestingly, this increase was not observed in 
ND-75-KD flies at 32°C, indicating that a fully functioning CI is required for ROS 
produced via RET (Figure 4.2C). 
The efficiency of the RNAi against ND-42 to deplete CI was again confirmed by 
measuring mitochondrial respiration. As observed when ND-75 subunit was KD, 
there was a significant decrease in CI-linked respiration in the ND-42-KD flies, 
(DaGAL4>ND-42-KD), compared to the control flies, (DAH>ND-42-KD) (Figure 4.3A). 
The decrease in respiration observed was similar in both CI subunits. As in the case 
of ND-75-KD, no effect in CIII-linked or CIV-linked respiration backflow in the mutant 
flies. However due to the experiments being performed separately it cannot be 
determined how strong the decrease in CI activity is when comparing the two 
subunits. The health of the flies does suggest that the expression of the ND-75-KD 
flies was stronger than the ND-42-KD flies, as they were weaker than the latter. 
 
 
Ex-vivo ROS measurements at 25°C showed no difference in ROS production 
associated with the KD of ND-42 (Figure 4.3B). However, under HS, we observed 
that mutant flies were not able to up-regulate ROS levels, as observed in the controls 
(Figure 4.3C). In summary, I have shown that genetic depletion of two CI subunits, 
which reduce mitochondrial respiration, prevent the triggering of ROS-RET in 
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physiological, together with the results obtained using rotenone to chemically block 




































Figure 4.2 Effect of ND-75-KD on ROS production in non-stressed conditions and 
during heat stress. 
 
(A) Mitochondrial respiration using CI-linked, CIII-linked and CIV-linked substrates in ND-75-
KD whole fly homogenates, (DaGAL4>ND-75-KD), compared to the respective controls, 
(DAH>ND-75-KD) (N = 7).  (B) Quantification of mRNA levels in ND-75-KD flies by qPCR. 
Control flies (DaGAL4>DAH and DAH>ND-75-KD) and KD flies (DaGAL4> ND-75-KD) were 
used (N = 3). (C) Quantification of ROS levels in fly brains in controls and ND-75-KD fly brains 
in non-stressed conditions (25°C) (N = >6). (D) Quantification of ROS levels in fly brains in 
controls and ND-75-KD fly brains subjected to HS (32°C) (N = 7). Flies were approximately 3 
days old. P Values were calculated using unpaired Student’s T-test and One-Way ANOVA, 
where appropriate. Data are shown as mean ± SEM. p < 0.05 was taken as statistically 










Figure 4.3 Effect of ND-42-KD on ROS production in non-stressed conditions and 
during heat stress. 
 
(A) Mitochondrial respiration using CI-linked, CIII-linked and CIV-linked substrates in ND-42-
KD flies whole fly homogenates, (DaGAL4>ND-42-KD), compared to the respective controls, 
(DAH>ND-42-KD) (N = 7). (B) Quantification of ROS levels in fly brains in controls and ND-42-
KD fly brains in non-stressed conditions (25°C) (N = >7). (C) Quantification of ROS levels in 
fly brains in controls and ND-42-KD fly brains subjected to HS (32°C) (N = 7). Flies were 
approximately 10 days old. P Values were calculated using unpaired Student’s T-test and One-
Way ANOVA, where appropriate. Data are shown as mean ± SEM. p < 0.05 was taken as 
statistically significant and represented by *, p<0.01 was represent by ** and p<0.001 was 




4.4 Reduction of CII activity  
CII is by far the simplest component of the ETC and is anchored into the IMM by the 
two smaller subunits. It consists of only 4 assembled subunits including SdhA and 
SdhB found in the soluble domain, which catalyses succinate oxidation, as well as 
SdhC and SdhD, which constitute the membrane-bound domain, responsible for 
transferring electrons to the ubiquinone pool (Rutter et al., 2010). To study how 
decreasing entry of electrons through CII affects ROS signalling, I inhibited CII using 
malonate, to block the entry of electrons into the complex and expressed an RNAi 
construct against the SdhD subunit, to prevent the binding of CoQ. 
 
Malonate is a well-established competitive inhibitor of CII. It reversibly binds to the 
active site, which resides in the SdhA subunit of the complex, therefore competing 
with the CII substrate, succinate (Kim, 2002) (Figure 4.4).  Here it was predicted that 
by using malonate to inhibit the oxidation of succinate, the transfer of electrons to the 
CoQ pool would be decreased, avoiding the reduction of CoQ and therefore 
preventing ROS-RET. Dimethyl-malonate was used instead of malonate to facilitate 
the entry of the inhibitor into the cells and subsequently into the mitochondria.  
 
Since malonate achieves inhibition of the SdhA subunit, found in the hydrophilic 
region of CII, I wanted to genetically target the membrane-bound region. For this 
reason, I chose to use and RNAi to knock down the SdhD subunit (Figure 4.4). This 
subunit participates in the direct reduction of the CoQ pool (Hagerhall, 1997). 
Therefore I anticipated that the disruption of electron transfer to ubiquinone, through 






























       Figure 4.4 Schematic diagram showing the methods of CII inhibition used. 
 
Malonate targets the catalytic region of CII found in the SdhA subunit, therefore 
preventing the entry of electrons into CII. RNAi construct of SdhD was used, which is 





4.5 CII is required for triggering ROS-RET. 
Mitochondrial respiration was measured to test whether malonate is able to reach the 
brain and inhibit CI-linked respiration, after 4 hours of feeding. Succinate, a CII 
substrate and citric acid cycle intermediate, has a very low permeability across the 
mitochondrial inner membrane in Drosophila melanogaster and other insects (Miwa 
et al., 2003) (Sanz et al., 2010c). For this reason, CII-linked respiration was not 
measured using this technique. Mitochondrial respiration showed no significant 
change in CI-linked respiration. Mitochondrial CI-linked respiration was not altered 
after feeding flies with dimethyl-malonate for 4 hours (Figure 4.5A). These results 
show that any effect on ROS production is not caused by the interruption of electron 
flow through CI, however, it is not known whether CII is inhibited in the experimental 
condition assayed.  
Under non-stressed conditions (25°C), dimethyl-malonate feeding had no effect on 
the ROS levels in the fly brain (Figure 4.5B). However, feeding with dimethyl-
malonate prevented the increase in ROS that occurs after 4 hours of HS. These 
results suggest that CII is also required for the production of RET (Figure 4.5C). 
To further confirm the requirement of CII for initiation of RET; I used an alternative 
approach depleting CII levels by expressing an RNAi construct against SdhD. Due to 
the lack of a reliable respirometry method to evaluate the efficiency of the KD, I 
validated the KD by qPCR. This experiment was done in collaboration with Dr Filippo 
Scialo. Figure 4.6A shows a significant decrease in the mRNA levels of SdhD. In 
addition, I measured mitochondrial respiration to check that CI-linked respiration was 
not affected by CII disruption. However, in contrast to the results gained using 
malonate, there was a decrease in CI-linked respiration in SdhD-KD flies, 
(TubGS>SdhD-KD), compared to control flies, (TubGS>DAH), whereas CIII and CIV 
linked respiration did not change (Figure 4.6B). This effect on CI activity could be due 
to the fact that CII is part of the Krebs cycle therefore inhibiting CII genetically may 
also inhibit CI indirectly by preventing the donation of electrons from NADH and other 
electron carriers.  
I then measured ROS levels in the SdhD-KD flies to see their effect on the 
stimulation of RET during HS. In non-stressed conditions (25°C) there was no 
change in ROS levels (Figure 4.6C), reflecting the results obtained from 
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pharmacological inhibition using dimethyl-malonate or when CI-subunits were 
knocked-down. However, when SdhD-KD flies were subjected to HS for 4 hours, a 
significant decrease in ROS levels was observed compared to the control flies at 
32°C (Figure 4.6D). The fact that CI-linked respiration was affected by depleting CII 
complicates the interpretation of the ROS data. Therefore is it not possible to discard 




























Figure 4.5 Effect of malonate on ROS production in non-stressed conditions and 
during heat stress. 
 
 
(A) Mitochondrial respiration of fly head mitochondria fed 600 μM of dimethylmalonate (N = 5). (B) 
ROS measurements of brains in flies fed 600 μM of dimethyl-malonate, in non-stressed conditions 
(25°C) (N = 7). (C) ROS measurements of brains in flies fed 600 μM of dimethyl-malonate subjected 
to HS (32°C) (N = 8). Flies were approximately 3 days old. P Values were calculated using unpaired 
Student’s T-test and One-Way ANOVA, where appropriate. Data are shown as mean ± SEM. p < 
0.05 was taken as statistically significant and represented by *, p<0.01 was represent by ** and 






















Figure 4.6 Effect of SdhD-KD on ROS production in non-stressed conditions and 
during heat stress. 
(A) Quantification of mRNA levels in SdhD-KD flies by qPCR. Control flies (TubGS>DAH and 
DAH>SdhD-KD) and KD flies (TubGS>SdhD-KD) were used (N = 3). (B) Mitochondrial 
respiration of SdhD-KD fly whole fly homogenates showing CI-linked, CIII-linked and CIV-
linked respiration as indicated (N = 7).  (C) ROS measurements of SdhD-KD in non-stressed 
conditions (25 °C) (N = >7). (D) ROS measurements of SdhD-KD flies in heat stress (32°C) (N 
= >7). Flies were approximately 10 days old. P Values were calculated using unpaired 
Student’s T-test and One-Way ANOVA, where appropriate. Data are shown as mean ± SEM. 
p < 0.05 was taken as statistically significant and represented by *, p<0.01 was represent by 





The results from this chapter show that limiting the entry of electrons into the ETC, 
via CI and CII inhibition, prevents the occurrence of RET. Thus confirming that CI 
and CII activity are both essential for the stimulation of physiological ROS-RET. 
Additionally, I was able to demonstrate that both short term and long term inhibition 
of CI and CII, using chemical inhibition and genetic silencing respectively, were 
sufficiently able to prevent the initiation of RET, during HS.  
As previously established in Chapter 3, short term chemical inhibition of CI using 
rotenone was able to inhibit RET from occurring, by preventing the backflow of 
electrons from the CoQ pool to CI. To further confirm this, I manipulated the 
expression of two CI subunits, ND-75 and ND-42, by genetically silencing them to 
achieve long term CI inhibition. Both models exhibited the same effect on ROS-RET 
as rotenone, where the burst in ROS production during HS-induced-RET was 
abolished. This provides strong evidence that active CI is necessary for RET. An 
interesting observation occurred when ND-42-KD flies in HS revealed an even further 
decrease in ROS levels, compared to the control flies in non-stressed conditions. 
This could be due to a reduction of CI assembly, which would lead to an overall 
decrease in ROS being generated at CI. The same decrease may not have been 
observed in the ND-75-KD flies due to a difference in the levels of RNAi expression 
between the two subunits. However, this would have to be tested using Blue Native 
Electrophoresis (BNE) to study the levels of CI in each model. In this case we would 
expect to observe even lower levels of CI in ND-42-KD flies in comparison to ND-75-
KD flies, resulting in the decrease in ROS.  
When CII was inhibited, using either chemical inhibition with dimethyl-malonate or 
genetic reduction using an SdhD-KD fly model, the stimulation of RET during HS was 
prevented. Mitochondrial respiration of SdhD-KD flies revealed a decrease in oxygen 
consumption specific to CI-linked respiration, which was not reflected in the dimethyl-
malonate fed flies. This is possibly due to the fact that CII, otherwise known as SDH, 
also plays a role in the CAC, which delivers electrons to the ETC. Hence, the long-
term and stronger inhibition of SDH by genetic depletion would most likely lead to a 
reduction in electron supply at CI, thus responsible for the decrease in respiration. 
This decrease was not observed in CIII respiration due to the substrate G3P being 
used, which introduces electrons directly to the CoQ pool via the enzyme G3PDH. 
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Electrons are then transferred directly to CIII, from CoQ, therefore bypassing CI. This 
effect was not observed when using chemical inhibition. This may be due to that fact 
that malonate feeding provided us with short-term inhibition of CII. Therefore, the 
effect after 4 hours may not have been enough to disrupt electron supply, from the 
Krebs cycle to CI. Unlike the long-term inhibition represented by the SdhD-KD flies, 
therefore resulting in decreased CI-linked respiration. An alternative explanation is 
that a increase in CII levels can affect the assembly of CI into supercomplexes, which 
has been shown in C.elegans and human cells (Guaras et al., 2016). Under these 
circumstances, degradation of CI from the supercomplexes would occur through long 
term chronic inhibition. Therefore allowing adaptations and changes to expression of 
transcripts and proteins, including posttranslational modification, which would not be 
possible under short-term inhibition, using malonate. Despite the fact that I was not 
able to confirm the inhibition of CII in the mitochondria of fly heads after 4 hours of 
malonate feeding, I was able to show that malonate elicits the same effect on ROS 
production as the SdhD-KD flies, indicating CII inhibition. Additionally, although there 
is the possibility that RET was prevented via CI inhibition in the SdhD-KD flies, 
malonate prevented RET without altering activity of CI respiration, suggesting that 
the genetic depletion of CII reduces RET through the same mechanism as malonate.  
In conclusion, these results show that CI and CII inhibition suppresses RET. This has 
been supported previously by numerous studies. For example, in flies expressing 
Ndi1, depletion of CI activity was shown to prevent the occurrence of ROS-RET 
(Scialo et al., 2016a). Another study showed that in Ndufs2-null mice the arterial 
chemoreceptors lost their ability to sense oxygen levels and stimulate a hypoxia 
response due to the suppression of RET (Fernandez-Aguera et al., 2015). In 
addition, the inhibition of CI has been shown to prevent succinate driven RET during 
IR, providing protection against IR injury (Chouchani et al., 2014a). Collectively, my 
results and those of previous studies show the necessity of both CI and CII activity to 
supply electrons to the CoQ pool, thus forming a high CoQH2:CoQ ratio and the 








Chapter 5 Effect of limiting the exit of electrons from the 
mitochondrial ETC on ROS-RET 
 
5.1 Halting the exit of electrons 
The stimulation of RET relies primarily on the flow of electrons, determining the redox 
state of the CoQ pool and the transport of protons across the inner mitochondrial 
membrane, to achieve a highly reduced CoQ pool and establish a high proton motive 
force, respectively (Scialo et al., 2017). At present, it is unknown how CoQ becomes 
highly reduced or how a high pmf is accomplished and sustained to trigger RET, in 
physiological conditions. Since the individual complexes, that constitute the ETC, 
orchestrate the movement of electrons and protons, it is reasonable to postulate that 
the manipulation of these complexes may produce the conditions favourable for RET.  
In Chapter 4, I demonstrated that RET requires free circulation of electrons through 
CI and CII to occur and that inhibiting these complexes prevents RET. Blocking the 
exit of electrons through the inhibition of either CIII or CIV should increase the 
reduction state of CoQ. However, it is unclear how the pmf will be affected under 
these conditions in vivo, as both CIII and CIV are involved in the translocation of 
protons across the IMM. Thus, inhibition of the complexes would block proton 
pumping. If upon CIII and CIV inhibition, CV starts to work in a reverse direction, by 
transporting protons from the matrix to the IMS, the pmf will be maintained and ROS-
RET may be triggered. However, if CV does not work in reverse or the binding of 
ATP Inhibitory Factor 1 (ATPIF1) to CV occurs, preventing CV from working in the 
reverse direction, then a high pmf will not be established and ROS-RET will not be 
stimulated.  
Different studies in isolated mitochondria and cells show that blocking respiratory CIII 
and CIV boosts mitochondrial ROS levels (Taylor and Moncada, 2010) (Rajendran et 
al., 2019). However, it is unclear whether this increase in ROS is produced at CI via 
RET, or by other sites within the ETC, such as CIII.  The effect of inhibiting CIV on 
ROS production is particularly relevant since three different signalling molecules 
have been reported to inhibit CIV in physiological conditions, namely CO 
(Zuckerbraun et al., 2007), NO (Beltran et al., 2002) and H2S (Sun et al., 2012). In 
addition, mutations in several CIV subunits, that affect the assembly and function of 
the complex, have been described in mitochondrial patients (DiMauro et al., 2012). 
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Therefore is it essential to understand whether blocking CIII and CIV increases ROS 
in vivo and if so where and how these ROS are generated.  
5.2  Maintaining a High Proton Motive Force 
RET is extremely sensitive to decreases in membrane potential, which constitutes 
one component needed to generate a pmf (Robb et al., 2018). Therefore it was 
important to address the question of how a high pmf is maintained during RET. In 
vitro, inhibiting CV with oligomycin slows down electron transfer, resulting in the 
reduction of CoQ. Oligomycin also maintains a high pmf by preventing the re-entry of 
protons from the matrix, therefore establishing the two conditions that are needed to 
trigger ROS-RET. Additionally, several publications have reported an increase in 
ROS production upon the addition of oligomycin in isolated mitochondria or cells in 
culture, including Drosophila S2 cells (Liu and Schubert, 2009) (Fukuoh et al., 2014) 
(Zhou et al., 2018). 
Furthermore, physiological inhibition of CV activity has also been reported to 
increase ROS levels. For example, in macrophages exposed to LPS, glycolysis is 
increased to compensate for the reduction in mitochondrial ATP production. Under 
these circumstances, mitochondria produced ROS via RET, resulting from an 
increase in succinate oxidation and inhibition of ATP synthase (CV), that increased 
membrane potential (Mills et al., 2016b). Similarly, blocking CV with oligomycin, or 
knocking-down CV subunits, in Drosophila S2 cells increased ROS production 
(Fukuoh et al., 2014). Thus these data suggest that the inhibition of CV can achieve 
a high CoQH2:CoQ ratio, by slowing down respiration and also establish a high pmf 
to potentially stimulate ROS-RET.  There are two prospective examples of how CV 
inhibition could be accomplished physiologically. The first is through a protein called 
ATP inhibitory factor 1 (ATPIF1). ATPIF1 has been shown to bind to CV during 
mitochondrial dysfunction, stopping CV from working in the reverse direction and 
therefore preventing ATP depletion (Chen et al., 2014). It has also been reported that 
ATPIF1 is capable of binding to CV in normal conditions when overexpressed, 
therefore preventing the movement of protons into the matrix, leading to a high 
proton motive force (Garcia-Bermudez and Cuezva, 2016). Experimental data has 
shown that during binding of ATPIF1 to CV in normal conditions, there is an increase 
in ROS production, suggesting the stimulation of RET (Esparza-Molto et al., 2017). 
The second mechanism proposed to inhibit CV physiologically is through alpha-
ketoglutarate (2-oxoglutaric acid).  A recent study showed that supplementation of 
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alpha-ketoglutarate was able to inhibit CV and extend lifespan by approximately 50% 
in C.elegans.  In parallel with alpha-ketoglutarate administration was an increase in 
ROS production (Chin et al., 2014a). Therefore it is possible that alpha-ketoglutarate 
is able to produce the conditions needed for the stimulation of RET resulting in the 
lifespan extension, also observed in the Ndi1 RET model (Scialo et al., 2016a). In 
addition, the Alzheimer’s candidate drug J147 has also been reported to inhibit CV. 
Alongside CV inhibition, J147 has also been shown to increase membrane potential 
and superoxide levels in human cells and extend lifespan in Drosophila (Goldberg et 
al., 2018). This beneficial effect on longevity, seen in Drosophila, could be related to 
the mechanism by which Ndi1 extends lifespan.  
Therefore, in this Chapter, I wanted to study the effect of manipulating the exit of 
electrons, from the ETC, in order to initiate RET. To do this, I inhibited CIII and CIV, 
to block the exit of electrons and CV, to slow-down electron exit and maintain a high 
pmf. In all three models, I used both chemical inhibition and genetic reduction of the 
complexes. I studied the effect of such experimental manipulations in non-stressed 
conditions to determine if RET could be initiated. ROS measurements were used to 
identify any increase in ROS production, characteristic of RET. Subsequently, 
rotenone was used to confirm if RET was the source of increased ROS, as in 
previous chapters I have shown that CI inhibition prevents RET from occurring. 
Additionally, I also checked the effect of CIII, CIV and CV inhibition under HS, which 
as I have demonstrated in Chapters 3 and 4 causes the stimulation of RET and the 










5.3 Decreasing Complex III activity 
Coenzyme Q: cytochrome c oxidoreductase, otherwise known as cytochrome bc1 or 
Complex III (CIII), is the third respiratory enzyme in the ETC. It is responsible for 
transporting electrons from the CoQ pool to Cyt C, as well as pumping protons to the 
IMS, to contribute to the generation of the electrochemical proton gradient, required 
for ADP phosphorylation (Berry and Huang, 2011). CIII consists of two Q sites, which 
both possess roles in the Q cycle needed for the transportation of electrons and 
protons. The first is the Qo site that resides near the outer face of the IM. The Qo site 
oxidises ubiquinol and transfers half of the electrons to Cyt C as well as transporting 
four protons to the IMS. The second is the Qi site, which is situated near the matrix 
side of the IM and is involved in reducing CoQ and taking protons from the matrix 
(Xia et al., 2013). To inhibit CIII, I used myxothiazol to block the Qo site and prevent 
the entry of electrons into CIII and I knocked-down UQCR-Q, (fly orthologue of the 
ubiquinol-cytochrome c reductase complex III subunit VII), to prevent the binding of 
CoQ to CIII.  
The antibiotic, myxothiazol, produced by Myxococcus fulvus can bind to the Qo site of 
CIII and therefore inhibit electron transfer from ubiquinol to the Rieske iron-sulfur 
protein (Thierbach and Reichenbach, 1981) (Figure 5.1). This specific inhibitor was 
chosen to stop the movement of electrons downstream of the CoQ pool. I 
hypothesised that by preventing the exit of electrons from the ETC, caused by the 
presence of myxothiazol, the CoQ pool will become highly reduced, allowing the 
stimulation of RET. The alternative CIII Qi site inhibitor, antimycin A, was not chosen 
as I wanted to prevent the entry of electrons into CIII, which occurs at the Qo site. 
Additionally, it has been reported that antimycin A dramatically increases ROS 
production at the Qo site of CIII. Therefore this inhibitor would not have been suitable, 
considering I was initially interested in studying the production of ROS from CI, when 
CIII is inhibited.   
UQRC-Q is a 9.5kDa core subunit within CIII responsible for the binding of 
ubiquinone (Barel et al., 2008) (Figure 5.1). Therefore silencing of this gene allowed 
me to inhibit CIII, by preventing the transfer of electrons from CoQ. I anticipated that 
knocking down this gene would lead to the accumulation of a high CoQH2:CoQ ratio, 




















Figure 5.1 Schematic diagram indicating the binding site of myxothiazol and the RNAi 








Myxothiazol binds to the Qo site of CIII, preventing the binding of ubiquinol and subsequently 
the transfer of electrons. UQRC-Q resides near the Qo site, and participates in CoQ binding.  
Both types of inhibition will inhibit the entry of electrons into CIII, therefore causing the 




5.4 The effect of decreasing CIII activity on ROS-RET signalling 
 The CIII inhibitor, myxothiazol, does not trigger ROS-RET in the brain of 
Drosophila melanogaster.  
The first experiments I carried out were to confirm that myxothiazol can reach the 
brain of the flies and inhibit CIII, after 4 hours of feeding. To determine a suitable 
concentration of myxothiazol, I measured mitochondrial respiration using a range of 
different drug concentrations. I wanted to find a high enough concentration, with the 
potential to trigger ROS-RET by reducing the CoQ pool but minimising any potential 
damage. I tested 5 different concentrations spanning from 10 μM to 1 mM (Figure 
5.2). Although reduced mitochondrial respiration was observed with all doses, 
statistical significance was only reached with doses ≥100 μM. The highest doses 
reduced respiration between 62 to 92% (Figure 5.2C-E). 
Next, I measured ROS in all 5 different concentrations of myxothiazol. No significant 
change in ROS was observed using 10 μM of myxothiazol; however flies fed with 50 
μM displayed a decrease in ROS (Figure 5.3A). When exposed to HS, the control 
flies showed an increase in ROS levels in the brain, as expected. Flies fed with 10 or 
50 μM of myxothiazol, under HS, also displayed increased ROS levels, however 50 
μm was significantly lower that the control at 32°C (Figure 5.3B). The effect of 100 
μM myxothiazol on ROS production led to a decrease, similarly to the lower dose of 
50 μM at 25°C (Figure 5.3C). However, at 32°C, the same dose completely abolished 
the increase in ROS, with levels reflecting those of the control in non-stressed 
conditions (Figure 5.3D). This was an interesting observation since the dose that 
suppresses ROS-RET, does not induce ROS at 25°C, discarding the possibility that 
CI is inhibited and suggesting that the effect was caused by dissipating the pmf. 
Surprisingly, higher doses of myxothiazol ≥500 μM, increased ROS both at 25 and 
32°C (Figure 5.4A-B). If this increase in ROS levels was due to the stimulation of 
RET, I would have expected this to be attenuated with the addition of rotenone. 
However, ROS levels increased even further, when 1 mM myxothiazol and rotenone 
were added together in the fly food (Figure 5.4C). It is also important to discuss the 
fact that 100 μM and 500 μM of myxothiazol both display similar degrees of inhibition, 
when comparing the respiration data, despite their opposing effects on ROS 
production. Although this is observed it is difficult to interpret the levels of inhibition 
from these experiments alone, due to the fact that they were performed on separate 
occasions and using a different pool of flies. It would be interesting to explore this 
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further in the future and test both concentrations of myxothiazol in the same 
experiment to compare the respiration rates. Here, it is possible that we would 
observe even higher levels of inhibition using the higher dose of 500 μM compared to 
100 μM, which could explain the opposing effects on ROS production. 
With the present data, it is clear that CI is not producing ROS via RET, during CIII 
inhibition with myxothiazol. It is possible, however, that CI could be producing ROS in 
a forward direction encouraged by a high NADH/NAD+ ratio, occurring as a result of 
strongly inhibited respiration, achieved in presented circumstances. In addition, it is 
also possible that ROS are being produced at other sites of the ETC, for example CII 
(Quinlan et al., 2012), alpha-ketoglutarate dehydrogenase (Mailloux et al., 2016) or 
























Mitochondrial respiration of fly head mitochondria after feeding flies with varied concentrations 
of myxothiazol using (A) 10 μM (N = 5), (B) 50 μM (N = 6), (C) 100 μM (N = 5), (D) 500 μM (N 
= 7) and (E) 1 mM (N = 5). Flies were approximately 3 days old. P Values were calculated 
using unpaired Student’s T-test. Data are shown as mean ± SEM. p < 0.05 was taken as 
statistically significant and represented by *, p<0.01 was represent by ** and p<0.001 was 





Figure 5.3 The effect of myxothiazol (10, 50, 100 μM) on ROS production in non-
stressed conditions and during heat stress. 
Quantification of ex vivo ROS measurements in fly brains fed 10-100 μM myxothiazol 
(A) 10 and 50 μM in non-stressed conditions (25°C) (N = >6), (B) 10 and 50 μM under 
HS (32°C) (N = 8), (C) 100 μM in non-stressed conditions (25°C) (N = >8)and (D) 100 
μM under HS (32°C) (N = >5). Flies were approximately 3 days old. P Values were 
calculated using unpaired Student’s T test and One-Way AVOVA, where appropriate. 
Data are shown as mean ± SEM. p < 0.05 was taken as statistically significant and 












Figure 5.4 The effect of myxothiazol (500 μM, 1 mM) on ROS production in non-
stressed conditions and during heat stress. 
 
 
Quantification of ex vivo ROS measurements in fly brains of flies fed 500 μM – 1 mM 
of myxothiazol (A) 500 μM and 1 mM in non-stressed conditions (25°C) (N = >7), (B) 
1 mM in HS (32°C) (N = >8) and (C) 1 mM in non-stressed conditions (25°C) also fed 
rotenone (600 μM) (N = >7). Flies were approximately 3 days old. P Values were 
calculated using One-Way AVOVA. Data are shown as mean ± SEM. p < 0.05 was 
taken as statistically significant and represented by *, p<0.01 was represent by ** and 




  Genetic depletion of CIII does not stimulate ROS-RET 
To understand whether the increase in ROS, observed by reducing electron transfer 
through CIII, was an acute effect or could also be observed during long-term CIII 
inhibition, I knocked-down the gene encoding for the CIII subunit, UQRC-Q. First, I 
confirmed the reduction in CIII-linked respiration by using high-resolution 
respirometry. As anticipated, CI and CIII linked respiration were reduced in the 
UQRC-Q-KD flies, (TubGS>UQCRQ IR), compared to the control group, 
(TubGS>w1118), whereas CIV-linked respiration was not affected (Figure 5.5A). This 
is in contrast with the results obtained when CI subunits were targeted (Figure 4.3A 
and 4.4A), where CIII linked and CIV linked respiration were not altered. However 
this is expected as blocking electron flow downstream of CI, leading to a decrease in 
CIII and CIV-linked respiration, will prevent the electrons reaching O2 and will 
subsequently lead to a decrease in CI-linked respiration. This correlates with 
previous studies, which show that CIII dysfunction can reduce CI levels in vitro. 
After validating the reduction of CIII activity, I carried out ROS measurements. In non-
stressed conditions, there was a significant increase in the levels of ROS in the brain 
of UQCR-Q-KD flies, compared to the controls (Figure 5.5B). When flies were 
exposed to HS, both the control and UQCR-Q-KD flies at 32°C had increased ROS 
levels, compared to the control at 25°C. However, the ROS levels in the UQCR-Q-KD 
flies subjected to HS were slightly lower than those of the HS controls (Figure 5.5C). 
To determine if this increase in ROS in the UQCR-Q-KD flies was as a result of RET 
being stimulated, I fed the KD flies rotenone. However, ROS levels did not change in 
the presence of rotenone, indicating that ROS-RET was not occurring (Figure 5.5D). 
These results are in agreement with the results observed using doses of myxothiazol 
that inhibit mitochondrial respiration more than 60% (Figure 5.2C-E) and indicate that 








































Figure 5.5 The effect of UQCR-Q-KD on ROS production in non-stressed conditions and 
during heat stress. 
 
(A) Mitochondrial respiration in UQCR-Q-KD whole fly homogenates, (TubGS> UQCR-Q-KD), 
compared to the respective controls, (TubGS>w1118) (N = 6). (B) ROS measurements of 
UQCR-Q-KD fly brains in non-stressed conditions (25°C) (N = >7). (C) ROS measurements of 
UQCR-Q-KD fly brains subjected to heat stress (32°C) (N = 8). (D) ROS measurements of 
UQCR-Q-KD fly brains at 25°C fed rotenone (600 µM) (N = >7). Flies were approximately 10 
days old after being fed RU-486 to induce expression. P Values were calculated using unpaired 
Student’s T-test and One-Way AVOVA, where appropriate. p < 0.05 was taken as statistically 






5.5 Decreasing Complex IV activity 
Cytochrome c oxidase or Complex IV (CIV) is the final respiratory complex, in the 
ETC, involved in electron transport. Its role is to accept four electrons from Cyt C and 
then carry out the reduction of O2, the final electron acceptor, into water (Timon-
Gomez et al., 2018). During this process, CIV also pumps four protons to the IMS 
contributing to the generation of the proton gradient, necessary for ATP synthesis (Lu 
and Gunner, 2014). The structure of mammalian CIV consists of 13 subunits where 3 
larger subunits form the catalytic core. Subunits I and II control the movement of 
electrons and protons, whereas subunit III confers structural integrity of CIV. Subunit 
I is home to 2 haem centres, haem a and haem a3. Additionally, haem a3 forms a 
binuclear centre with the copper centre, CuB, which is involved in the reduction of O2. 
Subunit II contains the copper centre CuA and binds directly to Cyt C to accept 
electrons (Srinivasan and Avadhani, 2012). To achieve CIV inhibition I used cyanide 
(CN) that prevents reduction of O2 to water and I knocked-down levy, which is 
required to assemble a fully functioning CIV. 
CN is a well-established competitive inhibitor of CIV and binds to the haem a3-CuB 
binuclear centre of subunit I (Jensen et al., 1984) (Figure 5.6). Binding of CN 
prevents electrons being transferred to molecular O2 and therefore blocks the exit of 
electrons from the ETC.   
The gene levy encodes the orthologue of the human subunit VIa (COX6A) in CIV and 
possesses a regulatory role, responsible for dimerisation of CIV (Kemppainen et al., 
2014) (Figure 5.6). In models where levy is mutated, it has been shown to reduce the 
activity of CIV (Liu et al., 2007) (Kemppainen et al., 2014). I predicted that by using 
both of these methods of CIV inhibition, I would be able to prevent electrons from 
leaving the ETC, increasing the reduction state of the CoQ upstream of CIV, 





















Figure 5.6 Schematic diagram indicating the binding site of CN and the RNAi construct 










CN binds to the binuclear centre, (haem a3-CuB) of CIV and inhibits the transfer of electrons 
to molecular oxygen. levy is responsible for the correct assembly and therefore activity of CIV. 
Both types of inhibition will inhibit the exit of electrons from the ETC, therefore causing the 




5.6 Inhibition of CIV increases ROS production but does not trigger ROS-RET 
 Pharmacological inhibition of CIV increases ROS production. 
To ensure that CN was able to reach the brain and inhibit CIV within the 4 hours of 
feeding, I measured mitochondrial respiration in the heads of the flies, using high-
resolution respirometry. I used two different doses of CN, 12 and 18 mM, that inhibit 
respiration less and more than 50%, respectively, to see if different effects were 
observed, depending on the inhibition of the complex (Figure 5.7A-B). An important 
rise in ROS production, which correlated with the amount of inhibition of CIV, was 
observed in non-stressed conditions (25°C) (Figure 5.7C). When subjected to HS, to 
initiate physiological RET, milder inhibition of CIV did not affect ROS levels, whereas 
stronger inhibition increased ROS levels even more (Figure 5.7D). Rotenone was 
then used in conjunction with the higher dose of CN, to determine if RET stimulation 
was occurring as a result of CIV inhibition. However, ROS levels did not change in 
the presence of rotenone, indicating that ROS-RET was not the cause of the 
increase in ROS observed (Figure 5.7E).  
Since inhibition of CIV activity is an important physiological mechanism to modulate 
mitochondrial respiration, I decided to dissect where the ROS were originating from 
using a combination of different ETC inhibitors.  I focused on CI and CIII since it has 
been widely established that these two respiratory complexes are the two major sites 
of in vivo ROS production, within the mitochondria. First, I decided to use FCCP to 
dissipate the pmf and study whether this manipulation would affect ROS levels after 
CIV inhibition. Interestingly FCCP (600 μM) significantly reduced ROS levels when 
combined with CN in the fly food (Figure 5.8A). Although the FCCP results could 
support ROS-RET as the mechanism triggered by CIV inhibition, the results using 
rotenone clearly demonstrated that RET was not responsible for the elevated ROS 
levels, as no decrease in ROS after blocking the quinone binding site, was observed. 
Therefore, I decided to test whether CIII was implicated, since production by the Qo 
site of CIII also requires a high membrane potential (Larosa and Remacle, 2018). To 
test the former hypothesis, I fed flies with both CN and myxothiazol (100 μM), to 
block the Qo site of CIII and measured ROS levels. Interestingly, myxothiazol 
completely abolished the increase in ROS (Figure 5.8B), supporting CIII as the site of 







 Figure 5.7 The effect of CN on ROS production in non-stressed conditions and during 
heat stress 
(A) Mitochondrial respiration of fly head mitochondria after feeding flies with 12 mM of CN for 
4 hours (N = 6). (B) Mitochondrial respiration after feeding flies with 18 mM of CN for 4 hours 
(N = 3). (C) Quantification of ROS measurements in fly brains fed 12 and 18 mM of CN at 25°C 
(N = >8). (D) ROS measurements in fly brains fed 12 and 18 mM of CN under HS (32°C) (N = 
9). (E) ROS measurements in fly brain fed 18mM of CN and rotenone (600 µM) at 25°C (N = 
>8). Flies were approximately 3 days old. P Values were calculated using unpaired Student’s 
T-test and One-Way AVOVA, where appropriate. p < 0.05 was taken as statistically significant 










Figure 5.8 The effect of CN on ROS production in combination with the uncoupler, 







(A) ROS measurements in fly brains of flies fed 18 mM of CN and 600 μM of FCCP at 25°C 
(N = >7). (B) ROS measurements in fly brains of flies fed 18 mM of CN and 100 μM of 
myxothiazol at 25°C (N = 10). Flies were approximately 3 days old. P Values were calculated 
using One-Way AVOVA. p < 0.05 was taken as statistically significant and represented by *, 
p<0.01 was represent by ** and p<0.001 was represented by ***. 
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 Genetic depletion of CIV elevates ROS production but does not trigger ROS-
RET 
As in the case of CIII, I was interested in identifying differences in blocking CIV, 
acutely (chemical inhibition) or chronically (genetic depletion), on ROS levels. I used 
an RNAi line expressing a transgene against levy to decrease CIV levels and used 
high-resolution respirometry to test the effect on mitochondrial respiration. I 
confirmed a significant decrease in CIV-linked respiration in the levy-KD flies, 
(DaGAL4>levy-KD), compared to the two controls used in this experiment, 
(DaGAL4>DAH and DAH>levy-KD) (Figure 5.9A). Inhibition of CI+CIII+CIV 
respiration was also observed in the levy-KD flies, whereas CIII+CIV respiration was 
significantly decreased only with respect to one of the controls, (DaGAL4>DAH). This 
could be due to background differences between the experimental groups since flies 
were not backcrossed for this experiment and two different backgrounds were used 
(our White Dahomey flies and w1118 flies from Vienna). My results confirm previous 
observations reporting that levy is required for the assembly of CIV and its knock-
down severely compromises the activity of the complex. Furthermore, levy is also 
involved in the assembly of respiratory supercomplexes containing CI (Kemppainen 
et al., 2014). Additionally, as discussed previously, the inhibition of electron flow 
downstream of CI, would lead to the reduction in CI linked respiration, which is 
observed in the both the UQRC-Q-KD and levy-KD fly models.  
Silencing the CIV subunit, levy, induced a large increase in ROS production 
compared to both of the controls (Figure 5.9B). When levy-KD flies were subjected to 
4 hours of HS this increase in ROS was also present compared to the control at 
25°C. However, compared to the control at 32°C there was a slight but non-
significant decrease in ROS levels (Figure 5.9C). To establish the site of ROS 
production and whether the increase in ROS was caused by the stimulation of RET, 
rotenone was fed to the levy-KD flies. Rotenone feeding caused a further increase in 
ROS production, therefore discarding ROS-RET as the source of ROS (Figure 5.9D). 
These results reflected those previously described using CN to inhibit CIV, therefore 
to establish where ROS was being produced during CIV inhibition, I employed the 
same strategy carried out for CN experiments and measured ROS levels in 
conjunction with other inhibitors of the ETC. Feeding FCCP to levy-KD flies 
significantly increased ROS levels, compared to the controls flies (Figure 5.10A). 
Feeding 100 μM of myxothiazol to levy-KD flies also supported the previous 
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conclusion of the CN experiments, where a decrease in ROS back down to control 
levels, was observed (Figure 5.10). 
Overall the results from both chemical and genetic inhibition of CIV indicate that 
when the exit of electrons is blocked, through CIV inhibition, electrons accumulate at 
the Qo site of CIII and consequently cause a dramatic increase in ROS production. 
These data confirm that inhibition of CIV, using two complementary approaches, did 



























Figure 5.9 The effect of levy-KD on ROS production in non-stressed conditions and 
during heat stress. 
(A) Mitochondrial respiration in levy-KD whole fly homogenates (DaGAL4>levy-KD) 
compared to the respective controls (DaGAL4>DAH and DAH>levy-KD) (N = >5). (B) 
Quantification of ex vivo ROS measurements of levy-KD fly brains in non-stressed 
conditions (25°C) (N = >7). (C) ROS measurements of levy-KD flies subjected to HS 
(32°C) (N = 9). (D) ROS measurements of levy-KD flies at 25°C fed rotenone (600 µM) 
(N = >8). Flies were approximately 10 days old. P Values were calculated using One-
Way AVOVA. p < 0.05 was taken as statistically significant and represented by *, p<0.01 



















Figure 5.10 The effect of levy-KD on ROS production in combination with the 





(A) ROS measurements in the brain of levy-KD flies fed 600 μM of FCCP at 25°C (N = >6). (B) 
ROS measurements in the brain of levy-KD flies fed 100 μM of myxothiazol at 25°C (N = >8). 
Flies were approximately 3 days old. P Values were calculated using One-Way AVOVA. p < 
0.05 was taken as statistically significant and represented by *, p<0.01 was represent by ** 
and p<0.001 was represented by ***. 
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5.7 Reduction of CV activity 
ATP Synthase or Complex V (CV) is the enzyme responsible for the production of 
energy in the form of ATP. It achieves this via the movement of protons down the 
electrochemical proton gradient, which drives ATP synthesis, from ADP and Pi. The 
structure of CV comprises of two key subcomplexes, F0 and F1. The integral 
membrane-bound F0 subcomplex facilitates translocation of protons through CV, 
triggering a rotary motion. The soluble F1 resides in the mitochondrial matrix and 
catalyses ATP synthesis. Connecting these two components is the stalk, which 
spans the length of the complex (Xu et al., 2015). In an attempt to inhibit CV, I used 
the established chemical inhibitor oligomycin and the proposed novel inhibitors 
alpha-ketoglutarate and J147. Additionally, I used an RNAi line targeting the ATPase 
synthase δ subunit to genetically inhibit CV. 
The macrolide antibiotic, oligomycin, is a highly specific inhibitor of CV. It binds to the 
c ring of CV, in the F0 subcomplex (Symersky et al., 2012) (Figure 5.11). Therefore 
its binding blocks the passage of protons through CV to the mitochondrial matrix. 
This should lead to the accumulation of protons in the IMS and subsequently, the 
generation of a high pmf. Another consequence of oligomycin binding is the 
interruption of proton pumping when the membrane becomes too hyperpolarised. 
Due to the electron transfer within the ETC being reliant on the movement of protons 
to drive the redox reactions, oligomycin causes the ETC to come to a halt, forcing 
mitochondria to remain in respiratory State 4. Electrons from within the ETC may 
then gather at CoQ to cause an increase in the CoQH2:CoQ ratio. From these 
observations, it is reasonable to speculate that oligomycin is capable of producing 
the two conditions needed to initiate a ROS-RET signal. Accordingly multiple 
publications have reported an increase in ROS levels in response to blocking CV with 
oligomycin, overexpression of ATPIF1 or the genetic depletion of CV (Liu and 
Schubert, 2009) (Fukuoh et al., 2014) (Formentini et al., 2012).  One publication 
showed that the addition of rotenone suppressed the increase in ROS, suggesting 
that ROS-RET is stimulated during CV inhibition (Chouchani et al., 2014a). However, 
to the best of my knowledge, there has not been a consistent attempt to investigate 
how and where ROS are generated in response to CV inhibition in vivo.  
As discussed previously, AKG has recently been characterised as a novel 
uncompetitive inhibitor of CV (Chin et al., 2014b). This study identified the catalytic β 
subunit of the F1 subcomplex, ATP5B, as the binding site for AKG (Figure 5.11). AKG 
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is a CAC cycle intermediate, produced by the enzyme isocitrate dehydrogenase, 
which catalyses the oxidative decarboxylation of isocitrate. Due to the fact that AKG 
is an endogenous metabolite, it has the potential to be a physiological stimulator of 
RET through the inhibition of CV. Therefore, I hypothesised that physiological 
changes that cause the accumulation of AKG could trigger ROS-RET as a 
physiological response to stress.   
ATP synthase, δ subunit (ATPsyn δ) is situated at the top of the stalk that connects 
F0 and F1 and is essential for the regulation of both proton translocation and ATP 
synthesis (Olahova et al., 2018) (Figure 5.11). RNA interference was used to silence 
































Figure 5.11 Schematic diagram indicating the binding sites of oligomycin and AKG 








Oligomycin binds to the c subunit of CV, which is responsible for the translocation of protons. 
AKG binds to the ATP5B subunit found in the β subunit of the catalytic head. ATPsyn δ resides 
at the top of the connective stalk. All types of inhibition will prevent the passage of protons and 
the synthesis of ATP, therefore allowing the ETC to slow down, producing a high CoQH2:CoQ 




5.8 Genetic inhibition of CV triggers ROS-RET 
 Oligomycin specifically inhibits CV without initiation of a ROS-RET signal.  
First, I performed experiments in fly homogenates, where oligomycin was directly 
added to the oxygraph chamber, to obtain a respiratory profile, showing the 
consequences of specific CV inhibition on respiration. This profile was necessary to 
test the abilities of AKG and J147 as CV inhibitors in Drosophila, by comparing the 
effects of the novel inhibitors with the effects of a validated inhibitor, oligomycin.  
Initially, I stimulated State 3, adding ADP and a combination of pyruvate and proline 
to feed CI+CIII+CIV respiration, which caused a significant increase in oxygen 
consumption. Adding oligomycin prevents the transit of protons through CV, raising 
the pmf and initiating State 4 (where oxygen is consumed but ADP is not 
phosphorylated to ATP). As expected, I observed a dramatic inhibition (>95%) in 
mitochondrial respiration, after the addition of oligomycin (Figure 5.12A). To confirm 
that the decrease in respiration was caused by specific inhibition of CV, I added the 
uncoupler FCCP that generates pores in the IMM, allowing protons to return to the 
mitochondrial matrix independently of CV, thus uncoupling mitochondrial respiration 
from ATP synthesis. As anticipated, FCCP restored respiration (Figure 5.12A). Since 
a real State 4 cannot be observed using pyruvate and proline in fruit flies (Miwa et al., 
2003), I repeated the experiments using G3P that feeds electrons directly to the CoQ 
pool, using the G3PDH located in the outer face of the IMM (Miwa et al., 2003). Once 
again, if oligomycin (or any other CV inhibitor) specifically inhibits CV then I expected 
to see a decrease in respiration back down to the levels observed in State 4. First, I 
initiated State 2, adding only G3P to the oxygraph chamber. State 2 is similar to 
State 4, however, during State 2 small amounts of endogenous ADP can be present, 
promoting minimal ATP synthesis. In contrast to State 4, where no ADP is present. 
Addition of ADP triggered State 3, which was once again inhibited by adding 
oligomycin, returning mitochondria into State 4 (Figure 5.12B). As anticipated no 
significant differences were observed between State 2 and State 4 and both were 
significantly lower that State 3. Finally, adding FCCP once again restored the 
respiration, by uncoupling electron transport from OXPHOS, as described in the 
previous experiment (Figure 5.12B). As one final experiment to validate the 
specificity of oligomycin, I initiated State 3 respiration and added FCCP, a slight but 
not statistically significant increase was observed (Figure 5.12C). However, on this 
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occasion oligomycin did not decrease respiration, due to the fact that electron 
transport was no longer dependent on CV to move protons into the matrix. 
In addition to the in vitro experiments, as I did with the previous inhibitors, I wanted to 
also confirm that oligomycin can reach the brain and inhibit CV, after 4 hours of 
feeding. I used two different doses of oligomycin and measured respiration using 
pyruvate and proline as CI substrates. After feeding flies for 4 hours with oligomycin, 
respiration decreased similarly using two doses, 50 μM and 100 μM (Figure 5.13A & 
B). 
To test the effect of oligomycin on the production of ROS, I used two different doses 
of 50 and 100 μM. Unexpectedly, oligomycin did not increase ROS in the brain of 
wild type flies (Figure 5.13C). Moreover, the highest concentration (100 μM) 
decreased ROS levels. Interestingly, oligomycin (50 μM) suppressed ROS-RET in 
wild type flies exposed to HS (Figure 5.13D). In a separate experiment, I tested the 
effect of 100 μM of oligomycin in flies expressing Ndi1. Reflecting the HS data, 
oligomycin decreased ROS, indicating that high doses of oligomycin can suppress 
ROS-RET (Figure 5.13E). Since oligomycin has been described before to increase 
ROS in isolated mitochondria and different cell types (Liu and Schubert, 2009), 
although not in fly brain to the best of my knowledge, I performed a few additional 
experiments. Firstly, I used a much higher concentration of oligomycin (400 μM) that 
decreased ROS levels in the brain, even further than 50 µm (Figure 5.14A). 
Secondly, I fed the flies with two doses of oligomycin 50 μM and 100 μM during a 3 
day period rather than 4 hours (Figure 5.14B). Surprisingly, I did not observe a 
reduction in ROS levels with the lowest dose but the higher dose clearly reduced 
ROS levels in the fly brain. My results show that none of the concentrations or 
experimental conditions assayed, induced ROS-RET. Moreover, oligomycin 
suppressed or reduced ROS-RET in two different models; Ndi1 and HS, discarding 
























(A) State 3 respiration using whole fly homogenates was initiated and Oligomycin was added, 
followed by FCCP to uncouple ETC from OXPHOS (N = 6). (B) State 2 for respiration was 
stimulated, followed by the addition of ADP to initiated State 3 (N = 6). Oligomycin was 
subsequently added followed by FCCP (N = 4). (C) State 3 respiration was initiated followed 
by FCCP and oligomycin. Flies were approximately 3 days old. P Values were calculated using 
One-Way AVOVA. Data are shown as mean ± SEM. p < 0.05 was taken as statistically 













(A) Mitochondrial respiration using whole fly homogenates in flies fed 50 µM of oligomycin for 
4 hours (N = 6). (B) Mitochondrial respiration in flies fed 100 μM of oligomycin for 4 hours (N 
= 6). (C) ROS measurements in brains of flies fed with 50 and 100 μM oligomycin at 25°C (N 
= >7). (D) ROS measurements in brains of flies fed with 50 and 100 μM oligomycin under HS 
(32°C) (N = >5). (E) ROS measurements in brain of flies expressing Ndi1 fed 50 and 100 μM 
of oligomycin (N = >6). Flies were approximately 3 days old. Ndi1 flies were approximately 10 
days old. P Values were calculated using unpaired Student’s T-test and One-Way AVOVA, 
where appropriate. p < 0.05 was taken as statistically significant and represented by *, p<0.01 





























(A) ROS measurements in brains of flies fed 400 μM of oligomycin (N = >7). (B) ROS 
measurements in brains of flies fed 50 and 100 μM of oligomycing for 3 days (N = 7). Flies 
were approximately 3 days old. P Values were calculated using unpaired Student’s T-test and 
One-Way AVOVA, where appropriate. p < 0.05 was taken as statistically significant and 
represented by *, p<0.01 was represent by ** and p<0.001 was represented by ***. 
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 Genetic depletion of CV, using ATPSynthase-δ-KD line increases ROS via RET 
Since the results obtained with oligomycin were in contradiction with other reports, 
including measurements in fly cells, showing a clear increase in mitochondrial ROS 
(Fukuoh et al., 2014), I decided to measure ROS levels in the brain of flies with 
depleted levels of CV. To deplete CV, I knocked-down ATPsynδ. To confirm the 
knock-down, I measured mitochondrial respiration. As anticipated, oxygen 
consumption was dramatically decreased using substrates that introduce electrons 
via CI (i.e. CI+CIII+CIV) or downstream (CIII+CIV) in the KD flies, (TubGS> 
ATPsynδ-KD), compared to control flies, (TubGS>DAH) (Figure 5.15A). I found that 
CIV-linked respiration was also reduced, which is surprising since CIV-linked 
respiration is not dependent on the membrane potential and should not be directly 
affected by reducing CV activity. This indicates a possible reduction in mitochondrial 
mass, which coincidentally, has been previously described when ATPsynδ and other 
CV subunits are depleted in Drosophila S2 cells (Fukuoh et al., 2014).  
Next, I tested whether the knock-down of ATPsynδ subunit could stimulate ROS 
production. In contrast to CV inhibition with oligomycin, the genetic depletion of CV 
increased ROS in the fly brain (Figure 5.15B). To establish whether or not this 
increase in ROS was as a result of RET, I fed the KD flies rotenone. In the presence 
of rotenone, ROS levels were decreased significantly, even further than those seen 
in the controls (Figure 5.15C). Under HS, KD and control flies exhibited similar levels 
of ROS (Figure 5.15D). These results were also in contrast to the results of 
oligomycin, which prevented the increase in ROS induced by HS. 
The results obtained by knocking-down ATPsynδ seem to support that genetically 
inhibiting CV, triggers ROS-RET. However, this conclusion should be approached 
with caution. Firstly, these results are in conflict with the results obtained using 
oligomycin, including experiments where higher concentrations (400 μM) or long term 
administration of the drug was used. Secondly, although it is possible that feeding 
flies with oligomycin does not establish a high enough membrane potential to trigger 
RET, it is also possible that the ROS observed in ATPsynδ-KD flies are not 
mitochondrial or are produced non-specifically in the mitochondria (i.e not via RET), 
due to the high levels of damage these flies seem to support. Under this model, the 
decrease in ROS observed after feeding flies with rotenone, would be the result of 
the collapsed pmf that would cause the mitochondria to stop generating ROS. It is 
worth mentioning that the knock-down of ATPsynδ causes an extremely debilitating 
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phenotype with the flies dying just a few days after eclosion. Therefore the flies used 
for these experiments were only 2-3 days old and fed RU-486 for the duration of this 
time after eclosion. Additionally, these flies were weak from eclosion however I did 
not perform analysis of their lifespan with and without RU-486 feeding. This 
phenotype was not observed in the CI, CII, CIII or CIV subunit knock-down models 
and is probably the consequence of extremely low levels of mitochondrial respiration. 
Furthermore, the low CIV-linked respiration observed indicated a reduction in 
mitochondrial mass, which has been shown in S2 cells, upon depletion of CV, by 
knocking down ATPsynδ and other CV subunits (Fukuoh et al., 2014). To determine 
if genetic inhibition of CV can stimulate a RET-ROS response other subunits should 
be explored especially those, which do not display the weak phenotype observed 
when using the ATPsynδ-KD. This may explain the contrasting results displayed 
between the oligomycin and the genetic model, even after feeding oligomycin over 
long periods of time. In the future, it will also be interesting to investigate if CV 
depletion stimulates mitophagy in vivo. Additionally, if this stimulation of mitophagy is 
















Figure 5.15 The effect of ATPSynδ-KD on ROS production in non-stressed conditions 
and during heat stress. 
 
(A) Mitochondrial respiration in ATPsynδ-KD whole fly homogenates, (TubGS> ATPsynδ-KD), 
compared to the respective controls, (TubGS>DAH) (N = 5). (B) Quantification of ex vivo ROS 
measurements using H2DCF of ATPsynδ-KD fly brains in non-stressed conditions (25°C) (N= 
9). (C) ROS measurements of ATPsynδ-KD flies subjected to heat stress (32°C) (N = >7). (D) 
ROS measurements of ATPsynδ-KD flies at 25°C fed rotenone (600 µM) (N = >7). The 
ATPsynδ-KD flies used in these experiments were approximately 2-3 days old and fed RU-486 
from eclosion. P Values were calculated using unpaired Student T-test and One-Way AVOVA, 
where appropriate. p < 0.05 was taken as statistically significant and represented by *, p<0.01 




 Alpha-ketoglutarate (AKG) is not a CV inhibitor in Drosophila melanogaster 
In an attempt to conciliate the opposite effects on ROS levels observed with the other 
models, oligomycin and knocking-down of ATPsynδ, I decided to test, whether AKG 
inhibited Drosophila CV as an alternative way to block the complex. To validate AKG 
as a specific inhibitor of CV, I carried out similar experiments to the ones shown in 
Figure 5.12, to allow the comparison with oligomycin.   
When using pyruvate+proline as substrates to feed CI with electrons, I observed that 
AKG (0.25 µM) had a potent inhibitory effect (Figure 5.16A). However, the addition of 
the uncoupler FCCP did not restore mitochondrial respiration, indicating that the 
effect of AKG was not caused by CV inhibition. I then used a different substrate, 
G3P, to feed respiration downstream of CI but no inhibition was observed with 0.25 
µM of AKG (Figure 5.16B).  With doses of AKG 3-4 times higher, I observed inhibition 
in respiration but once again it was not restored by FCCP (Figure 5.16B). This 
provides further support that the target of AKG in fly mitochondria is not CV. Finally, I 
performed the last experiment adding AKG + ADP and observed a modest but 
significant increase in respiration (Figure 5.16B). This was not unexpected since 
AKG is a CAC intermediate that can be oxidized producing NADH. My results 
disprove AKG as an inhibitor of Drosophila melanogaster CV, as it has been 
suggested in worms, bovine heart mitochondria and in mammalian cells (Chin et al., 
2014b). The experiments from this particular paper showed that AKG could inhibit CV 
activity by measuring the levels of ATP production, which were shown to decrease 
upon addition of AKG. Additionally, Chin et al demonstrated that in mammalian cells 
and worms AKG lowered oxygen consumption, similarly to my initial experiments. 
Interestingly, when using isolated mitochondria from mouse liver they found that AKG 
lowered respiration in State 3 however not in the presence of oligomycin (State 4). 
Therefore these data are in contrast to my results as I was not able to show that 
FCCP could restore respiration, as it does in presence of the CV inhibitor oligomycin.   
The decrease in respiration upon addition of AKG may be due to the fact that AKG is 
an intermediate belonging to the CAC. It is possible that a build-up of AKG could lead 
to disruption of the CAC. This in turn would affect respiration by hindering electron 
supply via NADH, a co-factor of the CAC. The lack of effect of low doses of AKG on 
respiration by CIII+CIV supports this hypothesis. Since AKG does not inhibit in vitro 


















Figure 5.16 High-resolution respirometry demonstrating the effect of AKG on State 3 
and 4 respiration. 
 
 
 (A) In the left panel State 3 respiration was initiated using whole fly homogenates and the 
uncoupler FCCP was subsequently added. In the right panel, AKG was added, after the 
initiation of State 3 respiration, followed by FCCP (N = 5). (B) State 4 respiration was initiated 
followed by the addition of ADP to stimulate State 3, to which AKG was added (N = 3). (C) 
State 3 respiration was initiated followed by State 4. AKG was sequentially added until a 
decrease in respiration is observed, followed by the addition of uncoupler FCCP (N = 6). (D) 
AKG was added as a substrate to initiate respiration followed by ADP (N = 4). Flies were 
approximately 3 days old. P Values were calculated using One-Way AVOVA. Data are shown 




 J147 does not significantly alter mitochondrial respiration in Drosophila 
melanogaster 
J147 has been reported to cause inhibition of CV activity, from isolated bovine heart 
mitochondria (Goldberg et al., 2018). Using fly homogenates, I tried a range of 
concentrations of J147 from 2 µM to 4 mM without observing any significant inhibition 
in respiration, using either pyruvate+proline to feed CI+CIII+CIV or G3P to feed 
CIII+CIV (data not shown). In an experiment comparing the effects of oligomycin and 
J147 run in parallel, I showed how different their effects are on respiration (Figure 
5.17). Using double the concentration of J147 shown to inhibit CV in isolated bovine 
mitochondria (i.e. 2 µM) and a combination of pyruvate+proline+G3P to feed the 
ETC, I did not find any inhibition in respiration, compared with oligomycin that 
strongly decreased State 3 respiration in the same experimental conditions (Figure 
5.17 compare panels A and B). Therefore, demonstrating contrasting results to 
previous studies showing that J147 could specifically inhibit CV. As expected, FCCP 
restored or prevented inhibition of respiration when added after or before oligomycin.  
In the previously mentioned Goldberg et al experiments they measured the 
enzymatic activity of CV in isolated bovine heart instead of oxygen consumption. 
Upon the addition of J147 they saw that there was partial inhibition (approximately 
30%) of CV activity, however even under saturating concentrations this inhibition did 
not increase further. During these experiments they used oligomycin as a positive 
control but the results using oligomycin were not shown. These results are in contrast 
with the results I obtained, which showed that J147 and oligomycin possessed 
different effects on respiration in isolated fly mitochondria.  
In summary, I did not find any evidence that J147 is a CV inhibitor in fruit flies, and 





















Figure 5.17 High-resolution respirometry demonstrating the effect of AKG on State 3 






(A) State 2 was initiated followed by the addition of ADP to stimulate State 3. J147 was added, 
followed by the uncoupler FCCP and finally the CV inhibitor oligomycin (N = 4). (B) State 2 
was initiated, followed by State 3. Oligomycin was added to inhibit CV, followed by the 
uncoupler FCCP and lastly J147 (N = 4). Flies were approximately 3 days old. P Values were 
calculated using One-Way AVOVA. Data are shown as mean ± SEM. * = p < 0.05 signifying 




Figure 5.18 The effect of ATPIF1-OE on ROS production in non-stressed conditions 
and during heat stress. 
(A) Mitochondrial respiration in ATPIF1-OE whole fly homogenates, (DaGAL4W1118> 
ATPIF1-OE), compared to the respective control, (W1118>ATPIF1-OE) (N = 5). (B) 
Quantification of ex vivo ROS measurements using H2DCF of ATPIF1-OE fly brains in non-
stressed conditions (25°C) (N= >8). (C) ROS measurements of ATPIF1-OE flies subjected to 
heat stress (32°C) (N = >8). (D) ROS measurements of ATPIF1-OE flies at 25°C fed rotenone 
(600 µM) (N = >8). Flies were approximately 10 days old. P Values were calculated using 
unpaired Student T-test and One-Way AVOVA, where appropriate. p < 0.05 was taken as 
statistically significant and represented by *, p<0.01 was represent by ** and p<0.001 was 






The aim for this chapter was to test the effects of inhibiting or reducing the activity of 
CIII, CIV and CV on ROS levels and whether blocking or slowing down the exit of 
electrons from the ETC triggers ROS-RET. To do this, I used both chemical inhibition 
and genetic depletion of the three respiratory complexes mentioned, to achieve both 
short- and long-term inhibition, respectively. ROS measurements were taken in order 
to detect changes in the levels of mitochondrial ROS in the fly brain and different 
inhibitors were used to dissect where and how ROS were being generated.  Although 
an increase in ROS was identified during both CIII and CIV inhibition, rotenone, an 
established RET inhibitor, did not decrease ROS levels. Thus showing that RET was 
not the mechanism responsible for ROS production, when CIII and CIV were 
inhibited. These results collectively show that in order to stimulate RET via 
manipulation of the ETC; preventing the exit of electrons to increase the reduction of 
CoQ pool is not sufficient. This could be due to the fact that pmf is reduced, resulting 
from a decrease in proton pumping by blocking CIII and CIV, which would prevent 
RET.  
When using long-term genetic inhibition of CV, by silencing ATPsynδ, an increase in 
ROS production, which was abolished by rotenone, was detected. This could be 
indicative that a reduction in CV activity, triggers RET. However, experiments 
blocking CV with oligomycin did not show the same result, so the effect of 
blocking/depleting CV on ROS-RET remains inconclusive. I tried to use two new 
proposed inhibitors of CV, AKG and J147 that have been reported to increase 
lifespan in worms and flies, respectively (Goldberg et al., 2018) (Chin et al., 2014b). 
However, in contrast to previous reports, I did not find any evidence of CV inhibition 
in fly homogenates. To the best of my knowledge, there is no published report 
showing direct inhibition of Drosophila CV for any of them and this is the first report 
testing their efficiency in fly mitochondria. 
Chemical inhibition of CIII, using myxothiazol, showed varying results according to 
the concentration used. The lowest dose, 10 µM, did not achieve inhibition of 
respiration and additionally had no effect on ROS production, therefore deeming this 
concentration of myxothiazol redundant for these experiments. Although no 
statistically significant inhibition of respiration was observed using 50 µM of 
myxothiazol, it did elicit a response when measuring ROS levels. This is similar to 
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results shown in Chapter 3, where smaller doses of rotenone were not shown to 
significantly inhibit respiration but increased ROS production to the same extent as 
higher doses, which did significantly reduce respiration. However, in the case of 
myxothiazol, a concentration of 50 or 100 µM, decreased ROS both at 25 and 32°C, 
whereas rotenone had the opposite effect at both temperatures. This indicates 
flexibility in the way CI produces ROS that changes from a forward to a reverse 
direction depending on the temperature, which CIII does not seem to demonstrate.  
Data from other studies have also shown that low doses of myxothiazol decrease 
ROS production at the Qo site. This is due to myxothiazol preventing the binding of 
CoQ to the Qo site and the subsequent transfer of electrons. My data suggests that in 
normal conditions, (25°C), the Qo site of CIII is an important generator of ROS, 
although further experiments are required to confirm this.  Under HS, flies treated 
with low doses of myxothiazol were still able to trigger ROS-RET but at a lower 
intensity than non-treated controls. I speculate that this is caused by a slight but 
significant reduction in proton pumping and therefore the pmf, as a result of 
decreasing the transfer of electrons through CIII. This has been shown in mammalian 
mitochondrial where a progressive reduction in the pmf, reduces ROS-RET (Robb et 
al., 2018). However, to confirm the former point, the pmf would need to be measured, 
which is not an easy task in whole fly brains.  
High doses of myxothiazol ≥ 500 µM, increased ROS production independently of the 
temperature, or the presence of rotenone. These results clearly show that ROS are 
not produced via RET, under these circumstances. However, it is not possible to 
discard CI as the source of ROS completely, given that higher concentrations 
myxothiazol also inhibits CI (Bacsi et al., 2006). Similarly, the genetic inhibition of 
CIII, via knocking-down UQCR-Q, led to a significant increase in ROS production. 
Corresponding to the results using high doses of myxothiazol, the increase in ROS 
was not reversed by the presence of rotenone. Collectively, the results from CIII 
inhibition show that RET cannot be induced using both chemical and genetic 
inhibition. Despite the possibility of a highly-reduced CoQ pool being established 
through CIII inhibition, the loss of two complexes involved in proton translocation 
(CIII-CIV), would prevent the generation of the pmf, required for RET. Accordingly 
previous studies have shown a decrease in membrane potential upon addition of 
myxothiazol. In conclusion, short-term chemical inhibition using 5 doses of 
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myxothiazol or knock-down of a CIII subunit, was not able to stimulate a ROS-RET 
response.  
Both forms of CIV inhibition, using CN and levy-KD flies, for chemical and genetic 
depletion respectively, elicited the same response in ROS production. In each case, 
there was a significant increase in ROS, which was maintained when flies were fed 
with rotenone. These data demonstrated that RET was not occurring, as rotenone 
should have prevented this increase in ROS production, if CIV inhibition had 
successfully initiated RET. To understand where this increase in ROS was originating 
from, other inhibitors of the ETC were used. Myxothiazol (100 µM) reversed the 
increase in brain ROS levels when CIV was inhibited or depleted, indicating the Qo 
site within CIII as the source of ROS production. The results show that ROS-RET 
cannot be initiated through short-term (chemical) or long-term (genetic) inhibition of 
CIV. Although a highly reduced CoQ pool could be achieved through CIV inhibition, it 
is unlikely that the second condition of RET, a high membrane potential, would be 
established. In fact, CIV inhibition would lead to reduced proton translocation to the 
IMS, therefore lowering the pmf. This may provide an explanation as to why RET 
cannot be stimulated. The former has been observed in a mouse model where the 
CIV subunit COX15 is knocked out, specifically in skeletal muscle. The mutant mice 
have a highly reduced CoQH2:CoQ ratio and elevated ROS levels compared to the 
controls but the membrane potential is decreased (Dogan et al., 2018). Suggesting 
that ROS are not being produced by RET, therefore supporting the data I obtained. 
The authors claim that mitochondria from the COX15 KD mice, produce ROS through 
the stimulation of RET, due to the fact that AOX abolished the excessive ROS 
production. However, as previously demonstrated AOX can reduce ROS induced by 
antimycin, at the Qo site of CIII (Sanz et al 2010), as well as ROS produced via RET. 
Paradoxically, decreasing ROS levels in the COX15 KD mice, using the co-
expression of AOX and antioxidants, did not ameliorate the phenotype but in fact 
caused the mice to die faster than the COX15 KD mice alone. This was due to 
impaired mitochondrial myopathy caused by the decreased ROS production.  In 
contrast, AOX extends the lifespan of another mutant mouse model; Bcs1lp.S78G  
knock-down mice. This mouse model displays defective CIII, which induces elevated 
ROS production (Rajendran et al., 2019). Interestingly, results indicate that AOX 
does not alleviate the phenotype through the reduction of ROS levels but rather by 
partially restoring respiration, proton pumping through CI and recycling reduced 
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CoQH2. Thus, leading to the partial restoration of numerous metabolic routes such as 
CAC, pyrimidine synthesis and glycolysis.  Overall, these results suggest that 
inhibition CIII and CIV can result in the production of ROS at different sites of the 
mitochondrial respiratory chain. Additionally, depending on the specific sites of ROS 
production they can promote different downstream physiological effects. Based on 
the results of the studies discussed above, in these mutant models the reduction of 
ROS can elicit positive or negative outcomes, which is dependent on the location of 
generation. These data support the results I obtained in my thesis, using the CIII/CIV 
inhibition models, by displaying increased ROS production by blocking the flow of 
electrons through CIII and CIV, which are not ROS-RET dependent.  In addition 
these models allow the possibility of studying the downstream physiological effects of 
ROS produced as a result of blocking CIII and CIV.  
Contrasting results were obtained when CV was chemically inhibited with oligomycin 
or depleted using an RNAi construct against ATPsynδ. Several experiments 
exposing flies to different concentrations of oligomycin, for different periods of time 
(hours or days), failed to show any increase in ROS levels in the fly brain. 
Furthermore, oligomycin attenuated ROS-RET in two different models, HS and Ndi1 
flies. The latter has been shown before both in mammalian cells and in isolated fly 
mitochondria, where oligomycin reduces ROS in conditions where RET is active, 
such as exposition to LPS, staurosporine or blocking of CV (Mills et al., 2016a) (Sanz 
et al., 2010c) (Santamaria et al., 2006) (Mills et al., 2016a).  These results therefore 
support my results obtained from feeding oligomycin to HS and Ndi1 fly models, 
which both displayed a decrease in ROS. This indicates that blocking CV, in 
situations where RET is occurring, can abolish the increase in ROS.  
Oligomycin has been reported to increase ROS in isolated mitochondria and several 
cell types (including Drosophila S2 cells) (Liu and Schubert, 2009). However, to the 
best of my knowledge, there have been no studies about mitochondrial ROS levels in 
the Drosophila brain. AKG and J147 have been reported to extend lifespan in worms 
and flies by inhibiting CV and triggering a ROS signal that attenuates TOR signalling 
(Goldberg et al., 2018) (Chin et al., 2014b). I hypothesized that the ROS could be 
generated by RET, leading to a similar lifespan extension observed in Ndi1. 
However, I did not find any evidence that either of the two inhibitors target CV in vitro. 
Although the results from depleting ATPsynδ support that long-term inhibition of CV 
triggers ROS-RET, these results must be approached with caution since the flies 
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were extremely weak and the decrease observed with rotenone administration, could 
be caused by a collapse of the membrane potential, rather than blocking RET. I 
observed a similar result when I overexpressed ATPIF1 (Figure 5.18). The 
overexpression of ATPIF1 lead to a dramatic increase in ROS that was attenuated 
with rotenone, indicative of RET stimulation, without altering O2 levels.  However, I 
could not confirm the overexpression of the gene and did not observe any decrease 
in oxygen consumption, therefore the definitive conclusion about the role of CV in 
ROS-RET requires to be addressed in the future.  The laboratory which created the 
OE flies did not carry out qPCR or any other method of confirmation therefore it is 
possible that the flies do not overexpress ATPIF1. In the future it would be of interest 
to try and confirm the OE of ATPIF1 so that the results gained in Figure 5.18 could 
be validated, supporting the hypothesis that CV inhibition can induce ROS-RET.  
In summary, my results indicated that CIII and CIV inhibition increased ROS 
production through an alternative mechanism to RET in the fly brain, whereas the 




















Chapter 6 A Genome-Wide RNA Interference screen to identify 
genes involved in the regulation of ROS-RET 
 
6.1 The importance of genome-wide RNA interference screens 
RNA interference (RNAi) is a powerful genetic tool in which the introduction of 
double-stranded RNA molecules can promote degradation of a targeted sequence, 
thereby allowing the genetic silencing of a single gene product (Ni and Lee, 2010). 
This technology enables the reverse genetic approach in revealing a gene’s function 
within a cell, through its inhibition (Mohr and Perrimon, 2012). The potential of 
reverse genetics has been harnessed, to carry out large scale genome-wide RNAi 
screens (Mohr et al., 2010). This systematic and unbiased approach allows the 
individual knockdown of genes, within an entire genome, to reveal those that produce 
a specific phenotype when inhibited, giving rise to the identification of novel genes 
involved in several biological pathways (Perrimon et al., 2010). At present, genetic 
screening has commonly been performed in models such as C.elegans, mammalian 
cells and Drosophila melanogaster, amongst others. Since the first genome-wide 
RNAi screen, using Drosophila cells; they have provided a vast amount of insight into 
a wide range of important processes. Drosophila screens alone have been able to 
discover genes involved in circadian rhythm (Sathyanarayanan et al., 2008), 
signalling (Kategaya et al., 2009), cell cycle (Bjorklund et al., 2006), infectious 
diseases (Foley and O'Farrell, 2004) and mitochondrial function (Chen et al., 2008). 
Due to the complete sequencing of the Drosophila genome, this makes flies an 
extremely useful model for carrying out in vivo high-throughput genetic screens. In 
addition, the availability of RNAi lines for the majority of fly genes provides the 
opportunity for genome-wide screening. The aim of this chapter was to take 
advantage of this technique to identify genes with a role in the regulation of 
mitochondrial ROS.  
 
6.2 The use of the alternative oxidase; AOX 
Present in the mitochondria of plants and fungi are alternative oxidases, which can 
bypass specific components of the ETC, namely respiratory complexes I, III and IV. 
Alternative respiratory enzymes are divided into two groups: those that give electrons 
to the CoQ pool, called NADH dehydrogenases, and those that extract electrons from 
the CoQ pool, called alternative oxidases (McDonald and Gospodaryov, 2019). 
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NADH dehydrogenases, such as Ndi1, oxidise NADH to NAD+ and transfer electrons 
to CoQ, by-passing CI. On the other hand, alternative oxidases, such as AOX, use 
electrons from ubiquinol to reduce O2 to water, by-passing complexes III and IV. 
Neither of these systems partake in the direct translocation of protons across the 
IMM. For my screen, I took advantage of the alternative oxidase, AOX, from Ciona 
intestinalis. AOX was cloned and introduced into the fly genome in the laboratory of 
Professor Howy Jacobs in Tampere (Finland) (Fernandez-Ayala et al., 2009). AOX 
resides in the IMM of the mitochondria and can reduce O2 to water directly with 
electrons from CoQH2, thereby supporting electron transport without the need for a 
functional CIII or CIV (Figure 6.1). Previous studies have shown that the expression 
of AOX confers resistance to chemical inhibitors of CIII and CIV, as well as reversing 
lethality caused by genetic modifications to the subunits of CIV (Kemppainen et al., 
2014) (Dogan et al., 2018) (Rajendran et al., 2019). These studies have also 
demonstrated that the phenotypic rescue conferred by AOX during CIII or CIV 
inhibition, occurs in parallel to a decrease in ROS levels (Rajendran et al., 2019) 
(Dogan et al., 2018) (Sanz et al., 2010a). 
It has been established that AOX is able to reduce ROS-RET elicited by ectopic 
expression of Ndi1 (Scialo et al., 2016a), or physiological exposure of flies to HS 
(Scialo, unpublished).  Similarly, AOX is able to decrease ROS-RET in mice when 
RET is induced by injecting mice with LPS (Mills et al., 2016a). In addition to ROS-
RET, AOX is able to attenuate the increase in ROS produced by CIII, when inhibited 
by antimycin in mouse cells (El-Khoury et al., 2013) (Cannino et al., 2012) and fly 
mitochondria (Sanz et al., 2010a). Given that AOX is capable of neutralising both 
CIII-derived ROS and ROS-RET, I undertook a genome-wide RNAi screen, using co-
expression of AOX with RNA interference constructs, targeted against specific 
Drosophila melanogaster genes, to identify novel genes involved in the regulation of 
ROS production. In the previous results chapters, I attempted to identify approaches 
which could initiate RET, physiologically in the fly. Therefore my aim for this chapter 
was to then further identify other genes that controlled the levels of ROS, focusing on 






















AOX resides on the matrix side of the IMM where it takes electrons directly from the ubiquinol 




6.3 Hypothesis behind the screen 
It has been well established that mitochondrial ROS signalling is required for 
maintaining cellular homeostasis (Shadel and Horvath, 2015). However, any 
imbalances in the redox signalling system can trigger oxidative stress. For example, 
ROS-RET seems to regulate many physiological processes, such as triggering 
appropriate cardiorespiratory responses to hypoxia (Fernandez-Aguera et al., 2015) 
or activation of macrophages in the presence of pathogens (Mills et al., 2016a). 
Nevertheless, in all redox-regulated processes, exquisite control of ROS levels is 
critical to prevent oxidative damage. In the case of IR, a pathological example of 
ROS-RET, ROS production is unregulated and produced under dysfunctional 
circumstances, resulting in tissue injury caused by excess ROS levels (Chouchani et 
al., 2014b). Due to AOX’s ability to decrease ROS production at CIII and prevent 
ROS-RET from occurring, I used the expression of AOX to identify genes involved in 
regulating ROS levels, during development. I hypothesised that the downregulation 
of genes involved in the maintenance of basal ROS levels, or switching off ROS-RET 
signal, would lead to dysfunctional ROS production and ultimately generate a lethal 
phenotype. Under these circumstances, expression of AOX would lead to the 
reduction of ROS levels and rescue or palliate any lethal phenotype, therefore 
allowing me to identify novel genes responsible for the regulation of mitochondrial 














Figure 6.2 Schematic diagram showing how the expression of AOX can manipulate 





In the left panel (without AOX expression) the KD of genes involved in regulating RET and CIII 
ROS production will cause excessive generation of ROS leading to a lethal phenotype. 
However, the expression of AOX, which prevents ROS-RET (through the oxidation of 
ubiquinol) and decreases CIII ROS production (through the reduction of electrons entering CIII) 
will rescue the lethal phenotype. 
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6.4 Screening strategy  
The screening strategy employed was based on the use of RNAi constructs targeted 
against specific fly genes, in combination with the Gene Switch GAL4 (GS) system, 
to allow spatial and temporal control of gene expression, previously explained in 
Chapter 2. The synthetic progesterone analogue mifepristone (RU-486) was used to 
drive RNA interference (and AOX) expression, during development. Figure 6.3 
summarises the overall strategy of the screen. UAS-RNA interference (RNAi) male 
flies were selected and crossed with virgin female flies carrying the Tubulin-GS driver 
alone (control group) or in combination with the UAS-AOX construct (AOX group). 
These crosses were then placed in vials of food containing 1 µM RU-486 and left to 
mate and lay eggs for 5 days, after which adults flies were discarded from the vials 
and eggs were left to develop. After 10 days the vials were scored for the presence 
of larvae, pupae or adult flies, which was then repeated for 2 consecutive days. 
Selection of candidate genes depended on the rescue of any developmental delay or 
lethal phenotype by AOX expression. The rescue was identified as the absence of 




















Figure 6.3 Diagram displaying the strategy of the genome-wide RNAi screen. 
 
UAS-RNAi male flies were crossed with control virgin females and UAS-AOX virgin females. 
The flies were placed in vial of food containing 1 µM drug (RU-486) and after 10 days the vials 
were scored for the presence of larvae, pupae or adult flies. Selection of candidate genes 
depended on rescue of any developmental delay or lethality phenotype by AOX expression. 
Therefore lines, which had normally developed flies in the control or those showing a lethal 




6.5 Analysis of the identified hits 
I screened 12,719 different RNAi lines from the VDRC RNAi Library (Dietzl et al., 
2007), covering 12,372 genes (>90% of the fly genome). From the first list of 
screened hits, I discarded any lines that were screened more than once, which did 
not produce the same result, in the different trials.  Then, I started my analysis with 
12,575 unique RNAi lines targeting 12,234 genes. The knockdown of 1,448 genes 
(12% of the total screened) caused a lethal phenotype (Table 6.1). Most lethal genes 
caused interruption of development at the pupal stage (61%), whereas only 8% of 
genes did not produce larvae when knocked down (Table 6.1). AOX rescued the 
lethal phenotype of 322 genes, (22% of total lethal genes), with most of the rescues 
occurring when development was arrested at the pupal stage (57%), versus 
embryonic and larval stages (18% and 25%, respectively) (Table 6.1).   
Next, I performed Gene Ontology (GO) term enrichment analysis, using those genes 
that caused a lethal phenotype. I used the Functional Annotation Clustering Analysis 
tool from DAVID (Huang da et al., 2009) to select clusters of genes containing 
specific enriched terms.  According to GO analysis (Table 6.2) most genes that were 
identified as lethal were related to “splicing” (Annotation Cluster 1), “cytosolic and 
mitochondrial translation of proteins” (Annotation Cluster 2), “nucleotide-binding” 
(Annotation Cluster 3), “transcription” (Annotation Cluster 4) and “cell cycle/division” 
(Annotation Cluster 5). These results are unsurprising since interrupting any of the 
former processes is expected to disrupt development. I found the term 
“mitochondrion” in Annotation Cluster 6, and “mitochondrial electron transport” term 
in Annotation Cluster 20 (data not shown). Based on the former results, I manually 
inspected genes encoding OXPHOS components and found that 36 out of 87 genes 
screened, caused a lethal phenotype (41%)  (Table 6.3). Between 40-60% of the 
genes encoding for CIII, CIV and CV subunits were lethal, whereas the same was 
true for fewer than 40% of the genes encoding for subunits of the other respiratory 
complexes (Table 6.3). AOX rescued 100% of lethal genes encoding CIV subunits 
and 67% of those encoding CIII subunits, whereas for the other respiratory 
complexes only 1 gene was rescued for each. Furthermore, a rescreen of the 
positive hits confirmed 100% of the genes encoding complexes III and IV subunits 
but none of those encoding for subunits of the other respiratory complexes (Table 
6.4). Interestingly, none of the genes encoding antioxidants caused lethality when 
knocked down (data not shown).  The latter was not completely unexpected since, in 
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different animal species, it has been shown that antioxidant levels can be drastically 
abolished without interrupting development (Martin et al., 2009) (Van Remmen et al., 
2003) (Elchuri et al., 2005) (Van Raamsdonk and Hekimi, 2012) (Doonan et al., 
2008). 
Given that Drosophila RNAi lethality screens are prone to both false positives and 
negatives (Dietzl et al., 2007), I rescreened 189 RNAi lines. I selected 156 (78%), 42 
(21%) and 6 (3%) lines where AOX rescued pupal, larval and embryonic lethality, 
respectively. The different number of lines rescreened was intended to reflect the 
different % of genes rescued by AOX at the three different stages. However, I chose 
to screen more lines rescued at the pupal stage rather than embryonic stage 
because the latter is more prone to suffer from false positives, caused by bacterial 
growth on food. I confirmed 41 hits (20%) as AOX rescue (Table 6.5), indicating that 
my screen strategy was prone to false positives. This was not unexpected and has 
been reported before in other RNAi fly screens (Fukuoh et al., 2014). In the rescreen 
list, 11 OXPHOS genes were included. Interestingly, the 11 genes were lethal again 
in the rescreen but only the 8 genes encoding subunits of CIII-CIV were rescued by 
AOX this time. This indicates that rescreening is required, to confirm AOX rescue 
hits. Accordingly, positive hits that were not rescreened this time should be 
rescreened in the future.  
The motivation behind the screen was to identify novel genes involved in the 
regulation of mitochondrial ROS. A large proportion of the 41 confirmed genes 
rescued by AOX (68% vs 32%), did not contain any reference to mitochondria, 
according to the GO information contained in Flybase (https://flybase.org/). This 
notable difference could be due to the overall abundance of mitochondrial proteins in 
a cell being significantly lower than non-mitochondrial. However, further 
characterisation of these non-mitochondrial genes may reveal a novel relationship 
involving the mitochondria, which has not been previously established. It is possible 
that some of the genes identified, encoded protein isoforms that can be targeted to 
the mitochondrion, however these mitochondrial isoforms have not yet been 
identified. For example, it has been recently described that mitochondrial isoforms 
can be produced by non-canonical translation in yeast (Monteuuis et al., 2019). It 
would be interesting to check whether this phenomenon also occurs in Drosophila 
and whether this applies to any confirmed hits, in my list. 
GO analysis of the confirmed rescued candidates showed two clusters of genes 
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(Table 6.6) containing terms related with “oxidative phosphorylation”, “mitochondrial 
respiratory chain complex IV” and “mitochondrial respiratory chain complex III”. I also 
performed network analysis for protein interactions using STRING (von Mering et al., 
2005) with default settings. This analysis revealed a clear network connecting all 
mitochondrial proteins (with the exception of ABCB7). Apart from the mitochondrial 
genes, only 2 other pair of genes were connected: CG7071 and VhPPA1-1 and Cul3 
and CSN3 (Figure 6.4). Kmeans clustering analysis revealed 3 different clusters with 
genes encoding ETC proteins, other mitochondrial genes (mRpS25, mRpS26 and 
Cchl) and the rest of genes confirmed as hits. 
Using FlyAtlas2 and Flybase to analyse tissue distribution of the AOX rescue hits I 
found that most genes had ubiquitous expression throughout the whole fly body, with 
moderate expression within the brain. A few of the hits had high expression on in 
specific tissues of the fly for example CG31882, CG9853, CG42616 and CG5585, 
where expression was mainly localised to the testis. Furthermore, hits such as 
CG2079 and CG16885 had high expression in the gut and trachea, with low 
expression elsewhere. As expected, those with the high tissue expression throughout 
the whole body included CG106604, CG9603, CG7181, CG8784 and CG4168, which 
all encode mitochondrial ETC subunits. From these hits CG33103, CG16885 and 
CG7007 had especially high expression in the head, eye and trachea and gut, 
respectively. Hits with very low tissue expression throughout the body included hits 




Table 6.1 Number of genes screened indicating lethal genes and lethal genes 
rescued by AOX. 
Phenotype Number 
of Genes 







Lethal 12234 1448 12 111 8 450 31 887 61 








Table 6.2 Functional Annotation Clustering Analysis of lethal genes. 
Annotation Cluster 1 Enrichment Score: 18.1 
  
Category Term Fold 
Enrichment 
Benjamini 
GOTERM_BP_DIRECT GO:0000398~mRNA splicing, via spliceosome 3.2 0.000 
GOTERM_CC_DIRECT GO:0071011~precatalytic spliceosome 3.7 0.000 
GOTERM_CC_DIRECT GO:0071013~catalytic step 2 spliceosome 3.5 0.000 
KEGG_PATHWAY dme03040:Spliceosome 2.2 0.000 
    
Annotation Cluster 2 Enrichment Score: 17.6 
  
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS Ribonucleoprotein 5.3 0.000 
UP_KEYWORDS Ribosomal protein 5.2 0.000 
GOTERM_BP_DIRECT GO:0032543~mitochondrial translation 4.7 0.000 
GOTERM_BP_DIRECT GO:0002181~cytoplasmic translation 4.1 0.000 
GOTERM_CC_DIRECT GO:0005840~ribosome 4.0 0.000 
GOTERM_CC_DIRECT 
GO:0005762~mitochondrial large ribosomal 
subunit 5.3 0.000 
GOTERM_MF_DIRECT GO:0003735~structural constituent of ribosome 2.5 0.000 
GOTERM_CC_DIRECT GO:0022625~cytosolic large ribosomal subunit 4.0 0.000 
GOTERM_CC_DIRECT GO:0022627~cytosolic small ribosomal subunit 4.3 0.000 
KEGG_PATHWAY dme03010:Ribosome 1.4 0.006 
    
Annotation Cluster 3 Enrichment Score: 14.4 
  
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS Nucleotide-binding 2.0 0.000 
UP_KEYWORDS ATP-binding 2.1 0.000 
GOTERM_MF_DIRECT GO:0005524~ATP binding 1.7 0.000 
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Annotation Cluster 4 Enrichment Score: 11.8 
  
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS Transcription 2.4 0.000 
UP_KEYWORDS Transcription regulation 2.2 0.000 
UP_KEYWORDS Activator 3.2 0.000 
GOTERM_BP_DIRECT GO:0006351~transcription, DNA-templated 1.9 0.000 
    
Annotation Cluster 5 Enrichment Score: 6.6 
  
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS Cell cycle 3.2 0.000 
UP_KEYWORDS Cell division 3.1 0.000 
UP_KEYWORDS Mitosis 3.1 0.000 
GOTERM_BP_DIRECT GO:0051301~cell division 2.4 0.000 
    
Annotation Cluster 6 Enrichment Score: 5.7   
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS Mitochondrion 2.1 0.000 
UP_KEYWORDS Transit peptide 2.5 0.000 
    
Annotation Cluster 7 Enrichment Score: 5.4   
Category Term Fold 
Enrichment 
Benjamini 
GOTERM_BP_DIRECT GO:0000470~maturation of LSU-rRNA 6.6 0.000 
GOTERM_CC_DIRECT 
GO:0030687~preribosome, large subunit 
precursor 4.1 0.000 
GOTERM_BP_DIRECT GO:0000460~maturation of 5.8S rRNA 6.7 0.006 
    
Annotation Cluster 8 Enrichment Score: 5.2   








GO:0003899~DNA-directed RNA polymerase 
activity 5.4 0.000 
GOTERM_CC_DIRECT 
GO:0005666~DNA-directed RNA polymerase III 
complex 6.4 0.000 
UP_KEYWORDS Nucleotidyltransferase 3.3 0.000 
GOTERM_BP_DIRECT 
GO:0006383~transcription from RNA polymerase 
III promoter 6.9 0.000 
KEGG_PATHWAY dme03020:RNA polymerase 3.1 0.000 
UP_KEYWORDS DNA-directed RNA polymerase 6.0 0.000 
GOTERM_BP_DIRECT 
GO:0006360~transcription from RNA polymerase 
I promoter 6.0 0.001 
GOTERM_CC_DIRECT 
GO:0005736~DNA-directed RNA polymerase I 
complex 5.1 0.006 
    
Annotation Cluster 9 Enrichment Score: 5.1   
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS DNA replication 4.1 0.000 
GOTERM_BP_DIRECT GO:0006260~DNA replication 3.4 0.000 
KEGG_PATHWAY dme03030:DNA replication 2.3 0.014 
    
Annotation Cluster 
10 
Enrichment Score: 3.9   
Category Term Fold 
Enrichment 
Benjamini 
UP_KEYWORDS Aminoacyl-tRNA synthetase 5.9 0.000 








Table 6.3 OXPHOS genes screened indicating the number of lethal genes (when knocked-
down) and rescued by AOX.  
Genes Genes Screened Lethal % Rescued % 
CI 48 38 14 37 1 7 
CII 6 5 1 20 1 100 
CIII 12 10 6 60 4 67 
CIV 17 14 6 43 6 100 
CV 21 18 9 50 1 11 
Table 6.4 OXPHOS genes rescreened indicating the number of lethal genes (when knocked-
down) and rescued by AOX. 
 Genes Genes Screened Lethal % Rescued % 
CI 48 1 1 100 0 0 
CII 6 1 1 100 0 0 
CIII 12 4 4 100 4 100 
CIV 17 4 4 100 4 100 
CV 21 1 1 100 0 0 
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Table 6.5 Confirmed candidate genes rescued by AOX 




Description in STRING 
FBgn0035244 CG7955 ABCB7 106039 "ATP binding cassette subfamily B member 7 (ABCB7) is a transporter that likely 
dimerizes to form a functional transporter. ABCB7 may act in the mitochondria to 
transport substrates necessary for the maturation of ICS proteins, which are involved 
in iron homeostasis (743 aa)". 
FBgn0265598 CG44425 Bx 109933 "Beadex, isoform B; Beadex (384 aa)". 
FBgn0037788 CG3940 CAH7 108233 "CG3940, isoform A; Carbonate dehydratase activity; zinc ion binding. It is involved in 
the biological process described with- one-carbon metabolic process (304 aa)". 
FBgn0024249 CG7760 cato 101564 "Cousin of atonal; Sequence-specific DNA binding transcription factor activity; protein 
dimerization activity. It is involved in the biological process described with- regulation 
of transcription, DNA-templated; sensory organ development (189 aa)". 
FBgn0038925 CG6022 Cchl 101382 "Cytochrome c heme lyase; Links covalently the heme group to the apoprotein of 
cytochrome c (281 aa)". 
FBgn0032811 CG10268 CG10268 110640 "Phosphomevalonate kinase activity. It is involved in the biological process described 
with- isoprenoid biosynthetic process; cholesterol biosynthetic process (189 aa)". 
FBgn0037543 CG10903 CG10903 109610 "Uncharacterized protein, isoform A; S-adenosylmethionine-dependent 
methyltransferase activity. It is involved in the biological process described with- 
neurogenesis; metabolic process (276 aa)". 
FBgn0034500 CG11200 CG11200 101697 "Carbonyl reductase (NADPH) activity. It is involved in the biological process 
described with- metabolic process; Belongs to the short-chain 
dehydrogenases/reductases (SDR) family (355 aa)". 
FBgn0040588 CG13841 CG13841 100876 "annotation not available (120 aa)". 
FBgn0031062 CG14230 CG14230 104096 "Probable RNA-binding protein CG14230; mRNA binding; nucleotide binding; nucleic 
acid binding. It is involved in the biological process described with- neurogenesis (580 
aa)". 




FBgn0050373 CG30373 CG30373 104802 "annotation not available (158 aa)". 
FBgn0051882 CG31882 CG31882 100160 "annotation not available (121 aa)". 
FBgn0260467 CG7071 CG7071 110726 “annotation not available (302 aa)”. 
FBgn0036173 CG7394 CG7394 101490 "Mitochondrial import inner membrane translocase subunit TIM14; Probable 
component of the PAM complex, a complex required for the translocation of transit 
peptide-containing proteins from the inner membrane into the mitochondrial matrix in 
an ATP-dependent manner. May act as a co-chaperone that stimulate the ATP-
dependent activity (By similarity) (128 aa)". 
FBgn0086605 CG9853 CG9853 107346 "Golgi to ER traffic protein 4 homolog; May play a role in insertion of tail-anchored 
proteins into the endoplasmic reticulum membrane (339 aa)". 
FBgn0044324 CG10712 Chro 101663 "Chromator, isoform A; Histone binding. It is involved in the biological process 
described with- metaphase plate congression; chromosome organization; mitotic 
spindle organization; mitotic anaphase; metamorphosis; chromosome segregation; 
chromatin organization; mitotic spindle assembly checkpoint (926 aa)". 
FBgn0032833 CG10664 COX4 109338 "Cytochrome-c oxidase activity. It is involved in the biological process described with- 
negative regulation of neuroblast proliferation; cell proliferation; mitochondrial electron 
transport, cytochrome c to oxygen; mitotic cell cycle; Golgi organization (182 aa)". 
FBgn0040529 CG9603 COX7A 106661 "Cytochrome c oxidase subunit 7A, mitochondrial; This protein is one of the nuclear-
coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in 
mitochondrial electron transport (98 aa)". 
FBgn0263911 CG7181 COX8 104047 "Cytochrome-c oxidase activity. It is involved in the biological process described with- 
mitochondrial electron transport, cytochrome c to oxygen (68 aa)". 
FBgn0259685 CG6383 crb 39177 "Crumbs, isoform C; Crumbs is a transmembrane protein that binds to multiple 
proteins such as sdt, par-6, AP-2alpha, yrt, ex and Moe. It contributes to organization 
of zonula adherens, epithelial morphogenesis, apico-basal cell polarity, and is a 
negative regulator of Notch activity and growth control via the Hippo pathway. In 
photoreceptor cells it is involved in morphogenesis, ninaE trafficking and prevention 
of light-dependent photoreceptor degeneration (2253 aa)". 
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FBgn0027055 CG18332 CSN3 101516 "COP9 signalosome complex subunit 3; Component of the COP9 signalosome 
complex (CSN), a complex involved in various cellular and developmental processes. 
The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway 
by mediating the deneddylation of the cullin subunits of the SCF-type E3 ligase 
complexes, leading to decrease the Ubl ligase activity of SCF. The CSN complex 
plays an essential role in oogenesis and embryogenesis and is required for proper 
photoreceptor R cell differentiation and promote lamina glial cell migration or axon 
targeting. It also promotes [...] (445 aa)". 
FBgn0261268 CG42616 Cul3 109415 "Cullin 3, isoform F; Ubiquitin-protein transferase activity; ubiquitin protein ligase 
binding; Belongs to the cullin family (934 aa)". 
FBgn0015031 CG14028 cype 102336 "Cyclope (Cype) is a cytochrome c oxidase subunit VIc homolog acting as an 
enhancer of dpp pathway phenotypes. Cype is involved in hair and cell growth and in 
ommatidia development (77 aa)". 
FBgn0035600 CG4769 Cyt-c1 109809 "Cytochrome c1, isoform A; Electron transporter, transferring electrons within CoQH2-
cytochrome c reductase complex activity; iron ion binding; heme binding. It is involved 
in the biological process described with- oxidative phosphorylation; mitochondrial 
electron transport, ubiquinol to cytochrome c (307 aa)". 
FBgn0029944 CG2079 Dok 108544 "Downstream of kinase (Dok) is a membrane-associated protein that functions 
upstream of Shark to activate Jun kinase signaling during embryonic dorsal closure 
(622 aa)". 
FBgn0053810 CG33810 His1:CG33810 109034 "His1-CG33810; DNA binding. It is involved in the biological process described with- 
chromatin assembly or disassembly; nucleosome assembly (256 aa)". 
FBgn0037657 CG11990 hyx 103555 "Hyrax, isoform A; Hyrax is recruited by signaling pathway specific transcriptional 
regulators such as arm and ci and is important for the output of Wingless and 
Hedgehog pathways, respectively (538 aa)". 
FBgn0019960 CG6455 Mitofilin 106757 "MICOS complex subunit Mic60; Component of the MICOS complex, a large protein 
complex of the mitochondrial inner membrane that plays crucial roles in the 
maintenance of crista junctions, inner membrane architecture, and formation of 
contact sites to the outer membrane (By similarity) (739 aa)". 
FBgn0030572 CG14413 mRpS25 101443 "Probable 28S ribosomal protein S25, mitochondrial; Structural constituent of 
ribosome. It is involved in the biological process described with- translation (167 aa)". 
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FBgn0036774 CG7354 mRpS26 100067 "Probable 28S ribosomal protein S26, mitochondrial; Structural constituent of 
ribosome. It is involved in the biological process described with- translation; Belongs 
to the mitochondrion-specific ribosomal protein mS26 family (225 aa)". 
FBgn0011227 CG8764 ox 35829 "Cytochrome b-c1 complex subunit 9; This is a component of the ubiquinol-
cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is 
part of the mitochondrial respiratory chain. This subunit interacts with cytochrome c1 
(By similarity)". 
FBgn0003137 CG33103 Ppn 108005 "Papilin; Essential extracellular matrix (ECM) protein that influences cell 
rearrangements. May act by modulating metalloproteinases action during 
organogenesis. Able to non- competitively inhibit procollagen N-proteinase, an 
ADAMTS metalloproteinase; Belongs to the papilin family (2898 aa)". 
FBgn0036973 CG5585 Rbbp5 106139 "Retinoblastoma-binding protein 5 homolog; Component of the SET1 complex that 
specifically di- and trimethylates ’Lys-4’ of histone H3 and of the MLL3/4 complex 
which also methylates histone H3 ’Lys-4’ (489 aa)". 
FBgn0261792 CG5454 snRNP-U1-C 108933 "U1 small nuclear ribonucleoprotein C; Component of the spliceosomal U1 snRNP, 
which is essential for recognition of the pre-mRNA 5’ splice-site and the subsequent 
assembly of the spliceosome. U1-C is directly involved in initial 5’ splice-site 
recognition for both constitutive and regulated alternative splicing. The interaction with 
the 5’ splice-site seems to precede base-pairing between the pre-mRNA and the U1 
snRNA. Stimulates commitment or early (E) complex formation by stabilizing the base 
pairing of the 5’ end of the U1 snRNA and the 5’ splice-site region (By similarity). 
Regulat [...] (145 aa)". 
FBgn0038320 CG4931 Sra-1 108876 "Cytoplasmic FMR1-interacting protein; Specifically Rac1-associated protein 1 (Sra-1) 
is an essential protein that is a component of the WAVE actin nucleator complex that 
controls actin cytoskeleton remodeling and also interacts with Fmr1 and Rac1. Sra-1 
controls morphogenesis and synapse organization (1291 aa)". 
FBgn0015828 CG10415 TfIIEalpha 100572 "Transcription factor IIEalpha (TfIIEalpha) is the large subunit of the RNA polymerase 
II general transcription factor TFIIE. TfIIEalpha, together with TfIIEbeta, is essential 
for transcription initiation in vitro and acts with RNA polymerase II and the other 
general transcription factors (429 aa)". 
FBgn0250814 CG4169 UQCR-C2 100818 "Ubiquinol-cytochrome-c reductase activity; metal ion binding. It is involved in the 
biological process described with- mitochondrial electron transport, ubiquinol to 
cytochrome c (440 aa)". 
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FBgn0036728 CG7580 UQCR-Q 101371 "Ubiquinone binding; ubiquinol-cytochrome-c reductase activity. It is involved in the 
biological process described with- mitochondrial electron transport, ubiquinol to 
cytochrome c (89 aa)". 
FBgn0032538 CG16885 Vajk2 102569 "annotation not available (270 aa)". 
FBgn0028662 CG7007 VhaPPA1-1 47188 "Vacuolar H[+] ATPase PPA1 subunit 1, isoform A; Proton-transporting ATPase 
activity, rotational mechanism; hydrogen ion transmembrane transporter activity. It is 
involved in the biological process described with- ATP hydrolysis coupled proton 
transport; mitotic spindle organization; Belongs to the V-ATPase proteolipid subunit 














Table 6.6 Functional Annotation Clustering Analysis of lethal genes rescued by AOX. 
Annotation Cluster 1 Enrichment Score: 3.8 
  
Category Term Fold 
Enrichment 
Benjamini 
KEGG_PATHWAY dme00190:Oxidative phosphorylation 9.8 0.000 
GOTERM_MF_DIRECT GO:0004129~cytochrome-c oxidase activity 51.6 0.002 
GOTERM_BP_DIRECT 
GO:0006123~mitochondrial electron transport, 
cytochrome c to oxygen 80.9 0.040 
GOTERM_CC_DIRECT 
GO:0005751~mitochondrial respiratory chain 
complex IV 65.1 0.014 
  
  
    
Annotation Cluster 2 Enrichment Score: 2.4 
  
Category Term Fold 
Enrichment 
Benjamini 
KEGG_PATHWAY dme00190:Oxidative phosphorylation 9.8 0.000 
GOTERM_CC_DIRECT 
GO:0005750~mitochondrial respiratory chain 
complex III 110.5 0.000 
GOTERM_BP_DIRECT 
GO:0006122~mitochondrial electron transport, 
ubiquinol to cytochrome c 80.9 0.002 
GOTERM_MF_DIRECT 
GO:0008121~ubiquinol-cytochrome-c reductase 

















Figure 6.4 Schematic diagram of STRING analysis showing protein interactions 









The mitochondrial genes, mostly consisting of subunits of the respiratory complexes III and IV 
and other mitochondrial proteins, are shown in green and blue. Two other connections also 




6.6 Selection criteria of candidate genes 
To further characterise the AOX rescue hits and test whether they were able to alter 
mitochondrial ROS levels, I measured mitochondrial ROS in the brain of selected 
RNAi lines. I used a specific selection criterion to comprise a shorter list of 12 
confirmed genes rescued by AOX. Selection of candidate genes was firstly 
dependent on the possession of human orthologues. This was important to identify 
genes involved in the regulation of RET that are also conserved in humans, giving 
the potential for future therapeutics involved in targeting ROS signalling. The second 
criterion was a moderate to high expression of the target gene in the head of the fly 
during early adulthood, according to data reported in Flybase in the “Expression 
Data” section. This was important due to the fact that ROS would be measured in the 
brain of the young fly.  
Table 6.5 outlines a brief description of each of the candidate genes including 
location and function within the cell. The only exception of these criteria was the gene 
CG30373, an uncharacterised Drosophila gene, unknown to possess any human 
homologues. This gene was chosen to validate the AOX rescue phenotype even 
further, by testing a gene of unknown function. This approach could also help reveal 
the different roles of ROS in different species (i.e. insects versus mammals) and how 
ROS levels are regulated, specifically in the fruit fly. From the remaining 11 
confirmed genes, 4 hits were well-characterized mitochondrial proteins whereas the 
rest had not been reported to possess any association with mitochondria, to the best 
of my knowledge. The genes encoding mitochondrial proteins were Cchl (CG6022), 
ABCB7 (CG7955), Mitofilin (CG6455) and mRpS25 (CG14413). ABCB7 and Cchl are 
involved in the processing of heme groups. ABCB7 (ATP-binding cassette subfamily 
B member-7) encodes a mitochondrial inner membrane heme transporter, important 
for delivering iron to proteins containing Fe-S clusters (Sato et al., 2011). Cchl 
(cytochrome c heme lyase) is found in the IMS and functions to aid the assembly of 
Cyt C, by providing the heme group (Babbitt et al., 2017). This heme is instrumental 
in the transfer of electrons from CIII to CIV. Another inner mitochondrial membrane 
protein is Mitofilin, in charge of maintaining mitochondrial cristae structure and 
contact sites with the ER, organisation of respiratory complexes and regulation of 
mitochondrial protein import (Xu et al., 2015). The final mitochondrial gene encoding 
mRpS25 (mitochondrial ribosomal protein subunit 25), is a structural component of 
the mitochondrial ribosome and is required for the synthesis of mitochondrial 
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proteins, encoded by genes arranged in the mitochondrial DNA (Bugiardini et al., 
2019a).  
Another candidate gene included the uncharacterised fly gene, CG7071, whose 
human homologue TMEM199 is a transmembrane protein. In yeast, this protein is 
responsible for the assembly of the proton pump, Vacuolar H+ ATPase (V-ATPase) 
(Vajro et al., 2018). Interestingly a gene encoding the subunit 1 of the Vacuolar 
H+ ATPase PPA1 (VhaPPA1-1) (CG7007) was another confirmed AOX rescue hit. As 
expected STRING network analysis showed that both these genes interact with each 
other (Figure 6.4), since TMEM199 ensures the correct assembly of the Vo domain 
embedded in the membrane, where VhaPPA1-1 resides. The role of this V-ATPase 
is the translocation of protons into endomembrane organelles and vesicles such as 
lysosomes and Golgi apparatus, to maintain a low pH required for digestion of 
damaged protein and organelles (Hirata et al., 1997).  
The final 5 hits were CG11200 (carbonyl reductase), Cul3 (Cullin3), Ppn (Papilin), 
GET4 (CG9853) and crb (crumb). CG11200 is an enzyme from a superfamily of 
short-chain dehydrogenase/reductase (SDR) (Zhang et al., 2014), specifically with a 
role as an NADPH-dependent carbonyl reductase involved in the reduction of 
carbonyl groups, where NADHPH serves as the donor (Sgraja et al., 2004). Cul 3 is 
an ubiquitin ligase protein, involved in the ubiquitination of damaged proteins 
targeted for degradation (Tan et al., 2017). Ppn is an extracellular matrix protein, 
required for the arrangement of the extracellular matrix, during development (Fessler 
et al., 2004). GET4 is required for the transport of tailor-anchored proteins from the 
Golgi to the endoplasmic reticulum (Gristick et al., 2014). The final candidate gene is 
crb a transmembrane protein involved in the organisation of the epithelia and 







6.7 Effect of knocking down candidate genes on brain mitochondrial ROS 
levels 
After comprising a list of 12 candidate genes rescued by AOX, I wanted to test 
whether they participate in regulating mitochondrial ROS levels. To achieve this, I 
measured ROS levels in the brains of the lines, carrying RNAi constructs against the 
candidate genes and their respective controls. To overcome the lethality observed as 
a result of knocking down the genes during development, I fed the flies RU-486 only 
after eclosion. Thus, limiting the depletion of the protein only during adulthood. I 
measured ROS in the brains of 10 day old flies. From the list, 10 out of the 12 genes 
had increased ROS levels when knocked down during adulthood (Figure 6.5).  
The two candidate genes that did not show a significant increase in ROS were 
mRpS25 and CG11200. It was surprising that downregulation of mRpS25 did not 
elicit an increase in ROS, due to the fact that it is responsible for the direct translation 
of the components from the ETC, encoded by mitochondrial DNA.  It is known that 
disruption of the respiratory chain components can lead to dysfunction and increased 
ROS production, which is commonly observed in mitochondrial diseases (Kirkinezos 
and Moraes, 2001).  Therefore, it was expected that the reduction of CIII and CIV 
subunits, resulting from the KD of mRpS25, would also lead to an increase in ROS 
production. Mutations in mitochondrial ribosomal proteins (MRP) subunits have been 
previously reported in patients clinically diagnosed with mitochondrial disorders 
(Menezes et al., 2015). A recent study showed that a patient suffering from 
mitochondrial encephalomyopathy, resulting from mutated MRPS25 (human 
orthologue of mRpS25), had decreased expression of CI, CIII and CIV (Bugiardini et 
al., 2019b). Although ROS levels in mRpS25 mutants have not been reported 
elsewhere, MRPL35, which encodes a protein in the large subunit of the 
mitochondrial ribosome, leads to elevated ROS levels, when down-regulated in vitro 
(Zhang et al., 2019). Similarly, in Chapter 5, I have shown that knockdown of 
subunits of CIII, CIV and CV increases mitochondrial ROS levels in the fly brain. 
However, I did not observe any significant change in ROS, when I knocked down 
mRpS25. It is possible that AOX rescued the lethal phenotype not by reducing ROS 
production but instead by improving electron transport and therefore overcoming any 
dysfunction occurring, due to the reduced activity of CIII and CIV. Interestingly, 
another MRP subunit (mRpS26) was also confirmed in my rescreen, which needs to 
be rescreened in the future (data not shown). Checking ROS levels in these other 
subunits could help to clarify the effect of interrupting mitochondrial translation on 
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ROS production. Furthermore, rescreening all the genes encoding mitochondrial 
ribosomal subunits in different conditions, such as using a different concentration of 
RU-486 or a different driver, could produce different results. Therefore, the question 
of whether interruption of mitochondrial translation increases ROS or not, remains 
unanswered. The second candidate gene which failed to show any rise in 
mitochondrial ROS levels was, CG11200, the predicted fly orthologue of the human 
dehydrogenase/reductase X-linked (DHRSX). DHRSX is a short-chain 
dehydrogenase/reductase (SDR).  Another member of the SDR superfamily, DHRS2 
(dehydrogenase/reductase 2), was found to be down-regulated in tumorous tissue 
associated with oesophageal cancer. In this cancer model, decreased activity of 
DHRS2 led to increased mitochondrial ROS production, in vitro (Zhou et al., 2018). It 
is possible that the knockdown of mRpS25 and/or CG11200 causes an increase in 
ROS only during development or in different tissues (or cell types) aside from the 
brain. Measuring mitochondrial ROS during development or in other tissues may 
produce a different result and explain why AOX rescued the lethal phenotype, without 
altering ROS production in the brain. Despite the two hits that did not exhibit an effect 
on ROS levels, the results from the other 10 candidate genes show that using AOX 
expression is a promising new strategy to reveal genes that possess a regulatory role 



















































Figure 6.5 ROS measurements of 12 candidate genes in normal conditions (25°C). 
 
(A) CG30373-KD (N = 7), (B) ABCB7-KD (N = >7), (C) Mitofilin-KD (N = >8), (D) Cchl-KD (N 
= >7), (E) mRpS25-KD (N = >7), (F) CG11200-KD (N = >7), (G) CG7071-KD (N = >8), (H) 
Cul3-KD (N = >8), (I) Ppn-KD (N = >9), (J) GET4-KD (N = >7), (K) VhaPPA1-1-KD (N = >7) 
and (L) crb-KD (N = >8). Flies were approximately 10 days old after being fed RU-486 to induce 
expression. P Values were calculated using unpaired Student’s T-test and One-Way ANOVA, 
where appropriate. Data are shown as mean ± SEM. p < 0.05 was taken as statistically 





6.8 AOX rescues the knockdown of genes that induce RET-dependent and 
RET-independent ROS 
Results from the previous section showed that most of the confirmed hits, rescued by 
AOX, increased mitochondrial ROS levels when knocked down. Following these 
data, I wanted to determine how those ROS were being produced. Therefore I chose 
3 candidate genes, to characterise their ROS production further and to test whether 
ROS were being generated via RET, or by another mechanism. The 3 genes I 
selected were VhaPPA1-1 (CG7007), Ppn (CG33103) and Cchl (CG6022). The 
reasoning for choosing the proton-pump subunit VhaPPA1-1 was due to the fact that 
another hit, CG7071, encoding an assembly factor of this transmembrane protein, 
was also a positive AOX rescue hit. Therefore, I wanted to explore this pathway 
further, to study whether reduction in the acidification of non-mitochondrial 
organelles, such as lysosomes, could induce ROS-RET. The second gene, Ppn, was 
chosen as previous experimentation had confirmed lethality in Drosophila and 
C.elegans, when it was knocked down during development. In these models, severe 
cellular defects in ECM arrangement were observed without reporting any alterations 
to mitochondrial phenotype (Kramerova et al., 2000). Therefore I wanted to study 
how alterations in ECM caused a mitochondrial phenotype that was rescued by AOX. 
Lastly, I chose to characterise, Cchl, a gene encoding a protein needed for the 
assembly of heme group in mitochondrial Cyt C. This gene was selected to serve, as 
a positive control since the KD of Cchl would prevent Cyt C from accepting or 
donating electrons from CIII to CIV, respectively. Thus, effecting the electron flow 
through CIV, which as I described in Chapter 5, increases the leak of electrons at the 
Qo site of CIII. Furthermore, the bypassing CIII and CIV, ellicted by AOX expression 
should decrease the ROS production in Cchl-KD flies and rescue the lethal 
phenotype.  
The method of characterisation was to measure ROS levels in the brain, in 
combination with feeding the CI inhibitor rotenone to one of the experimental groups. 
Given that rotenone inhibits RET, this would allow the distinction between ROS-RET 
and non-ROS-RET production. Respiration was also measured to infer whether ROS 
were being increased due to alterations in mitochondrial respiration.  
To check the knockdown of VhaPPA1-1, I performed qPCR, which confirmed lower 
expression levels of the gene in the line expressing the RNAi construct (Figure 6.8A). 
To validate the rise in ROS production observed previously, I repeated ROS 
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measurements in normal conditions. As expected, the ROS levels increased when 
VhaPPA1-1 was genetically silenced, compared to its respective controls (Figure 
6.8B). In an attempt to determine the type of ROS responsible for the elevated levels, 
during inhibition of VhaPPA1-1, I fed the knockdown flies rotenone. The effect of 
rotenone feeding completely abolished the increase in mitochondrial ROS (Figure 
6.8C). These results suggest that ROS-RET is activated when VhaPPA1-1 is down-
regulated. The developmental lethality observed in the VhaPPA1-1 knockdown flies 
may be caused by a sustained un-regulated ROS-RET signal, which is ultimately 
rescued by the expression of AOX. When I measured mitochondrial respiration using 
high-resolution respirometry, I did not observe any difference between the groups, 
indicating that the knockdown of VhaPPA1-1 does not significantly impair 
mitochondrial respiration in adult flies (Figure 6.8D). 
qPCR measurements confirmed a significant decrease in the expression of Ppn in 
the knockdown flies, compared to the control, therefore I moved onto ROS 
measurements (Figure 6.9A). In normal conditions, inhibition of Ppn elevated the 
ROS levels significantly, in comparison to the control, reflecting prior data (Figure 
6.9B). To depict where this ROS generation was occurring, within the ETC, I fed the 
knockdown flies rotenone. Quantification of ROS levels in the brain, revealed that 
rotenone had no effect on ROS production in the Ppn knockdown flies (Figure 6.9C). 
These results determined that the ROS production occurring, as a result of Ppn 
inhibition, was not through the activation of ROS-RET. Based on the fact that AOX 
was able to rescue the lethal phenotype of Ppn-KD during development, it is 
therefore reasonable to postulate that this was due to AOX preventing excess ROS 
production, caused by electrons leaking from the Qo site of CIII. However, to confirm 
this hypothesis experiments using myxothiazol will need to be conducted. Finally, no 
difference was detected in CI, CIII or CIV-linked respiration (Figure 6.9D). Suggesting 
that Ppn does not have a direct effect on the mitochondrial ETC and that ROS 
elevation, when Ppn is down-regulated, is not a direct consequence of interrupting 
electron flow or proton pumping.  
The targeted decrease in Cchl expression of the knockdown flies was confirmed by 
performing qPCR (Figure 6.10A). Repetition of ROS measurements in normal 
conditions confirmed that the knockdown of Cchl increases mitochondrial ROS levels 
(Figure 6.10B). To further characterise the origin of ROS produced during inhibition 
of Cchl, I fed rotenone to the knockdown flies; however no effect on ROS production 
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was observed (Figure 6.10C). The lack of effect of rotenone confirmed that the 
stimulation of RET was not the source of ROS, in this case. These data indicate that 
excessive ROS production is occurring at CIII, suggesting that AOX is able to 
alleviate this increase during development. This result was expected since 
knockdown of Cchl will limit the amount of Cyt C that is able to transfer electrons 
from CIII to CIV. Therefore mimicking the consequences observed during the 
inhibition of CIV with cyanide or preventing the assembly of the CIV, by knocking 
down levy. Accordingly, I observed a specific decrease in CIV-linked respiration in 
the knock down flies (Figure 6.10D). This was caused by a decrease in Cyt C activity, 
which in normal conditions is able to accept electrons from TMPD (Veltri et al., 1978). 
The fact that inhibition was specific to CIV-linked respiration, indicates that the 
knockdown only mildly affects the levels of active Cyt C and that the block in electron 
flow is not as strong as those implemented in Chapter 5. Although, it was enough to 
increase ROS in the fly brain, indicating that even moderate reduction in electron 


















Figure 6.6 Characterisation of VhaPPA-1-1-KD flies. 
(A) Quantification of mRNA levels in VhaPPA1-1-KD flies by qPCR. Control flies 
(TubGS>Empty vector and w1118> VhaPPA1-1-KD) and KD flies (TubGS>VhaPPA1-1KD) 
were used (N = 4). (B) ROS measurements in the brain of VhaPPA1-1-KD flies in non-stressed 
conditions (25 °C) (N = >7). (C) ROS measurements in the brain of VhaPPA1-1-KD flies fed 
rotenone (600 µM) in 25 °C (N = >8). (D) Mitochondrial respiration of VhaPPA1-1-KD whole fly 
homogenates showing CI-linked, CIII-linked and CIV-linked respiration as indicated (N = 4). 
Flies were approximately 10 days old after being fed RU-486 to induce expression. P Values 
were calculated using unpaired Student’s T-test and One-Way ANOVA, where appropriate. 
Data are shown as mean ± SEM. p < 0.05 was taken as statistically significant and represented 
by *, p<0.01 was represent by ** and p<0.001 was represented by ***. 
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Figure 6.7 Characterisation of Ppn-KD flies. 
(A) Quantification of mRNA levels in Ppn-KD flies by qPCR. Control flies (TubGS>Empty 
vector) and KD flies (TubGS> Ppn-KD) were used (N = 4). (B) ROS measurements in brains 
of Ppn-KD flies in non-stressed conditions (25 °C) (N = >8). (C) ROS measurements in brains 
of Ppn-KD flies fed rotenone (600 µM) at 25 °C (N = >9). (D) Mitochondrial respiration of Ppn-
KD whole fly homogenates showing CI-linked, CIII-linked and CIV-linked respiration as 
indicated (N = 6). Flies were approximately 10 days old after being fed RU-486 to induce 
expression. P Values were calculated using unpaired Student’s T-test and One-Way ANOVA, 
where appropriate. Data are shown as mean ± SEM. p < 0.05 was taken as statistically 





Figure 6.8 Characterisation of Cchl-KD flies. 
 
(A) Quantification of mRNA levels in Cchl-KD flies by qPCR. Control flies (TubGS>Empty 
vector) and KD flies (TubGS> Cchl-KD) were used (N = 4). (B) ROS measurements in brains 
of Cchl-KD flies in non-stressed conditions (25 °C) (N = >7). (C) ROS measurements in brains 
of Cchl-KD flies fed rotenone (600 µM) at 25 °C (N = 10). (D) Mitochondrial respiration of Cchl-
KD whole fly homogenates showing CI-linked, CIII-linked and CIV-linked respiration as 
indicated (N = 6). Flies were approximately 10 days old after being fed RU-486 to induce 
expression. P Values were calculated using unpaired Student’s T-test and One-Way ANOVA, 
where appropriate. Data are shown as mean ± SEM. p < 0.05 was taken as statistically 





Elucidating the processes behind the generation of mitochondrial ROS, is central to 
gaining insight into their complex relationship with ageing, in order to ameliorate age-
related disease and promote healthy ageing. To confront this challenge, I conducted 
a genome-wide RNAi screen to identify new genes involved in the regulation of 
mitochondrial ROS production. This method facilitated an unbiased and systematic 
approach on a large scale, taking advantage of AOX that reduces excessive ROS 
production at both CI and CIII.  After screening >13,500 RNAi lines (covering >90% 
of the fly genome), I reported 41 genes, whose knockdown during development 
caused a lethal phenotype, which is rescued by AOX expression. The former 
suggests that these genes are involved in the regulation of ROS during development 
and supports ROS signalling as a vital process needed for normal development, of 
an adult fly. As expected, many of the genes identified, encoded both CIII and CIV 
subunits, due to AOX being able to complement mutations or chemical blocks in both 
CIII and CIV (Rajendran et al., 2019) (Dogan et al., 2018) (Fernandez-Ayala et al., 
2009) (Sanz et al., 2010a). Subsequent analysis of 12 confirmed hits showed that the 
majority of genes, (10 out of 12), increase ROS levels when knocked down, only in 
adults.  My results support the concept of using AOX to screen for genes involved in 
the generation of mitochondrial ROS. Remarkably 67% of genes encoding CIII 
subunits and 100% for genes encoding CIV subunits, which caused a lethal 
phenotype, were rescued by AOX, with 100% confirmation in the rescreen. On the 
other hand, AOX did not rescue any of the genes encoding subunits of complexes I, 
II or V. Among the CIII subunit RNAi lines, whose lethality was rescued by AOX, I 
found UQCR-Q. Surprisingly, the knockdown of either levy or ATPsynδ did not cause 
any developmental arrest. However, the knockdown of 9 different genes, encoding 
CV subunits, were lethal and none of them were rescued by AOX. This indicates that 
those flies are probably arrested during development for a lack of ATP, rather than 
excess ROS levels.   
Although some new and novel ROS regulators were identified by the screening 
strategy, used in the present study, I have identified numerous drawbacks that will 
need to be addressed for future screens or rescreens. (i) The confirmation of targets 
identified during the initial screen was quite low (~20%), which may be due to several 
reasons. For example, Drosophila lethality screens are prone to false positives and 
negatives, due to contamination of the vials with bacteria that prevent the 
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development of viable flies. Here, if the contamination is confined to the controls, a 
false positive would be detected, whereas, if it occurred in the AOX group, it would 
produce a false negative, resulting in this gene being discarded. Similarly, if not all 
female flies are virgins, or there is a male fly among the females, a false negative or 
positive may occur. For example, if there is one or more non-virgin fly among the 
controls a false negative is possible, whereas if the same occurs among the AOX 
flies the outcome would be a false positive. Since hundreds of vials were 
simultaneously prepared and screened every week, the technical errors described 
above may have occurred more often than anticipated. Additionally, due to the high 
numbers of vials needed per week, the quality of the food and concentration of RU-
486 could also be variable between repetitions. For future work regarding the screen 
it may be useful to make note of those hits, which showed signs or bacterial infection 
and carry out rescreens to identify any false negatives or false positives. (ii) Due to 
technical reasons the completion of the screen took over four years, which could 
have led to changes in the food, flies (do to background changes and accumulation 
of mutations) or even the RU-486, during this time. In addition, the dose of drug used 
to express the RNAi constructs (and AOX) was set up at the beginning of the screen 
and was optimal to rescue the lethal phenotype, caused by the knockdown of three 
different CIV subunits, by AOX. Lower doses did not cause a lethal phenotype, 
whereas higher doses prevented the rescue by AOX. This explains why only a 
moderate number of OXPHOS genes were lethal (41%). Higher doses would have 
increased the number of lethal genes detected but as a side effect the number of 
genes rescued by AOX would have decreased. Although, internal controls including 
an RNAi line against COX4 (CIV-IV-KD), was used during the screen, ‘recalibration’ 
of the optimal concentration every time would have helped to increase the 
reproducibility. (iii) The use of duplicates or triplicates in each round would also have 
helped to increase the reproducibility, although this would have raised both costs and 
time required to complete the screen. (iv) Using a ubiquitous driver may prevent the 
detection of genes that are important for ROS regulation in specific tissues. Similarly, 
genes that are involved in ROS regulation, in a certain tissue, can cause lethality in 
another tissue by a mechanism that is not ROS dependent. (v) Finally, an alternative 
to a genome-wide RNAi screen may be to screen only certain families of genes, such 
as, mitochondrial ribosomal proteins or MAPK proteins, instead of the whole genome. 
A limited screen would allow using different concentrations of drug, more replicates in 
each round and the use of several different drivers.  
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For a small number of the confirmed hits, an increase in ROS can be justified by their 
function within the cell. For example, the ABCB7 protein is responsible for the 
transport of iron from the mitochondria, into the cytosol. Therefore, its inhibition would 
cause a build-up of iron within the mitochondria and lead to an increase in ROS 
generation. Additionally, the role of Mitofilin involves the organisation of the ETC in 
supercomplexes; hence any disruption to the activity of Mitofilin would lead to a 
dysfunctional ETC and elevate ROS levels in the mitochondria. Nevertheless, the 
majority of hits possess no previous association with the mitochondria, or the 
production of ROS and therefore they are possible novel ROS regulators.  
From the 3 confirmed genes that increased mitochondrial ROS levels and were 
characterised further, VhaPP1-1 was identified as a potential novel regulator of ROS-
RET.  When down-regulated, VhaPP1-1 displayed an increase in ROS, which was 
abolished in the presence of the RET inhibitor, rotenone. These data suggested that 
depletion of VhaPP1-1 can trigger ROS-RET. Interestingly another gene required for 
the assembly of the VhaPPA proton pump, CG7071, was also identified as an AOX 
rescue hit, which reinforces the involvement of VhaPPA1-1 as a ROS regulator. In 
the future, it would be interesting to test whether the increase in ROS, elicited by 
CG7071, is also caused by triggering RET.  Vacuolar ATPses are instrumental for 
the acidification of the lysosome, which is required for the turnover of damaged 
proteins and organelles. Therefore depletion of VhaPPA1-1 could cause the 
accumulation of damaged mitochondria that activates a ROS-RET signal, to 
stimulate mitochondrial turnover. Mitochondrial ROS levels have been described to 
activate mitophagy (Pirastu et al., 1990) (Wang et al., 2012) but where and how 
these ROS are generated remains to be elucidated. The models developed during 
my thesis could help answer that question. 
Although inhibition of VhaPPA1-1 had no effect on the mitochondrial respiration of 
the knockdown flies, this may have been due to the sample preparation, as samples 
consisted of whole bodies. Under these conditions, most of the mitochondria are 
muscle mitochondria from the thorax (Cocheme et al., 2011); therefore it is possible 
that mitochondrial respiration is altered specifically in the brain where ROS were 
measured.  
Ppn is a component of the ECM. Results from downregulation of this gene revealed 
an increase in ROS production that was not attenuated when the RET inhibitor 
rotenone was administered. It is plausible that this ROS is generated at the Qo site of 
205 
 
CIII. However, to confirm this, it will be necessary to repeat ROS measurements in 
the presence of myxothiazol.  The inhibition of Ppn also had no effect on 
mitochondrial respiration when whole flies where used but a different result could be 
obtained if only fly heads are used instead. With the present information, it is not 
possible to depict the mechanism by which Ppn increases mitochondrial ROS and 
how this alteration interrupts fly development. In the future, further experiments 
including tissue-specific measurements of mitochondrial respiration and knockdown 
of other proteins that interact with Papilin, such as metalloproteinases, will help to 
understand how its knockdown affects mitochondrial ROS levels. 
Cchl was identified as a novel fly regulator of both CIV activity and ROS production. 
Downregulation of Cchl exhibited a CIV-specific decrease in respiration, explained by 
lower levels of functional Cyt C, which normally functions to transfer electrons to CIV. 
The fact that CI and CIII-linked respiration were not affected, indicates that Cyt C is in 
excess, in the ETC.  Interestingly, reducing the amount of functional Cyt C 
reproduces the effect of chemical inhibition and genetic silencing of CIV subunits. In 
Chapter 5, it was established that the Qo site of CIII was the most probable source of 
ROS, during CIV inhibition and I hypothesize that the same site is producing ROS 
when Cchl is knocked down. The AOX rescue can be explained either because its 
expression prevents excessive ROS production by CIII, or because it complements 
the reduction in CIV activity. Experiments overexpressing antioxidants such as SOD2 
or mitochondrial-targeted catalase, used in Chapter 3, will help to clarify this point. 
In summary, my screen strategy using AOX has been able to identify new regulators 
of mitochondrial ROS production, in the fly brain. The effectiveness of this strategy 
requires the rescreen of any candidate gene, confirmation of the knockdown by 
qPCR or western-blot and measuring ROS levels in independent experiments with 
and without specific ETC inhibitors. Furthermore, the use of other RNAi fly lines 
targeting other parts of the gene is highly recommendable, to further confirm the 
results. The latter will need to be performed in the future for the different genes I 
have found and described. Finally, the strategy presented here can be adapted to the 
specific needs of any researcher for example screening deformations of the fly eye 
(Ma et al., 2009), using tissue-specific drivers to study particular organs or cells, or 




Chapter 7 General Discussion 
 
7.1 Introduction  
It has become apparent over the last decade that the behaviour of Reactive Oxygen 
Species (ROS), within our cells, represents a double-edged sword. On the one hand, 
their excessive production is responsible for oxidative stress that drives cellular 
dysfunction and damage (Barja, 2014). On the other hand, basal levels of ROS are 
essential for maintaining cellular homeostasis (Ray et al., 2012). From the 
perspective of the MFRTA, ROS have been well documented. Here, mitochondrial 
ROS are described as toxic by-products of metabolism that accumulate with age and 
create a vicious cycle of mitochondrial dysfunction, a universal hallmark of ageing 
(Lopez-Otin et al., 2013). Studies have been able to confirm an age-dependent 
increase in the extent of oxidative damage, as well as a negative correlation between 
ROS levels and lifespan, in multiple animal models and species (Cui et al., 2012). 
Moreover, chronic mitochondrial ROS production has been recognised in a diverse 
range of age-related diseases such as Parkinson’s disease (Zhang et al., 1999), 
Alzheimer’s disease (Wang et al., 2014), diabetes (Anderson et al., 2009), 
cardiovascular disease (Puca et al., 2013) and cancer (Kudryavtseva et al., 2016). 
Despite the vast amount of experimental data supporting the MFRTA, contradictory 
evidence has challenged the integrity of this theory. For example, it is anticipated that 
the concentration of mitochondrial ROS influences lifespan, however, administration 
of antioxidants or manipulation of endogenous antioxidant expression, to moderate 
ROS levels, has not been shown to extend lifespan (Sanz et al., 2006) (Liu, 2014). 
Additionally, the direct reduction of ROS,  by e.g. the expression of AOX in fruit flies, 
does not increase longevity (Sanz et al., 2010a). In fact, in many cases an increase 
in mitochondrial ROS has led to lifespan extension (Yang and Hekimi, 2010) (Scialo 
et al., 2016a) (Hekimi et al., 2011) (Schmeisser et al., 2011). These contrasting data 
highlight the complexity of studying the role of ROS, due to their dual identity both as 
signalling molecules and toxic by-products of metabolism. 
 
In their role as cellular messengers, mitochondrial ROS production has been shown 
to be necessary for many biological processes. For example, without mitochondrial 
ROS it is not possible to initiate a pro-inflammatory response required for activating 
innate immunity or establishing a senescence phenotype to prevent cancer (Mills et 
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al., 2016a) (Soberanes et al., 2019) (Nelson et al., 2018). Paradoxically, ROS are 
also required for promoting cell proliferation and differentiation (Diebold and Chandel, 
2016). A primary example of this is seen in cancer cells, where ROS are maintained 
at heightened levels in order to encourage proliferation (Moloney and Cotter, 2018). 
To achieve this process, ROS target specific pathways including HIF, NF-ĸB, MAPKs 
and PI3K (Galanis et al., 2008) (Huang et al., 2016) (Wang et al., 2017) (Lu et al., 
2017). Other studies have also shown that mitochondrial ROS can regulate blood 
pressure (Dhalla et al., 2000), programmed neuronal cell death (Tan et al., 1998) and 
even the length and quality of sleep (Kempf et al., 2019). These findings all support 
the role of mitochondrial ROS as essential regulators in redox signalling.  It is now 
essential to study what defines the behaviour of ROS, for example the mechanisms 
behind how they are produced.  
 
CI and CIII, of the respiratory chain, are the two major sites of ROS production within 
the mitochondria and have both been implicated in numerous specific cellular 
pathways. One of the most characteristic and best-described processes, leading to 
site- and time-specific ROS production is RET. The process of RET, which results in 
augmented ROS production at CI, has recently been described to play a central role 
in distinct physiological and pathological processes. These include the differentiation 
of myoblasts into myotubes, triggering an immune response to bacterial infection and 
sensing and reacting to hypoxia by arterial chemoreceptors in the carotid body 
(Garaude et al., 2016) (Fernandez-Aguera et al., 2015) (Lee et al., 2011). In all of the 
former situations, ROS are not produced at random but rather as a signal in 
response to specific stimuli, at specific times and specific sites. Furthermore, there 
are mechanisms that both stimulate and terminate the ROS-RET signal. Interestingly, 
it has also been shown that the expression of Ndi1 from Saccharomyces cerevisiae 
promotes a sustained ROS-RET signal, when expressed in the mitochondria of 
Drosophila melanogaster (Scialo et al., 2016a). Continuous activation of ROS-RET 
signalling leads to lifespan extension in fruit flies (Scialo et al., 2016a) (Sanz et al., 
2010b) (Bahadorani et al., 2010) . Unfortunately, the downstream pathways 
responsible for these beneficial effects, elicited by Ndi1 expression, are yet to be 
determined. Presently, we know that activation of RET requires a highly reduced 
CoQ pool, along with a high proton motive force but so far only speculation has been 
provided surrounding how RET can be stimulated, in physiological conditions. 
Exploring the mechanisms behind ROS-RET and the signalling pathways that drive 
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its downstream outcomes may be instrumental in understanding the role of ROS in 
health and disease. Thus, it can provide us with new strategies to stimulate ROS 
signalling in young individuals or to restore it in later life, to promote healthy ageing.  
 
7.2 Main findings and contributions to the field 
 
Since its discovery in 1961, RET was considered to be an in vitro phenomenon 
(Chance and Hollunger, 1961). This perception began to change when publications 
reporting the production of ROS-RET in the mitochondria from ischemic tissues 
started to emerge, thus increasing the interest surrounding RET (Lesnefsky et al., 
2004), (Chen et al., 2006). These reports showed that the detrimental effects of IR 
were palliated when rotenone was administered to animal models (Lesnefsky et al., 
2004), (Chen et al., 2006). However, it was a publication from the laboratory of Mike 
Murphy in Cambridge, which brought RET to the forefront of research. This study 
confirmed the existence of ROS-RET in vivo as well as being the main mechanism 
responsible for the oxidative damage, occurring as a result of IR (Chouchani et al., 
2014a). Since then, ROS-RET has been shown to be instrumental in many biological 
events, discussed previously in this thesis. It has been well documented that the 
stimulation of RET requires both a high CoQH2:CoQ ratio and a high proton motive 
force, to make RET favourable. Nevertheless, evidence surrounding how these two 
essential conditions are achieved in vivo has not been established (Scialo et al., 
2017).  
 
One of the aims of my thesis was to test whether ROS-RET occurs in physiological 
conditions and to dissect how the redox state of CoQ and the proton motive force 
contribute to this. In Chapter 3, I showed that heat stress (HS) triggers ROS-RET in 
the brain of Drosophila melanogaster. Under HS, there is an increase in energy 
demand that enhances oxidative phosphorylation, increasing the entry of electrons 
into the ETC. According to unpublished data from our laboratory, the increase occurs 
due to a rise in the activity of not only CI and CII but also of other dehydrogenases, 
such as G3P, ETF-QO and DHOD, which can also reduce the mitochondrial CoQ 
pool. This boost of electrons entering the ETC increases the reduction state of CoQ 
and also drives the transport of protons across the inner membrane, thus 
establishing a high proton motive force.  In summary, HS creates the perfect 
conditions for inducing RET, allowing CI to switch from a forward to a reverse 
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direction, thereby altering the mechanism of CI ROS production.  This burst in 
mitochondrial ROS can be modulated in intensity and duration, to produce a signal in 
response to stress. To confirm that ROS were produced via RET; I used the specific 
CI inhibitor, rotenone and the mitochondrial uncoupler, FCCP. Both of them have 
been extensively used to confirm the existence of ROS-RET in the literature (Robb et 
al., 2018) (Scialo et al., 2016a) (Chouchani et al., 2014a). When rotenone and FCCP 
were supplemented, to block the quinone binding site of CI and dissipate the proton 
motive force respectively, ROS-RET was prevented. Interestingly, in non-stressed 
conditions (25°C), both rotenone and FCCP increased ROS in the fly brain, indicating 
production of ROS by CI and/or CIII in the forward direction. However, under HS both 
mitochondrial inhibitors decreased ROS levels, supporting production of ROS by CI 
in the reverse direction. These results reflected those seen in Ndi1 flies, where 
rotenone and FCCP decrease ROS (Scialo et al., 2016a).  
 
Lastly, I used the over-expression of two antioxidants SOD2 and a mitochondrial-
targeted catalase to confirm the location of the ROS production. Results from these 
experiments showed that the increased ROS production, in response to HS, was 
originating exclusively from the mitochondrial matrix, as expected from a ROS-RET 
signal. My results using the referred specific mitochondrial inhibitors and antioxidants 
showed that ROS-RET can occur in the fly brain in physiological conditions. 
Interestingly, mitochondrial ROS levels were increased after only 3 hours at 32°C 
and returned to the level of unexposed controls, after 5 hours. This supports the idea 
that ROS-RET is not produced randomly but as a signal to adapt to HS. Accordingly, 
unpublished data from the Sanz’s laboratory showed that preventing ROS-RET 
under HS, attenuates the expression of genes involved in the anti-stress responses 
and dramatically shortens the lifespan of the flies. 
 
It is widely accepted that mitochondrial dysfunction is one of the hallmarks of ageing 
(Lopez-Otin et al., 2013). The two main phenotypes of ‘old’ mitochondria are a 
decrease in ATP production and an increase in mitochondrial ROS generation 
(Gabbita et al., 1997) (Drew et al., 2003) (Sanz et al., 2010a) (Cocheme et al., 2011), 
(Pollard et al., 2016). Some reports have described that during ageing, CI activity is 
the first to be altered and to a much greater extent than the other ETC components in 
flies and humans (Scialo et al., 2016a) (Cooper et al., 1992) (Cabre et al., 2017). 
Similarly, in Parkinson’s patients, CI has been reported to be the most affected 
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respiratory complex. CI inhibitors elicit a Parkinson’s like phenotype in humans and 
animal models (Tanner et al., 2011). Additionally, CI dysfunction has also been 
observed in mouse models of ataxia (Pollard et al., 2016), associated with cancer 
proliferation (Gui et al., 2016) and even in psychiatric conditions such as bipolar 
disorder (Duong et al., 2016). Our laboratory has shown that CI-linked respiration is 
specifically reduced from 50 days onwards followed by a decrease in the levels of CI, 
in 75 days old flies (Scialo et al., 2016a). Interestingly, the decrease in CI-activity 
occurs in parallel with the increase in mitochondrial ROS levels in the fly brain (Scialo 
et al., 2016a). Given that ROS-RET is dependent on the activity of CI, I hypothesized 
that age-related alterations of CI could lead to changes in redox signalling, mediated 
by ROS-RET.  This would explain the protective effect of Ndi1 on mitochondrial 
function observed both in old flies (Sanz et al., 2010b) and in pink1 and Sod2 
mutants, since Ndi1 would rescue redox signalling, through the stimulation of ROS-
RET (Scialo et al., 2016a), (Vilain et al., 2012). 
 
As I anticipated, at 50 days, mitochondria from old flies were unable to trigger ROS-
RET, in response to HS. Similarly, no increase in ROS was observed in response to 
rotenone, under non-stressed conditions. 50 day old flies had very high levels of 
mitochondrial ROS in the brain and did not change ROS production in response to 
stress, in contrast to the younger flies. For example, 25 day old flies, had higher 
levels of mitochondrial ROS than controls but they were still able to trigger ROS-
RET, in response to HS. I proposed a model where HS (and possibly other types of 
stress) during early life, would encourage a fully functioning CI to switch from 
producing ROS in a forward direction to RET. Producing a rise in ROS that would act 
as signalling molecules, to trigger various pro-survival pathways. Once the 
appropriate pathways are stimulated, and cellular homeostasis is re-established, the 
ROS-RET signal is terminated, and ROS decreases to basal levels. However, during 
ageing the decline in CI activity attenuates the ROS-RET response, preventing the 
stimulation of the required survival pathways. Thus, providing an explanation as to 
why I did not observe a ROS-RET response, in 50 day old flies, when mitochondrial 
respiration is significantly decreased. I speculated that the decline of redox signalling 
contributes to the accumulation of damaged mitochondria, which causes the 
unregulated production of ROS. In contrast to ROS-RET, the high levels of 
mitochondrial ROS observed in old individuals, cannot be neutralised, which 
therefore drives the oxidative stress that is observed in old flies (Jacobson et al., 
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2010), (Magwere et al., 2006). In addition, the background oxidative stress also 
interferes with normal redox signalling, altering processes that require ROS signalling 
(Figure 7.1). For example, autophagy (Scherz-Shouval et al., 2007); a process that is 
strongly reduced when flies become old (Simonsen et al., 2008). 
Figure 7.1 The effect of CI ROS production in young versus old flies. 
Inducing ROS-RET by subjecting flies, for four hours, 3 times per week to HS, did not 
extend lifespan. This is in contrast with the results previously shown by Ndi1 
In young flies, when a stress occurs, RET is stimulated to produce ROS signalling messengers 
which can leave the mitochondria and target cysteine groups of specific proteins to restore 
cellular homeostasis. Eventually, the ROS signal is terminated. However, in old flies, CI levels 
progressively decrease during ageing. Thus, RET can no longer be stimulated to overcome 
the stress condition by promoting cellular survival pathways. Instead, CI dysfunction leads to 
chronic ROS production, which drives oxidative stress and further damage.  
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expression (Scialo et al., 2016a). This could be due to a number of different reasons, 
for example, the duration of ROS-RET, the intensity of the signal or the tissues where 
ROS-RET is induced. In the case of Ndi1, the signal seems to be activated all of the 
time, whereas, in the HS model, RET only lasts for 2 hours. It would be interesting to 
test whether exposing flies to HS more often (e.g. every day), would positively affect 
lifespan. In addition, Ndi1 increases mitochondrial ROS levels higher than HS, so it is 
possible that the intensity of the signal during HS is not enough to activate the same 
mechanisms that Ndi1 does. It cannot be discarded either that the effect of Ndi1 on 
longevity, is due to its expression during development. Alternatively, it is possible that 
ubiquitous Ndi1 expression, increases ROS-RET in tissues that are not affected by 
HS. Time- and tissue-specific expression of Ndi1 will help to answer the former 
questions.  Interestingly, exposing flies to HS in combination with rotenone, 
dramatically shortened lifespan, when the combined treatment was administrated 
after day 25. Thus, when I fed 50-day-old flies with rotenone and exposed them to 
HS, many of them died within hours. This data indicates that ROS-RET is 
instrumental for stress adaptation, thus preventing RET, dramatically decreases 
survival under stress, in an age-dependent manner. The fact that suppressing ROS-
RET did not have any effect in young flies, in the conditions assayed, indicates the 
existence of stress adaptation mechanisms in early life that are lost during ageing.   
 
After establishing that ROS-RET occurs physiologically, I developed different fly 
models to study in detail how the individual components of the ETC contribute to the 
formation of ROS-RET, in vivo. Starting with CI and CII, I was able to confirm that the 
entry of electrons into the ETC is essential for the production of ROS-RET. When 
electron entry was blocked, using both short-term and long-term inhibition of CI and 
CII during HS, the increase in ROS was abolished. This data indicated that without 
the activity of CI and CII the CoQ pool could not reach the reduction state required to 
initiate ROS-RET. Previous studies from our laboratory, have shown that reduction of 
CI activity (by knocking down ND-39) reduces RET, during expression of Ndi1 (Scialo 
et al., 2016a). Other laboratories have also found that CI inhibition by rotenone was 
able to prevent ROS-RET during IR (Chouchani et al., 2014a) or to stop the pro-
inflammatory response caused by injecting mice with LPS that is also ROS-RET 
dependent. Additionally, genetic depletion of CI, specifically in cells of the carotid 
body abolished the increase in ROS in response to hypoxia, as well as the 
organismal response, of increasing respiratory rate in mice, in the presence of low 
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oxygen levels (Arias-Mayenco et al., 2018) (Mills et al., 2016a). Collectively, these 
observations all confirm the necessity of CI and CII activity in the formation of ROS-
RET.  
 
I then studied the effect of blocking the exit of electrons from the ETC, via the 
inhibition of CIII and CIV. In contrast to blocking CI and CII, I hypothesised that 
inhibiting the flow of electrons would lead to an accumulation of electrons upstream 
of CIII and CIV, promoting a highly reduced CoQ (Jacobson et al., 2005), (Drew et 
al., 2003), (Zuckerbraun et al., 2007), (Eghbal et al., 2004). Prior to my own 
experimentation, it has been documented that the endogenous CIV inhibitors, such 
as NO, CO and H2S, could elicit an increase in mitochondrial ROS levels after 
blocking CIV (Taylor and Moncada, 2010). Therefore I hypothesised that inhibition of 
either CIII or CIV would trigger ROS-RET. The conclusion from all my experiments 
was that blocking the exit of electrons elevated ROS production, as previously 
described but not due to the stimulation of RET.  
  
The results obtained after CIII short-term inhibition were difficult to interpret. I 
observed a dose-dependent effect, where small doses reduced ROS production and 
high doses lead to increased ROS levels. The decrease in ROS, caused by low 
doses of myxothiazol, may be explained by two previous observations. The first is 
partial inhibition of CI, caused by the inhibition of CIII (Bacsi et al., 2006), which 
would prevent ROS-RET from occurring. The second and non-exclusive is a 
decrease in membrane potential caused by the inhibition of CIII. It has been reported 
in mammalian cells that inhibition of CIII with antimycin A, makes CV work in the 
reverse direction (i.e. transporting protons from the matrix to the intermembrane 
space) to maintain the mitochondrial membrane potential (Metzen et al., 2003). 
Under these circumstances, ATPIF1 is activated to inhibit the reverse motion and 
prevent ATP hydrolysis. This preserves energy levels, but it decreases membrane 
potential (Gaude and Frezza, 2014). It is possible that the same depolarisation 
occurs in fruit flies, since ATPIF1 has two fly orthologues, explaining why ROS-RET 
does not occur in the fly brain in response to CIII inhibition (Metzen et al., 2003). 
Obviously to confirm the implication of the membrane potential, its measurement in 




Higher concentrations of myxothiazol induced a substantial rise in mitochondrial ROS 
levels. This increase in ROS was insensitive to rotenone feeding, discarding ROS-
RET as the source. It is possible that under these conditions, the increase in ROS is 
the result of chronic damage to the mitochondria and global dysfunction, with 
electrons leaking from non-specific places, within and outside the ETC. Long-term 
genetic inhibition of CIII also resulted in a large increase in ROS production that was 
proven not to be due to RET either. An alternative possibility is that CII is generating 
the ROS since it has been described that CII ROS production may occur in response 
to CIII/CI inhibition (Quinlan et al., 2012). To test the latter hypothesis, I fed flies with 
the CII inhibitor, malonate and observed a significant decrease in ROS production 
(data not shown), supporting CII as the source of ROS, during inhibition of CIII with 
high doses of myxothiazol. However, this may require further confirmation, by testing 
a genetic model of CII depletion, since I was not able to confirm CII inhibition in the 
fly brain using malonate. In any case, my results clearly show that CIII inhibition, both 
long and short term, was not able to stimulate ROS-RET in vivo.  
 
CIV inhibition using either chemical or genetic approaches, elicited an increase in 
ROS production. Further characterisation indicated that the increase in ROS was not 
produced via RET but instead was originating from the Qo site of CIII. This was 
confirmed by the use of the Qo site inhibitor, myxothiazol. Similarly to CIII inhibition, 
blocking the electron flow through CIV would decrease the proton motive force, due 
to CIV no longer contributing to the transfer of protons across the inner membrane. 
Consequently, the decrease in the proton motive force would prevent the occurrence 
of ROS-RET at CI. However, the first upstream site of CIV able to generate ROS is 
CIII. Therefore the inhibition of electron flow at CIV would lead to an accumulation of 
electrons at CIII, increasing the electron leak and ROS generation at the Qo site of 
this complex. ROS produced at the Qo site are released into both the mitochondrial 
matrix and the intermembrane space (Muller et al., 2004). Superoxide produced in 
the intermembrane space is usually converted into peroxides by SOD, which enables 
them to diffuse into the cytoplasm and interact with proteins. This makes CIII an 
advantageous site for sending ROS signals directly to the cytoplasm (Chandel, 
2010).  Recently, ROS generated at the Qo site of CIII have been described as 
initiators of important signalling events. For example, during hypoxia, CIII acts as an 
oxygen sensor and releases ROS from the Qo site, to trigger a survival response. 
CIII-derived-ROS are required to stabilise HIF-1α, therefore when the Qo site inhibitor 
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stigmatellin, is administered, HIF-1α is not stabilized and consequently degraded 
(Chandel et al., 2000).  During the last 10 years the laboratory of Navdeep Chandel 
and associates, have shown that ROS produced at the Qo site are required for 
physiological processes, such as proliferation in certain types of cancer, activation of 
T cells, adipocyte differentiation or production and release of IL-6 (Chandel et al., 
2000) (Diebold et al., 2019) (Weinberg et al., 2010) (Tormos et al., 2011). However, it 
remains unsolved how CIII increases ROS production in vivo. In the future, it would 
be interesting to test whether the inhibition of CIV, is responsible for the processes 
mentioned before and if this inhibition occurs physiologically. The latter is possible 
since at least three endogenous messengers (NO, CO, H2S) have been shown to 
block CIV as previously discussed (Taylor and Moncada, 2010).  
 
One of the genes identified from the screen, Cchl, reduced CIV activity and also 
increased mitochondrial ROS levels. Knockdown of Cchl during development was 
lethal, despite no significant alterations in mitochondrial respiration, apart from the 
mild decrease in CIV-linked respiration. The fact that the lethal phenotype was 
rescued by AOX, indicates that even mild inhibition of CIV can increase ROS and this 
can have deleterious consequences in the normal development of the fly. Our results 
do not support the idea that blocking CIV induces ROS-RET (Dogan et al., 2018), 
although this may not be the case in other organisms or tissues. In summary the 
results from the inhibition of CIII and CIV showed in both cases, an important 
increase in ROS as previously reported (Srinivasan and Avadhani, 2012). However, 
my results demonstrated that ROS are not produced via RET in the mitochondria of 
the fly brain when electron flow through CIII and CIV is interrupted.  
 
Finally, CV showed contrasting results when inhibited. Results regarding acute CV 
inhibition, using oligomycin, could not elicit a ROS-RET response. This contradicts 
what has been previously reported in the literature using different models (Chouchani 
et al., 2014a; Fukuoh et al., 2014; Mills et al., 2016a), see Chapter 5 for details. 
Feeding flies with oligomycin resulted in a decrease in mtROS, in the brain, using a 
wide range of concentrations and varying time periods. During HS, a physiological 
RET model, oligomycin also attenuated the ROS-RET response. Furthermore, 
feeding oligomycin to Ndi1 flies also decreased mitochondrial ROS levels. 
Suppression of ROS-RET by oligomycin, has been independently reported by other 
studies (Sanz et al., 2010c), (Santamaria et al., 2006), (Mills et al., 2016a). When 
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long-term genetic inhibition was employed, a rotenone sensitive increase in 
mitochondrial ROS levels was detected, suggestive of ROS-RET. However, these 
results should be interpreted with caution. Knockdown of ATPsynδ produces a 
dramatic decrease in mitochondrial respiration and the flies that eclose are very weak 
and die within days. Therefore, it is possible that rotenone feeding alongside strong 
CV inhibition could produce severe mitochondrial dysfunction, resulting in the proton 
motive force becoming completely collapsed. This could cause massive cell death 
leading to the observed decrease in mitochondrial ROS levels. Studying cell death in 
the fly brain, under these experimental conditions, will help to confirm or discard this 
hypothesis. In summary, my results regarding the role of CV inhibition, in relation to 
the stimulation of ROS-RET, were inconclusive and further investigation is required 
to establish how manipulation of CV affects mitochondrial ROS levels.  
 
In an alternative attempt to study the mechanisms behind the regulation of ROS-
RET, I used a high-throughput unbiased approach, by performing a genome-Wide 
RNAi screen that covered over 90% of fly genes. Using the expression of AOX, a 
RET suppressor (Scialo et al., 2016a); I identified various genes involved in the 
modulation of mitochondrial ROS levels.  Given that AOX is also able to decrease 
ROS produced by CIII (Sanz et al., 2010a), I used rotenone in my ROS 
measurements to distinguish between ROS-RET and CIII-derived ROS production. 
Using this strategy, I identified a new gene whose knockdown stimulates ROS-RET 
in the fly brain: VhaPPA1-1. Interestingly, another gene, CG7071, required for the 
assembly of VhaPPA1 was also identified in my screen, and I confirmed that upon its 
knockdown, mtROS levels are also increased. However, whether the increase in 
ROS, after the knockdown of CG7071, is ROS-RET dependent requires further 
confirmation. Two other genes, Ppn and Cchl, were shown to be involved in the 
regulation of mitochondrial ROS levels. However, my data does not support ROS-
RET, as the mechanisms of production. It is possible that they are produced at the 
Qo site of CIII, which would explain why AOX was able to decrease and rescue the 
lethal phenotype. However, confirmation with CIII inhibitors, such as myxothiazol, is 
needed.  Additionally I showed that knockdown of Cchl, limited the entry of electrons 
to CIV and supported previous results of CIV inhibition, such as depletion of levy or 
cyanide administration, which resulted in an increase in ROS upstream of CIV. 
Overall, my screen strategy was successful in identifying new genes involved in the 
regulation of mtROS levels, in the brain. Thus, it shows AOX as a powerful tool for 
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similar screens, where the strategy could be adapted to the needs of the user, e.g. 
performing tissue-specific screens or targeting only individual families of genes.  
 
In summary, my work has dissected how ROS-RET occurs in the fly brain.  Using ex 
vivo ROS measurements, I provided evidence that ROS-RET can be stimulated 
physiologically using HS. I have shown that RET depends on the free entry of 
electrons into ETC and that blocking electron exit increases ROS but not via RET.  
This is particularly interesting for CIV, which can be blocked by endogenous 
messengers, such as NO and CO. My experiments using myxothiazol showed that 
CIII is the place where electrons leak when CIV is blocked. I have also generated a 
list with more than 40 candidate genes, with the potential to regulate mitochondrial 
ROS levels in vivo. In addition, I have characterised three of the candidate genes, 
including one that is involved in the generation of ROS-RET. Finally, one of the most 
important contributions of my thesis is the generation of several new fly models to 
study ROS. Including, ROS specifically produced via RET (HS and knockdown of 
ATPsynδ) or ROS produced by CIII (inhibition using cyanide or knocking down levy 
or Cchl). Similarly, these fly models will make it possible to study the physiological 
consequences of being unable to induce ROS-RET under stress (e.g. by knocking 
down CI/CII subunits or blocking RET with rotenone or FCCP). In addition, they will 
allow the study of how sporadic or chronic high levels of mitochondrial ROS 
upstream of CIV (blocking CIII/CIV with myxothiazol/cyanide or knocking down 
UQCR-Q, levy or Cchl) affects lifespan. Characterising these fly models in detail will 
provide us with a more comprehensive understanding of how ROS signalling 
operates in vivo, allowing the discovery of new drug targets to combat ageing and 
age-related diseases. 
 
7.3 Future Work  
The on-going challenges regarding the measurement of ROS levels have previously 
limited the study of ROS. The vast majority of previous studies have been performed 
in vitro using isolated mitochondria or cell culture, which presents a range of 
drawbacks, reviewed in my introduction. Briefly, the use of isolated mitochondria 
removes the organelle from its natural environment, leading to a loss of physiological 
relevance. Although cell culture eliminates this disadvantage, the conditions in which 
they are grown in, for example, hyperoxic oxygen levels and glucose-rich media 
again, lead to poor physiological relevance. Furthermore, the use of non-
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physiological concentrations for ETC substrates or the use of inhibitors can lead to 
high rates of ROS production that are not observed in vivo. To overcome these 
limitations observed with in vitro techniques, in vivo strategies of ROS measurements 
are starting to be implemented (Cocheme et al., 2011) (Albrecht et al., 2011). The 
use of in vivo or ex vivo methods allows for a more accurate representation of ROS 
dynamics, occurring within an organism. 
 
For my thesis, I have measured mitochondrial ROS levels in the dissected brain of 
Drosophila melanogaster. This approach allows ex vivo measurements with a 
consistent area of tissue (the whole brain) to minimise variation between samples, a 
disadvantage of using other tissue such as muscle. I initially used two fluorescent 
dyes to validate the results obtained in Chapter 3. First of all H2DCF, a well-
established cell-permeable and highly sensitive general ROS detector 
(Kalyanaraman et al., 2012) and secondly MitoSOX, another extended ROS probe 
that is targeted into the mitochondrion and is preferentially oxidised by superoxide 
(Zielonka and Kalyanaraman, 2010). I confirmed that the signals detected using 
H2DCFA and MitoSOX were attenuated in response to the expression of a 
mitochondrial-targeted catalase and the overexpression of SOD2 in the 
mitochondrion, respectively. However, both probes present several drawbacks as 
reviewed in (Sanz, 2016). To confirm the results of my thesis, it may be beneficial to 
explore other complementary approaches to quantify mitochondrial ROS, in vivo. 
This will help to validate my results and test the physiological relevance of the 
processes, described in my thesis. I propose several alternative approaches. First of 
all, the use of the ratiometric probe MitoB/MitoP (Cocheme et al., 2011), which would 
allow a precise estimation of the levels of mitochondrial H2O2 in Drosophila 
homogenates or specific tissues. In addition, I would image cells or fly organs 
measuring ROS using both ex vivo and in vivo techniques, by using the genetically 
encoded mitochondrial H2O2 redox reporter mtORP1-roGFP (Albrecht et al., 2011). 
Furthermore, highly sensitive reporters, using the same principle as the former 
example, have been engineered by the laboratory of Tobias Dick in Heidelberg that 
could be expressed in the fly, to replace the old mtORP1-roGFP (Albrecht et al., 
2011). It may also be interesting to measure ROS in different fly tissues, such as the 
flight muscle, gut or fat body, which have been shown to have different proteomic 
responses to alterations that extend lifespan, such as reduced insulin signalling (Tain 
et al., 2017). In this study, mitochondrial respiration was altered in fat body but not in 
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brain, skeletal muscle or gut. It would be interesting to test whether ROS are altered 
in these alternative tissues and if alterations in ROS are instrumental for extending 
lifespan. In addition, unpublished results from the Sanz’s laboratory, show that 
genetic depletion of CoQ, by knocking down genes involved in CoQ synthesis, 
causes an increase in mitochondrial ROS in skeletal muscle but not in the brain.   
 
The next step in this line of research will be to take advantage of the HS model to 
induce ROS-RET and explore the pathways that are activated in response to this 
signal. Unpublished data from our laboratory show that preventing ROS-RET, using 
AOX or mitochondrial-targeted catalase expression to decrease ROS levels, 
shortens lifespan under HS. This supports a major role of ROS-RET signalling, in 
stress adaptation. To study this further, a hypothesis-driven approach could be used 
to test whether pathways that have been shown to be ROS regulated, for example, 
Nf-ĸB, HIFs, PI3K and MAPK, are activated by ROS-RET. A non-hypothesis driven 
approach to study transcriptomic and metabolomics changes, in response to ROS-
RET, has been already carried out in our laboratory. The results from this approach 
have shown that ROS-RET is required for activating pro-survival pathways in 
response to HS (Scialo and colleagues, unpublished results). ROS-RET activation 
diverts glycolytic intermediates to the pentose phosphate pathway, to produce 
NADPH and precursors for nucleotide biosynthesis. Finally, in the future, it will be 
interesting to use new proteomics approaches (Bagwan et al., 2018) to detect post-
translational modifications in proteins (including changes in redox-sensitive 
cysteines) (Menger et al., 2015) in response to ROS-RET.  
 
The identification of ROS-RET is based on the administration of rotenone and FCCP, 
to block the CI quinone-binding site and dissipate the mitochondrial proton motive 
force, respectively. Although these effects are well characterized in vitro, it remains to 
be determined whether they accomplish the same in vivo and specifically in the 
conditions assayed in the present work, i.e. the Drosophila brain. Therefore, another 
future objective is to assess both parameters in parallel to ROS measurements in the 
brain. Measuring the redox state of the CoQ pool is relatively simple using LC-UV, 
which our group has done in the past for Ndi1 flies in collaboration with Prof Placido 
Navas (Scialo et al., 2016a). However, measuring the proton motive force is more 
technically challenging. In fact, in most cases, only one of its components, the 
mitochondrial membrane potential, is assessed. Although measurements of the 
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mitochondrial membrane potential per se are easier to perform, there are still a lot of 
technical difficulties summarised in (Perry et al., 2011). Therefore, similarly to 
mitochondrial ROS measurements, most data have been obtained in vitro using 
isolated mitochondria or cells.  A new method combining MS and click chemistry has 
been recently published showing promising results in the mouse heart (Logan et al., 
2016). Using the same approach in the fly brain will help to determine how 
mitochondrial membrane potential changes during ROS-RET, as well as allowing us 
to confirm the role of FCCP in dissipating the membrane potential and how CIII and 
CIV inhibition affects this parameter.  
 
My experiments involved in the manipulation of CV levels or activity were 
inconclusive. Unexpectedly, the well-characterized CV inhibitor, oligomycin, 
decreased ROS under non-stress conditions and prevented ROS-RET under HS as 
well as in Ndi1 flies. Future work should explore alternative CV inhibitors and 
knocking down other CV subunits, including different components of the F1 and F0 
regions. Alternatively, experiments overexpressing the fly orthologue of ATPIF1 ( 
CG13551) must be repeated. Despite the promising data I obtained, I was not able to 
demonstrate the overexpression of ATPIF1 and neither were the authors that 
generated the UAS-ATPIF1 flies. Therefore these results have not been included in 
my thesis. Making new fly models of ATPIF1 with and without e.g. a GFP tagged 
version to confirm its expression will help to clarify the role of ATPIF1 and CV, in 
mitochondrial ROS production. Experiments involving ATPIF1 are particularly 
relevant due to the many functions ATPIF1 seems to play in cancer and non-cancer 
cells (Garcia-Aguilar and Cuezva, 2018).  
Future work regarding the screen should focus on dissecting how VhaPPA1-1 
triggers ROS-RET. First, I would repeat the ROS experiments with CG7071, to test 
whether its knockdown also triggers RET. Following confirmation, I would test other 
subunits of the V-ATPase, by knocking them down, to observe if they are also 
involved in regulating ROS-RET to identify if this effect is dependent of the activity of 
V-ATPase. Secondly, I would try to dissect the mechanisms, by which V-ATPases 
regulate mitochondrial ROS production. Additionally, I would study the rest of the 
confirmed genes from the AOX screen to identify new regulators involved in ROS-
RET signalling. These experiments must include confirmation that AOX not only 
rescues the lethal developmental phenotype but also reduces ROS in adult flies. 
Finally, I would perform alternative screens using AOX, by targeting families of genes 
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that based on data from the literature affect ROS production. These screens, with 
fewer lines to be studied, will allow the use of different RU486 concentrations to 
titrate AOX expression and the expression of the RNAi construct and different drivers 
to study tissue-specific ROS production.  
 
7.4 Final Conclusions 
In conclusion, in my thesis, I described a physiological method of inducing ROS-RET 
in the fly brain, using HS. To dissect this ROS signal further, I manipulated the levels 
of individual components of the mitochondrial ETC. Here, my results showed that 
maintaining electron flow through CI and CII , of the respiratory chain, is instrumental 
for triggering ROS-RET. Blocking the exit of electrons from the ETC via CIII and CIV 
inhibition increased ROS through an alternative mechanism, excluding RET. The 
effect of CV inhibition of ROS-RET was inconclusive with acute and long-term 
inhibition providing contrasting results. Finally, I performed a genome-wide RNAi 
screen that was successful in identifying new genes involved in the regulation of 
ROS. Using AOX I reported 40 candidate genes, one of which, VhaPP1-1, I 














































Figure 7.2 Diagram displaying the ROS-RET signal. 
 
 
The results of this thesis show that subjecting flies to heat stress, provides the conditions 
needed in order to stimulate ROS-RET physiologically in the fly brain, between 3-5 hours. In 
addition, I have been able to demonstrate that CI and CII are essential for establishing a 
ROS-RET signal. Furthermore, results from a genome-wide RNAi screen were able to 
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